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This study addressed the role of neurokinin] (NKi) receptors in nociceptive transmission and
their participation in a series of events involving glycine and NMDA receptor-mediated
effects on spinal neurones. Using an in vivo electrophysiology protocol utilising ionophoresis
and extracellular recording from laminae III-V dorsal horn neurones of anaesthetised rats,
the mechanisms of these interactions were assessed.
The functions of the inflammatory cytokine leukaemia inhibitory factor (LIF) were also
considered. Injury-induced alterations in the spinal expression pattern of this factor and the
consequences of these changes to neuropeptide and excitatory amino acid expression were
measured using in situ hybridisation.
1. The involvement of NK] receptors in spinal pain transmission may be dependent upon
the duration and intensity of the nociceptive stimulus. Since activation of spinal NK]
receptors leads to increases in the concentration of glycine in the dorsal horn, the role of the
inhibitory glycine receptor as a regulator of NKj receptor function was investigated.
Ionophoretic application of GR82334, a selective NK] receptor antagonist did not alter
activity evoked by cutaneous applications of mustard oil. Flowever in the presence of the
glycine antagonists strychnine or phenylbenzene-co-phosphono- a-amino acid (PMBA),
GR82334 displayed inhibitory properties. Therefore inhibitory glycine receptors may mask
the contribution made by NK] receptors to nociceptive processing. This is discussed with
reference to the role of NK] receptors during brief nociceptive transmission.
2. NK] receptors can contribute to the processing of sustained nociceptive stimuli by
modulating excitatory amino acid-mediated transmission, particularly through potentiation of
NMDA receptor activity. Experiments were carried out to investigate the possible role of the
glycine site of the NMDA receptor (GlyNMDA) and of protein kinase C (PKC) activation to
the NK]/NMDA interaction.
Ionophoresis of the NMDA receptor agonist 1 -aminocyclobutane-m-1,3-dicarboxylic acid
(ACBD) produced a sustained increase in the firing rate of dorsal horn neurones that was
facilitated by the NK] agonist acetyl-[Arg6,Sar9,Met(02)11]-SP6-ii (Sar9-SP). GlyNMDA site
antagonists 2-carboxy-4,6-dichloro-(lH)-indole-3-propanoic acid (MDL 29951), 7-chloro-3-
(cyclopropylcarbonyl)-4-hydroxy-2(lH)-quinoline (L701,252), 5,7-dinitroquinaxoline-2,3-
dione (MNQX) and 7-chlorothiokynurenic acid (7-CTK) or PKC inhibitors, chelerythrine
and GF109203X significantly reduced this facilitation whilst having no effect on activity
driven by ACBD alone. Like the NK] receptor agonist, a selective GlyNMDA site agonist 1-
vm
aminocyclopropanecarboxylic acid (ACPC) also caused facilitation of ACBD-evoked
activity and this was inhibited by the GlyNMDA site antagonist L701,252 in a similar manner.
These data suggest that NKi receptors facilitate NMDA receptor by potentiating the positive
influence of the GlyNMDA site. This may be bought about by the NKi receptor-induced
glycine release and/or by a PKC mediated increase in the sensitivity of the GlyNMDA site.
This demonstrates that co-transmitters released from fine primary afferent fibres may interact
postsynaptically to alter central hyperexcitability, particularly that associated with more
prolonged noxious events.
3. LIF is a neuroactive cytokine that is associated with peripheral nerve injury. Using in situ
hybridisation, the present study has examined the distribution of LIF mRNA in the spinal
cord, normally or following peripheral inflammation or nerve injury and determined the
consequences of intrathecally applied LIF on spinal expression of NK, receptor and the high
affinity glutamate transporter, EAAT2.
In control animals, dorsal horn expression of LIF was high in superficial laminae I-II with
only light expression in the deeper laminae III-V and in the ventral horn. Both peripheral
inflammation and neuropathy significantly increased levels of LIF mRNA in the dorsal horn
and this was most evident in the lateral parts of laminae I and II.
NKi and EAAT2 expression was normally associated with cells in laminae I-II, IV-V and
ventral horn motorneurones. Intrathecal LIF administration significantly increased this
expression for all three mRNAs and resulted in dense hybridisation throughout the dorsal
horn.
These results show that LIF is normally expressed in the spinal cord in a specific laminar
pattern that increases dramatically following peripheral inflammation or nerve damage.
Furthermore, LIF upregulates the expression of NKi receptors and EAAT2 transporters
indicating that it may be a critical regulator of the central changes that occur following
peripheral injury.
Interactions within the spinal cord may underlie the plasticity of the dorsal horn in sensory
processing. This has been discussed with reference to the regulation of short-term co¬
operation between NIG and NMDA receptors by glycine and to long-term modifications of







ACBD 1 -aminocyclobutanc-cA-1,3-dicarboxylic acid
ACPC 1 -aminocyclopropanecarboxylic acid
ACPD 1 -aminocyclopentane-1,3 -dicarboxylate
ALS Amyotrophic lateral sclerosis
AMPA Alpha-amino-3-hydroxy-5-methyl-4-isoxazole proprionic acid
AP7 2-amino-7-phosphonoheptanoic acid
APV 2-amino-5-phosphonovalerate
BDNF-LI Brain derived neurotrophic factor-like immunoreactivity
CaM-KII Calcium/calmodulin-dependent protein kinase II
CDF Cholinergic nerve differentiation factor
CFA Complete Freund's adjuvant
CGRP Calcitonin gene related peptide
CNQX 6-cyano-2,3-dihydroxy7-nitroquinoxaline
CNS Central nervous system
CNTF Ciliary neurotrophic factor
CNTFR CNTF receptor
CPP 4-[3-phophonopropyl]-2-piperazine-carboxylic acid




DNIC Diffuse noxious inhibitory control
DRG Dorsal root ganglion
EAA Excitatory amino acid
EAAT Excitatory amino acid transporter
FA Fast adapting
GABA y-aminobutyric acid
GFAP Glial fibrillary acidic protein
GlyNMDA Glycine site of the NMDA receptor
GLYR Strychnine-sensitive glycine receptor
GLYT Glycine transporter





LCN Lateral cervical nucleus
LI Like immunoreactivity
LIF Leukaemia inhibitory factor
LIF-IF LIF-induction factor
LIF-R LIF receptor
LTD Long term depression
LTP Long term potentiation
MAPK Mitogen activated protein kinase
MDL 29951 2-carboxy-4,6-dichloro-(lH)-indole-3-propanoic acid
mGluR Metabotropic glutamate receptor
MNQX 5,7-dinitroquinaxoline-2,3 -dione






OSM-R Oncostatin M receptor
PBS Phosphate buffered saline
PHA-L Phaseolus vulgaris leuko-agglutinin
PKA Protein kinase A
PKC Protein kinase C
PLC Phospholipase C
PMBA phenylbenzene-co-phosphono- a-amino acid
PPT Preprotachykinin
PSDC Postsynaptic dorsal column
PTX Pertussis toxin
rhLIF Recombinant human LIF
RSA Rat serum albumin
RT-PCR Reverse transciption-polymerase chain reaction
SA Slowly adapting





SPOMe SP methyl ester
SRT Spinal reticular tract
SSC Standard sodium citrate
STAT3 Signal transduction and activators of transcription 3
SIT Spinothalamic tract
TDT Terminal deoxynucleotidyl transferase
TH-IR Tyrosine hydroxylase-immunoreactive
Tm Melting temperature
TNF Tumour necroses factor
Trk A Tyrosine kinase A
TTX Tetrodotoxin
VH Ventral horn





Understanding the neural mechanisms that contribute to the perception of sensation has been
a principal task of sensory physiology. The category of cutaneous sensation has been central
to this issue and since the early 19th century significant advances in the knowledge of brain
systems have been made from this field.
Historically, two major theories on mechanisms of cutaneous sensation have been proposed,
the specificity theory (Muller, 1842) and the pattern theory (Nafe, 1997). The specificity
theory stated that separate specialised nerve endings accounted for each variety of the touch
sensation on the basis that the skin could be mapped into distinct and fixed sensory spots of
differing sensation (Goldscheider, 1987). Early histological evidence of several types of
cutaneous sense organ were then used by the protagonists of this theory as conclusive proof.
However, matches between sensory receptors and sensory spots proposed by Von Frey
(1906) were found to be incorrect and the finding that most tactile stimuli would activate a
large number of sensory units led to the development of the pattern theory (Weddell and
Miller, 1962). This theory states that sensory stimuli are encoded by trains of nerve impulses
and a patterned sequence of nerve activity leads to a learned sensation (Sinclair, 1955), but
the theory is flawed by histological evidence on the existence of specialised sensory
receptors. A further modification, the gate control theory (Melzack and Wall, 1965) tried to
account for this discrepancy by describing central summation of peripheral inputs. It was
suggested that slowly conducting fibres signalling pain were under the segmental control of
fast fibres that gated the information as a continuous process of filtering throughout the
central nervous system (CNS). However, the neuronal circuit proposed by Melzack and Wall
has been challenged and direct experimental evidence for the theory is contentious (Cervero
and Iggo, 1980).
Currently the predominant understanding of cutaneous sensation relies on sensory channels
where each modality of sensation depends upon information transmitted along these
channels (Willis and Coggeshall, 1991). However, the idea of a hard-wired, modality-
specific system of nerve fibres running from the periphery to cortex has attracted much
controversy (Wall, 1996). For example, psychophysical studies have shown that the
perceptual nature of a stimulus can be profoundly altered by the environmental situation
(McGrath, 1994) and in clinical studies it is known that surgical lesions of pain pathways
rarely produce lasting analgesic effects (Gybels and Sweet, 1989). This contextual nature of
1
sensory perception emphasises the plasticity of the somatosensory system and the
complexity of its underlying mechanisms.
1.2 Peripheral Sensory Nerves and Receptors
Peripheral sensory nerves pass information on the intensity, modality and location of a
stimulus to the spinal cord. These nerves have been classified according to their conduction
velocity and hence the diameter and myelination properties of their axons. In cutaneous
nerves, the largest sensory axons belong to the Ap class conducting at 30-100m/s, the small
myelinated fibres are called A8 fibres (4-30m/s) and unmyelinated nerves are designated as
C fibres (less than 2.5m/s) (Willis and Coggeshall, 1991).
A different terminology is used for nerves innervating muscle and joint where myelinated
axons are divided into groups I. II and III and unmyelinated axons, group IV (Willis and
Coggeshall, 1991).
The threshold for electrical excitation of sensory axons is inversely proportional to their
diameter. It is therefore possible to experimentally activate Ap fibres alone, all classes of A
fibre, or all A and C fibres simulating different intensities and modalities of natural
activation. However a further classification of sensory nerves based on receptor properties
gives a more accurate definition of the modality of the fibre.
Cutaneous receptors can be classified into mechanoreceptors, nociceptors and
thermoreceptors. Here only mechanoreceptors and nociceptors will be considered.
1.2.1 Mechanoreceptors
Mechanoreceptors are activated by mechanical and occasionally thermal stimuli. They can
be organised as slowly adapting receptors that discharge continuously during stimulation and
signal stimulation pressure, and rapidly adapting receptors discharging only when a stimulus
is applied and signalling the rate of stimulation or transition (Burgess and Perl, 1973).
There are 2 types of slowly adapting (SA) mechanoreceptors associated with different
receptor structures. SA1 receptors are linked to dome-like Merkel cell complexes (Iggo,
1963) and SA2 receptors have been identified with Ruffini endings located in the dermis
(Chambers et al. 1972). Both of these signal skin deformation.
Rapidly adapting (FA) mechanoreceptors can be further divided upon their location in either
hairy or glabrous skin. There are at least 5 types of cell in hairy skin (tylotrich hairs, down
hairs, field receptors and C mechanoreceptors) signalling velocity (the rate at which skin is
displaced) and transition (the acceleration of the stimulus; guard hairs) and 2 types in
glabrous skin: Meissner's corpuscles (Kruase's end bulb in the cat) for stimulus velocity
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(FA1) and Pacinian corpuscles (FA2) for transients in skin indentation (Willis and
Coggeshall, 1991).
1.2.2 Nociceptors
Nociceptors are free nerve endings that are activated by stimuli that threaten or actually
damage tissue. There are 2 major types of nociceptor, A5 mechanical nociceptors that
respond to mechanical stimuli that damage the skin (Burgess and Perl, 1967) and C
polymodal nociceptors that are activated by noxious mechanical, thermal and chemical
stimuli (Bessou and Perl, 1969). There are also other types of less common nociceptor
including the C mechanical nociceptor (Bessou and Perl, 1969) and the AS mechanoheat
nociceptor (Iggo and Ogawa, 1971). In addition to their transduction of noxious stimuli
many of these receptors may also signal in the innocuous range at lower intensities (Willis
and Coggeshall, 1991).
The response properties of sensory neurones are therefore dependent upon a number of
factors including their degree of myelination, their axonal diameter and the type of sensory
receptor they innervate. However, these responses do not necessarily reflect the perception
of a given stimulus and it is only when the stimulus can be shown to activate a certain fibre
and activity in the fibre correlates with the perceptive quality of the stimulus that the
specificity of the system can be proven (Sinclair, 1981). Recently this assumption was tested
using intraneural microneurography in human subjects (Torebjork and Ochoa, 1980). A
single peripheral nerve was stimulated with a microelectrode and its psychophysical
properties investigated. The electrode was then switched to recording mode and the receptive
field, response properties and conduction velocity of the sensory neurone analysed.
Invariably, the referred receptive field matched with the recorded field and the evoked
sensation correlated with the type of stimulation needed to activate that class of neurone. For
example, repetitive stimulation of a SA1 fibre evoked the feeling of sustained pressure
whereas FA2 fibres (Pacinian corpuscles) evoked a vibration sensation. Importantly, it was
also found that pain could not be generated from mechanoreceptors and required the
activation of either A8 mechanical nociceptors (a sharp pain) or C polymodal nociceptors (a
dull burning pain). These experiments provided substantial evidence that primary afferents
are specific to both stimulus and evoked sensation.
From the periphery, sensory neurones extend to their cell bodies at the dorsal root ganglion
(DRG). DRG cells are usually divided into two categories, large clear cells and small dark
cells and these categories correlate with axon diameter and function (Ramon y Cajal, 1909).
This has led to the characterisation of peptide and enzyme morphological markers for these
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cells on the assumption that differential labelling of small or large cells may help elucidate a
functional role for the markers.
Extending from the DRG to the CNS, the processes of primary afferents are referred to as
dorsal root axons and these branch into a series of rootlets as they approach the cord. Here,
primary afferents terminate in a strict topographical and organisational pattern in the dorsal
horn of the spinal cord.
1.3 The Dorsal Horn
The dorsal horn is the first synapse for incoming sensory information (Figure 1.1). The area
is rich in interneurones and descending inputs exerting both positive and negative effects and
initial processing and modulation of sensory signals may occur here. There are 3 major
functional types of neurone present in the dorsal horn; low threshold (class I) which respond
to only innocuous information, wide-dynamic range (WDR or class II) which respond to
both innocuous and noxious stimulation and high threshold (class III) neurones which are
activated by only noxious inputs (Mendell, 1966; Handwerker et al. 1975; Cervero et al.
1976).
The dorsal horn has a laminar structure that was initially described by Rexed (1952) in the
cat (Figure 1.2). This anatomical classification has since been correlated with physiological
and pharmacological observations and it appears that these laminae are divided on both
structural and functional properties. This study will concentrate on the organisation of
lumbar spinal cord and hence on laminae I-VI which extend from the dorsal surface of the
grey matter towards the central canal.
1.3.1 Lamina I
The neurones of lamina I can be divided into small-unclassified cells and larger marginal
cells that have wide ranging dendrites often elongated in the rostrocaudal direction (Light et
al. 1979). These neurones respond chiefly to noxious stimuli, although some WDR neurones
are also present, and in agreement with this, electrical activation of A5 and C fibres brings
about activity in lamina I (Christensen and Perl, 1970; Handwerker et al. 1975; Cervero et
al. 1976; Menetrey et al. 1977; Rethelyi et al. 1983). Anatomical tracing studies using
retrograde transport of horseradish peroxidase (HRP) or more recently a plant lectin,
phaseolus vulgaris leuko-agglutinin (PHA-L), have also shown that primary afferent
innervation of lamina I consists mainly of small myelinated and unmyelinated fibres (Light
and Perl, 1979; Gobel et al. 1981; Sugiuraeta/. 1986).
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1.3.2 Lamina II
Lamina II, or the "substantia gelatinosa" is characterised by many small cells giving it a
gelatinous appearance (Cervero and Iggo, 1980). These cells have been divided into the outer
most stalked cells and the more central islet cells (Gobel, 1975; Gobel, 1978). At the
synaptic level, neurones of this and deeper laminae often consist of glomeruli -
morphological structures consisting of a central primary afferent terminal surrounded by
dendrites and other axonal terminals (Ralston, 1968; Ralston, 1971). These structures allow
both presynaptic and postsynaptic modification of primary afferent input and may contribute
to modulation of information transfer in the dorsal horn.
Histological studies indicate that unmyelinated fibres form most of the primary afferent input
into lamina II (LaMotte, 1977; Rethelyi, 1977; Ralston and Ralston, 1979; Sugiura et al.
1989) and accordingly electrical stimulation of C-fibres activates lamina II neurones
(Kumazawa and Perl, 1976; Kumazawa and Perl, 1978). However many groups report A8
and even Ap activation of lamina II, although longer latencies indicate that this may be due
to polysynaptic activation (Bennett et al. 1979; Wall et al. 1979; Fitzgerald, 1981). Natural
stimulation of lamina II cells supports the above evidence but some responses may be
subject to more complex form of regulation. For example habituation to repeated
stimulation, strong inhibition and fluctuating receptive field sizes are sometimes seen (Wall
etal. 1979).
1.3.3 Lamina III-VI
Neurones in laminae III-VI increase in size towards the deeper dorsal horn. Lamina III
contains many small cells whilst lamina IV has a more heterogeneous population, laminae V
and VI contain fewer but larger neurones (Ramon y Cajal, 1909; Rexed, 1952). A
characteristic of many of these cells is their dorsally directed projections to laminae I and II
and these interlaminar neurones allow direct input from superficial to deeper laminae (Willis
and Coggeshall, 1991).
Primary afferent input into these areas is predominantly from large myelinated fibres.
Lamina III and IV receive both Ap and A5 fibres and consequently most neurones are class
2 WDR (Kumazawa and Perl, 1977; Menetrey et al. 1977). Many of these myelinated fibres
have specific patterns of innervation; for example inputs from large hair follicles follow a
longitudinal plane whereas inputs from SAII mechanoreceptors are transversely orientated
(Brown, 1981). Laminae V and VI are also innervated by Ap and A8 fibres and both high
threshold (class 3) and WDR neurones are found in this area (Kumazawa and Perl, 1977;
Menetrey et al. 1977; Rethelyi et al. 1982). Afferents from visceral, joint and muscle also
terminate in the deeper dorsal hom (Willis and Coggeshall, 1991).
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1.4 Ascending Somatosensory Pathways
Sensory information passes from the dorsal horn to the brain through ascending sensory
pathways in the white matter. Historically these pathways have attracted both experimental
and clinical interest and consequently a major strategy for pain relief has been to lesion
specific parts of the ascending tracts.
If the spinal cord is divided into three parts through the cross-section a loosely defined
anatomical and physiological classification of the pathways can be made. In the dorsal most
division, the dorsal funiculus (or posterior column in humans) is generally thought to
transmit discrimination, vibration and positional sense and surgical lesions of this area do not
usually relieve pain (Nathan et al. 1986). Further laterally, the dorsal lateral funiculus
(posterior lateral funiculus in humans) contains pathways that convey information similar to
that transmitted in the dorsal funiculus, although in humans, lesions in this area produce little
alteration in perception of sensations. However, in animals, combined interruptions of both
the dorsal lateral funiculus and the dorsal funiculus produce more profound changes
indicating that these areas act together to contribute to sensory discrimination (Nathan et al.
1986). The most ventral section, the ventral quadrant (the anterolateral quadrant in humans)
contributes to pain and temperature sensation. This area has attracted the most interest from
clinical research as lesions here may reduce chronic pain without affecting innocuous tactile
sensation. However cordotomy often only produces temporary pain respite emphasising the
general plasticity of these pathways and the ability of the spinal cord to redirect inputs after
interruption (White and Sweet, 1969).
Specific pathways in each of these areas will be considered.
1.4.1 Sensory Pathways in the Dorsal Funiculus
The dorsal funiculus consists of branches of primary afferent fibres and second order
neurones which belong to the postsynaptic dorsal column pathway (PSDC). The primary
afferents enter the cord through the cervical and lumbar dorsal roots, turn rostrally and
ascend to the dorsal column nuclei, and the PSDC system receives input from the spinal cord
grey matter (Ramon y Cajal, 1909).
1.4.1.1 Postsynaptic Dorsal Column Pathway
Neurones in the PSDC project from laminae III-V of the dorsal horn to the nucleus gracilis
and nucleus cuneatus (Giesler et al. 1984). These neurones have convergent inputs from low
and high threshold cutaneous afferents and are best activated by innocuous stimuli and
strong mechanical stimuli, however very few are activated by noxious heat in the rat
indicating that this pathway is probably not involved in nociception in this animal (Giesler
and differ, 1985). In the cat, PSDC neurones may be low threshold, WDR or high threshold
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cells responding to innocuous and noxious mechanical or thermal stimuli and these cells
have receptive fields on both glabrous and hairy skin (Angaut-Petit, 1975; Brown et al.
1983).
1.4.2 Sensory Pathways in the Dorsal Lateral Funiculus
The dorsal lateral funiculus consists of two major pathways, the spinocervical and
spinomedullary tract. Since the spinomedullary tract is mainly concerned with type I muscle
afferents only the spinocervical tract will be considered here.
1.4.2.1 Spinocervicothalamic Tract
The spinocervical tract (SCT) originates in the dorsal horn and terminates in the lateral
cervical nucleus (LCN). Neurones from this area then project to the contralateral thalamus,
the midbrain or both (Morin, 1955). Using retrograde labelling of HRP injected into the
LCN, it has been shown that SCT cells initially synapse in laminae III-IV of the dorsal horn
and then extend into the dorsal lateral funiculus (Brown et al. 1980).
SCT neurones are activated by electrical stimulation of cutaneous A(3, A5 and C fibres
(Mendell, 1966) and by noxious and innocuous natural stimuli especially hair movement
(Brown and Franz, 1969). However this tract is under tonic inhibitory modulation via
descending fibres such that the proportion of nociceptive responses transmitted by the SCT
increases dramatically when the descending inhibition is reduced (Kenshalo, Jr. et al. 1982).
The receptive fields of these neurones are confined to the hairy skin in the cat and tend to be
small with an adjacent inhibitory field (Hongo et al. 1968). This may serve to enhance the
contrast of inputs and contribute to the tactile discrimination of the very small hair
movements.
1.4.3 Sensory Pathways in the Ventral Quadrant
There are three major pathways in the white matter of the ventral quadrant of the spinal cord.
These are the spinothalamic, spinoreticular and spinomesencephalic tracts.
1.4.3.1 Spinothalamic Tract
The spinothalamic tract (STT) passes sensory information from the dorsal horn to the
thalamus. Using HRP tracing methods, it has become apparent that there are 3 components
of the STT at the lumbosacral level: A projection that originates in lamina I and extends to
the thalamus via the contralateral dorsal lateral funiculus (Willis and Leonard, 1978), a
projection from laminae IV- VI that travels via the contralateral ventral quadrant to the
thalamus (Giesler et al. 1981) and a third component that arises from laminae VII-X and
again ascends through the contralateral ventral quadrant (Giesler et al. 1981; Eccleston,
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1995). Neurones from all 3 components are activated by AP, AS and C fibres but receptive
field properties differ (Foreman et al. 1975; Chung et al. 1979). Lamina I STT cells have
small cutaneous receptive fields and are mostly WDR types with a subpopulation being
thermoreceptive (Willis et al. 1974; Applebaum et al. 1975), whereas Laminae IV-VI STT
cells have larger receptive fields and are usually WDR or sometimes high threshold or low
threshold cells (Chung et al. 1979; Giesler et al. 1981).
Due to their putative involvement in pain transmission, STT neurones have attracted
additional attention as potential analgesic targets. Initial attempts to relieve chronic pain by
surgically lesioning the anterolateral quadrant in humans have produced mixed results. The
current consensus is that this form of analgesia is usually only temporary and is often
replaced by neurogenic pain of a different and sometimes worse quality (White and Sweet,
1969; Tasker and Dostrovsky, 1989). However STT cells are still potential pharmacological
targets and demonstrations that these cells can become sensitised to repetitive input and
contribute to behavioural hyperalgesia emphasises the likely importance of this tract in
nociceptive transmission (Kenshalo et al. 1979).
1.4.3.2 Spinoreticular Tract
The spinal reticular tract (SRT) projects from the spinal cord to the brain stem reticular
formation, which in turn relays information to the thalamus. Most SRT cells are contralateral
to their reticular formation targets and are located in Laminae V, VII, VIII and X with a few
in laminae I and VI (Kevetter and Willis, 1983). SRT cells receiving cutaneous input have
restricted receptive fields and may be low threshold, high threshold or WDR neurones. Many
SRT cells have visceral, muscle or joint inputs (Fields et al. 1977).
1.4.3.3 Spinomesencephalic Tract
Spinomesencephalic tract (SMT) cells project from the dorsal horn to the mesencephalic
reticular formation and the periaquaductal grey matter with some collaterals reaching the
thalamus. There are 2 populations of SMT cells, one that extends from laminae I and the
lateral spinal nucleus through the contralateral dorsal lateral funiculus and another that
originates in laminae V, VII and X and travels through the contralateral ventral quadrant
(Menetrey et al. 1982; Yezierski and Mendez, 1991). SMT cells may be low-threshold, high
threshold or WDR neurones and many of these also respond to noxious heat (Menetrey et al.
1980; Yezierski and Broton, 1991).
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1.5 Descending Inputs to the Dorsal Horn
In addition to primary afferents, intrinsic interneurones and ascending fibres, the dorsal horn
has a significant population of neurones descending from the brain. These exert important
modulatory actions and allow higher levels of the CNS to influence sensory input. Some of
these neurones may have excitatory actions but greater attention has been paid to descending
inhibitory control, particularly tonic inhibition of dorsal hom nociceptive interneurones.
Using reversible cold block, properties of dorsal horn neurones can be examined before and
after the block to ascertain the degree of inhibition (Brown, 1971). It has been found that
nociceptive responses of neurones in laminae I and IV-VI (Wall, 1967; Besson et al. 1975;
Handwerker et al. 1975; Cervero et al. 1976; Duggan et al. 1981) but not those in lamina II
are subject to inhibitory control (Cervero et al. 1979). Lesion studies have identified an
important source of this inhibition as the nucleus paragigantocellularis lateralis and
microinjection of a GABA agonist in this area reduces the inhibition (Foong and Duggan,
1986).
Inhibition can also be evoked in a phasic manner by stimulation of many sites in the brain
including the periaquaductul grey, the raphe nuclei and the locus coeruleus. These
supraspinal sites exert their influence via specific pathways and are often analgesic
(Reynolds, 1969; Oliveras et al. 1974; Segal and Sandberg, 1977).
An important supraspinal loop that brings about a powerful and selective inhibition known as
Diffuse Noxious Inhibitory Control (DNIC) has been observed by Le Bars et al. (1979a and
1979b). They reported that inhibition of WDR neurones occurs after noxious stimuli are
applied to any part of the body or face. It is specific to WDR neurones, is graded according
to stimulus intensity and depends upon ascending pathways in the ventrolateral quadrant
(Villanueva et al. 1986b) and descending pathways in the dorsal lateral funiculus
(Villanueva et al. 1986a). This form of descending control may enhance the contrast of
noxious signals reaching the brain, as DNIC will suppress the activity of WDR neurones
with inactive receptive fields.
The pharmacology of descending inhibition depends upon several inhibitory
neurotransmitters. These include the opioid peptides, serotonin, noradrenaline, dopamine and
the inhibitory amino acids GABA and glycine. Descending pathways probably exert much of
their influence indirectly through excitation of interneurones emphasising the complexity of
the chemical anatomy of these projections (Besson and Chaouch, 1987).
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Figure 1.1
Schematic organisation of the neuronal organisation of the superficial dorsal
horn and its afferent input
A hypothetical transverse section of the dorsal horn is represented, showing the types of
neurones and afferent fibres that terminate there. The receptors, which are associated with
each fibre type, are listed on the left of the diagram. Indicated on the right are the laminar
divisions of Rexed (1952), along with the corresponding anatomical nomenclature. The
neurones schematised are typical of those found in each lamina: (from top to bottom) a
marginal cell, and SG limiting cell, two SG central cells and two neurones of the nucleus
proprius, the most superficial of which has dendrites penetrating lamina II (Cervero and
Iggo, 1980).
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I Outer II Inner III
Marginal zone Substantia gelatinosa Nucleus proprius
IV
Figure 1.2
Schematic drawings of the cytoarchitectonic subdivisions of the segments L1-L6
of the rat spinal cord
The laminar divisions described by Rexed (1952) in the cat spinal cord can also be seen in
the rat (Molander et al. 1984). The dorsal horn consists of laminae I-VI.
CC, column of Clarke; IL, intermedio-lateral nucleus; IM, intermedio-medial nucleus; LSN-
lateral spinal nucleus; Liss, Lissauer's tract; LG-lateral group of large cells in the dorso¬
lateral part of the ventral horn; LM, latero-medial nucleus; MG, medial group of large
neurones in the intermediate zone.
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1.6 Hyperalgesia and Sensitisation
The nociceptive system is unique amongst sensory systems in that is has the capacity to
sensitise to repetitive stimulation. Nervous system responses are enhanced by continued
activity and this leads to behavioural and perceptual changes with a corresponding increase
in the intensity of the perceived pain. This behavioural response is called hyperalgesia and its
physiological correlate is termed sensitisation.
Hyperalgesia is defined as a lowered pain threshold and an increased response to
suprathreshold stimuli, similarly sensitisation is characterised by a lowered neuronal
response threshold and enhanced responses in the suprathreshold range (Treede et al. 1992).
Hyperalgesia can be further divided into primary and secondary types (Lewis, 1942; Hardy
et al. 1950) where primary hyperalgesia refers to an enhancement at the site of injury and
secondary hyperalgesia refers to changes in the surrounding undamaged skin. These types
have different qualitative aspects with regard to the modality of the perceived pain such that
primary hyperalgesia is characterised by enhanced responsiveness to mechanical and heat
stimuli and secondary hyperalgesia is an enhancement to only mechanical stimuli.
Consequently they may also utilise different neuronal mechanisms.
1.6.1 Primary Hyperalgesia
Primary hyperalgesia to heat can be accounted for by the sensitisation of peripheral
nociceptors (Reeh et al. 1986). In hairy skin, this occurs predominantly in C-fibres (LaMotte
et al. 1982) whereas in glabrous skin, A5 mechanical nociceptors become sensitised and
expand their modality range to include heat (Campbell et al. 1979). This sensitisation is
believed to occur through a chemical cascade involving many inflammatory mediators
including histamine, serotonin, bradykinin, substance P and prostaglandins and have been
collectively referred to as an "inflammatory soup" (Handwerker and Reeh, 1991).
In contrast, there is less evidence to suggest that nociceptor sensitisation can fully account
for primary hyperalgesia to mechanical stimulation. Whilst some investigators report that
mechanical sensitisation can be induced by tissue acidosis or injection of inflammatory
mediators (for review see Meyer et al. 1994) the majority of studies suggest that
quantitatively, nociceptor sensitisation cannot readily account for the large changes in
mechanical threshold observed in primary hyperalgesia (see Treede and Magerl, 1995).
Several alternative mechanisms have been suggested, such as expansions of the receptive
fields of A8 fibres to include initially unresponsive branches (Reeh et al. 1987), recruitment
of previously silent afferents that become sensitised and then respond to mechanical
stimulation (Davis et al. 1990), and changes in the response properties of neurones in the
CNS (Laird and Cervero, 1989).
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1.6.2 Secondary Hyperalgesia
The mechanism of secondary hyperalgesia has historically been the subject of controversy.
Arguments have been based upon the location of the mechanism and whether it occurs in the
peripheral nervous system or centrally. The major protagonist for a peripheral site was Lewis
(1942) and using evidence from a series of nerve block experiments he argued for the
existence of a network of "nocifensor" nerves that release substances and sensitise
nociceptors adjacent to the injury site. This theory accords well with the phenomenon of
neurogenic inflammation where cutaneous vasodilatation and inflammation occurs after
antidromic stimulation (Chapman et al. 1961). However, secondary hyperalgesia reflects an
increase in sensitivity to mechanical stimulation and most evidence implies that nociceptors
cannot be sensitised in this way. In agreement with this, Reeh et al. (1986) have
demonstrated that mechanical sensitisation does not occur after antidromic nerve stimulation.
Furthermore, it has recently become apparent that there is no anatomical evidence for a
nocifensor network of nerves and very little support for the idea that secondary hyperalgesia
results from sensitised primary afferents. Instead, current opinion supports the ideas of
Hardy et al. (1950) who proposed that secondary hyperalgesia is mediated via enhanced
sensitivity of central neurones.
Indirect evidence for central sensitisation was first demonstrated by Woolf who reported
changes in the excitability of the hamstring flexor withdrawal reflex after conditioning
stimuli were applied to C-fibres from different origins (Woolf and Wall, 1986). This work
was followed up with studies recording directly from dorsal horn neurones where it was
found that sustained activation of C-fibres modified both the receptive field size and
response properties of central neurones for a prolonged period of time (Cook et al. 1987).
The perceptual counterpart of central sensitisation is an enhanced sensitivity to mechanical
stimulation where low intensity input becomes noxious. For this to occur in the absence of
nociceptor sensitisation there must be either an increased summation of nociceptor input by
central neurones or an enhanced or altered connectivity of low threshold mechanoreceptor
connections in the dorsal horn. Evidence from a study by Torebjork et al. (1992) supports the
latter. Using intraneural microstimulation in humans they demonstrated that weak electrical
stimulation of low threshold mechanoreceptors elicited a tactile sensation in the projected
receptive field. When this field became part of a zone of secondary hyperalgesia, the tactile
sensation was accompanied by pain. This indicated that low threshold mechanoreceptors
were transmitting painful information and mechanoreceptors might have access to high
threshold and/or WDR central neurones during secondary hyperalgesia.
The principal mechanisms of secondary hyperalgesia therefore appear to lie in the plasticity
of dorsal horn neurones. These neurones must be able to increase their receptive field size to
accommodate the extended hyperalgesic zone and enhance their excitability to transmit
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previously innocuous information as painful. It has been demonstrated that STT neurones
maintain these properties and following peripheral injury high threshold neurones develop
sensitivity to low-intensity mechanical input and WDR neurones increase their discharge
(Simone et al. 1991). An essential component of this process may be the complicated
pharmacology of the dorsal hom. Here, interactions between excitatory systems and
disinhibition of negative inputs define the plasticity of these neurones and contribute to the
behavioural changes.
Ma and Woolf (1996) recently described an extension of the demonstrations of Torebjork et
al. on the enhanced connectivity of low threshold mechanoreceptors. They reported that
following peripheral inflammation, light touch or electrical stimulation of rat Ap fibres at 5
minute intervals brought about an incremental increase in the excitability of the spinal cord
that was not seen in normal animals. They called this process progressive tactile
hypersensitivity and stressed that it was quite different from central sensitisation in that it
had a slow build up, relied on activity in AP fibres and was dependent on the presence of
inflammation. Progressive tactile hypersensitivity was further characterised by this group
and shown to be due to a nerve growth factor dependent phenotypic switch in myelinated
sensory neurones (Ma and Woolf, 1997) such that they increased their expression and release
of substance P in the same way as pain fibres (Neumann et al. 1996). This process may
therefore contribute to the enhanced mechanical sensitivity seen in primary and secondary
hyperalgesia.
Central sensitisation is similar to many other kinds of neuronal plasticity in the CNS such as
hippocampal long-term potentiation (LTP) and ocular dominance, however there are some
fundamental differences (Treede and Magerl, 1995). Most importantly, central sensitisation
is a heterosynaptic event i.e. activity in nociceptors alters synaptic efficacy for inactive
nonnociceptive contacts. In contrast LTP is homosynaptic and any heterosynaptic events
must occur simultaneously and will result in long term depression (LTD). Similarly the type
of stimulation required to induce LTP is vastly different from that required to induce central
sensitisation; LTP requires repetitive trains of synchronous input at frequencies of about
100Hz whereas central sensitisation needs only C-fibre input at 1 Hz. Finally the time course
of each type of potentiation is different. LTP may last for weeks after stimulation of only a
few seconds, but central sensitisation is dependent on continued nociceptive input and
decays within hours of cutaneous nerve stimulation. The mechanisms of hyperalgesia are
therefore relatively short and unstable and this is reflected in the physiological role of this
phenomenon, i.e. to promote wound healing by protecting the injured site from further
damage for only the duration of the injury. However there are certain pathological situations
such as neuropathic pain where the pain outlasts the injury and these may also to be due to
altered sensory processing in the periphery and CNS.
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Hyperalgesia is a lowered threshold and enhanced response to painful stimulation and is
caused by both peripheral and central mechanisms. In the CNS, the plasticity of dorsal horn
neurones contributes to the process and this is mediated via pharmacological processes such
as interactions between fast and slow excitatory transmission and disinhibition of negative
inputs. These regulatory aspects will now be discussed with reference to excitatory amino
acids, tachykinin transmitters and the inhibitory amino acid glycine.
1.7 Glutamate as a Neurotransmitter
There is now considerable evidence that glutamate and other excitatory amino acids (EAAs)
such as aspartate are major neurotransmitters eliciting fast excitatory responses in the CNS
(Watkins and Evans, 1981; Mayer and Westbrook, 1987). The first demonstration that
glutamate could depolarise neurones was made in the spinal cord of the cat by Curtis et al.
(1960), however technical difficulties associated with the extensive involvement of
glutamate in cellular metabolism initially hindered its establishment as an excitatory
neurotransmitter. Despite this, histochemical techniques including glutamine uptake assays
(Duce and Keen, 1983) and immunohistochemical localisation of glutaminase (Cangro et al.
1985), glutamine or glutamate itself (Wanaka et al. 1987a; Battaglia and Rustioni, 1988a)
initially demonstrated higher levels of glutamate throughout primary afferents fibres and
dorsal horn interneurones.
In DRG cells, glutamate has been localised immunologically in both small cells and large
cells (Wanaka et al. 1987a; Battaglia and Rustioni, 1988a). More general evidence such as
higher concentrations of glutamate-like immunoreactivity (-LI) in unmyelinated dorsal root
axons (De Biasi and Rustioni, 1988; Westlund et al. 1989), confinement of glutaminase
immunoreactivity to smaller cells (Cangro et al. 1985) and the specific accumulation of
radioactive glutamine by this subpopulation (Duce and Keen, 1983) indicated a more
prominent role for glutamate in small cells. Similarly, in the dorsal horn, glutamate
terminals, axons and cells were found in laminae I-II (Greenamyre et al. 1984; Magnusson et
al. 1986; De Biasi and Rustioni, 1988; Broman et al. 1993) the area of termination for fine
primary afferents. Using double-labelling immunocytochemistry, Battaglia and Rustioni
(1988b) showed that staining for the metabolic marker cytochrome oxidase did not correlate
with glutamate staining and, glutamate-LI was seen in synaptic vesicles in the central
terminals of glomeruli (Maxwell et al. 1990). Overall this evidence supports a
neurotransmitter function for glutamate beyond its metabolic roles.
In agreement with the histochemical data, electrophysiological experiments also implicated a
role for glutamate as a spinal neurotransmitter. Since Curtis et al. first demonstrated that
ionophoretic application of glutamate produced an excitation of dorsal horn neurones, many
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groups have reported similar excitation both in vivo and in vitro (Zieglgansberger and Herz,
1971; Davies and Watkins, 1983; Peet et al. 1983; Jahr and Jessell, 1985; Schneider and
Perl, 1985; King et al. 1988; Yoshimura and Jessell, 1990). Interestingly, these responses
were often most prominent in neurones concentrated in laminae I and II and Schneider and
Perl (1985a and 1985b) demonstrated that these same neurones could be activated by C fibre
volleys. However several of these groups reported that almost all spinal cord interneurones
were responsive to glutamate. This discrepancy may be resolved by the possible influence of
uptake systems on exogenously applied amino acid. Cells and synapses that are not affected
by glutamate might be surrounded by uptake sites that control the concentration of
exogenous agent and reduce the level of excitation. These sites could also exert their effects
under more physiological conditions and participate in the control of glutamate
neurotransmission (Headley and Grillner, 1990).
In addition to their fast effects, there is evidence that EAAs are also involved in long-term
functional changes such as central sensitisation. Spinal application of glutamate produced an
incremental increase in the activity of dorsal horn neurones that altered receptive field sizes
(Zieglgansberger and Herz, 1971) and enhanced neuronal responses to innocuous and
noxious stimulation (Aanonsen et al. 1990b; Dougherty and Willis, 1991b). Similarly, dorsal
horn neurones sensitised by peripheral inflammation showed increased responsiveness to
ionophoretic application of EAAs (Dougherty and Willis, 1992) and intrathecal application
of these compounds produced an increase in the excitability of flexor efferents (Woolf and
Wiesenfeld-Hallin, 1985).
Taken together, the histochemical and electrophysiological data suggest that glutamate has a
more pronounced role in the transmission of nociceptive responses and this is supported by
experiments examining the release of EAAs and from behavioural evidence. For example,
noxious simulation and peripheral inflammation raised levels of extracellular glutamate in
the spinal cord (Skilling et al. 1988; Sorkin et al. 1992), and intrathecally applied EAAs also
produced nociceptive behaviours, (Aanonsen and Wilcox, 1987) secondary hyperalgesia
(Coderre and Melzack, 1991a) and enhanced formalin-induced behaviour (Coderre and
Melzack, 1992). However evidence from some studies supports a role for glutamate in
mediating low threshold inputs. This will be considered below with reference to the receptor
subgroups involved.
1.7.1 Glutamate Transporters
A fundamental requirement for fast and accurate information processing and hence
glutamatergic neurotransmission is the existence of a system to rapidly terminate glutamate
action. Unlike many other neurotransmitters, there is no extracellular enzyme to do this and
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instead a family of uptake carriers or transporters terminates the synaptic action of glutamate
through removal from the synaptic cleft.
Currently, four glutamate transporters have been cloned to form a new gene family with
significant differences from other transporter systems. Excitatory amino acid transporter 1
(EAAT1, also known as GLAST) and EAAT2 (or GLT-1) are located predominantly in glial
cells in the CNS and disruption of these systems leads to a general rise in extracellular
glutamate often resulting in excitotoxicity and cell death. EAAT3 (or EAAC1) is expressed
in neurones throughout the brain and deletion of this molecule can cause epileptiform
seizures. EAAT4, the most recently cloned transporter is located in the cerebellum but its
cellular distribution is not yet known (Rothstein et al. 1994; Fairman et al. 1995; Rothstein et
al. 1996).
All four glutamate transporters share similar mechanisms of glutamate uptake. Briefly, this is
coupled to cotransport of two Na+ into the cell with the counter transport of one K and
either the cotransport of one H or the countertransport of one OH" (Takahashi et al. 1997).
Glutamate transfer may also activate a chloride conductance through the transporter channel
that if located presynaptically, would presumably clamp the terminal at a relatively negative
potential and further reduce glutamate release (Wadiche et al. 1995b; Wadiche et al. 1995b).
During hypoxia or ischemia the fall in brain ATP levels leads to a slowing of the pump that
may eventually result in a reversal and release of glutamate back into the extraceullar space
(Attwell et al. 1993). In transient situations this process is slowed by the accompanying
acidic pH (Billups and Attwell, 1996), but sustained ischemia can lead to excessive
glutamate release and neuronal cell death. Similarly, neurodegeneration associated with
amyotrophic lateral sclerosis (ALS) might also be due to glutamate excitotoxicity. Chronic
excess glutamate has been shown to contribute to selective motorneurone degeneration as a
result of impaired functioning of the EAAT2 type of transporter highlighting the importance
of glutamate regulation and transmitter uptake (Smith and Dewey, 1992).
1.8 Glutamate Receptors
The actions of glutamate are mediated through several receptor subtypes. These are divided
into the ionotropic ligand gated ion channels and the metabotropic G-protein linked
receptors. Further classification based upon pharmacological analysis subdivides these into
the ionotropic NMDA, AMPA and kainate receptors named after their selective agonists, and
the metabotropic groups I-III, organised by signal transduction mechanisms. The molecular
structure of all of these receptors has now been ascertained and this substantiates the
pharmacological data.
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1.8.1 Metabotropic Glutamate Receptors
Glutamate was initially thought to activate only ligand-gated ion channels. However, in
1985, it became apparent that glutamate was able to stimulate phospholipase C (PLC)
presumably through a receptor coupled to a GTP-binding protein (Sladeczek et al. 1985).
This was confirmed in 1987 using the Xenopus oocyte system (Sugiyama et al. 1987) and in
1991 the first metabotropic glutamate receptor (mGluR) was cloned with a functional
expression screening procedure (Masu et al. 1991). Since then, the number of receptors has
grown to include a family of eight, numbered sequentially as mGluRl - mGluR8. MGluRs
are similar to all other G-protein linked receptors in that they have 7 transmembrane
domains. However, they are much larger and do not share any close sequence homology
with that gene superfamily and therefore represent a new class of G-protein-coupled receptor
(for review see Hollmann and Heinemann, 1994; Pin and Duvoisin, 1995).
The amino acid sequence of mGluRs reveals that they can be divided into three groups based
upon sequence homology. Group I consists of mGluRl and mGluR5, group II, mGluR2 and
mGluR3 and group III, all the others. This classification is also supported by their
pharmacology (Houamed et al. 1991; Abe et al. 1992; Tanabe et al. 1992) and respective
transduction mechanisms. Group I receptors stimulate PLC via a pertussis toxin (PTX)
insensitive G-protein (Houamed et al. 1991; Masu et al. 1991) resulting in an increase in
2+
phosphoinositide turnover and Ca release from internal stores (Tanabe et al. 1992). In
addition, these receptors may have auxiliary linkages to adenylyl cyclase signal transduction
and arachadonic acid release (Aramori and Nakanishi, 1992). Group II and III mGluRs
activate a PTX-sensitive G-protein and are linked to the inhibition of adenylyl cyclase (Abe
et al. 1992). The activation of these second messenger systems may result in regulation of
ion channels with either inhibitory or excitatory pre- and postsynaptic effects. These include,
2"b
NMDA, AMPA and GABA-gated channels as well as voltage-gated Ca channels and K
channels, indeed mGluR agonists probably exert slow depolarisations and neuronal
excitation through these types (Pin and Duvoisin, 1995).
MGluRs are distributed throughout the CNS with a degree of regionally specific expression
for each subtype. For example, group I receptors are highly expressed in the hippocampus
(Masu et al. 1991) and mGluR2 and mGluR4 are found in the cerebellum and olfactory bulb
as is mGluR8 (Houamed et al. 1991). Interestingly mGluR8 mRNA is expressed exclusively
in the retina whilst mGluR7 has a widespread distribution (Pin and Duvoisin, 1995).
MGluRs are also present in the spinal cord.
1.8.1.1 Metabotropic Glutamate Receptors and Sensory Processing
Distribution of mGluRs in the spinal cord implies a nociceptive function for these receptors.
Immunocytochemical studies have located Group I receptors in the superficial laminae I-III
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(Fotuhi et al. 1993; Romano et al. 1995) on dendritic profiles targeted by synaptic boutons
with the morphological characteristics of C fibre terminals (Vidnyanszky et al. 1994)
Furthermore mRNA for these receptors is present in these areas indicating that a major
source of receptor is intrinsic interneurones (Shigemoto et al. 1992). Other mGluR subtypes
have not been extensively studied in the spinal cord. However there is evidence that
mGluR7-LI is localised in neurones double labelled with either substance P or the isolectin I-
B4 (Li et al. 1997). The authors of this study suggest that mGluR7 is found on nociceptive
primary afferent fibres.
Electrophysiological and behavioural evidence also implicates a role for mGluRs in
nociceptive transmission. Ventral root potentials evoked by electrical or chemical
stimulation (Boxall et al. 1996) and dorsal horn neuronal responses to joint (Neugebauer et
al. 1994b) and cutaneous inflammation (Young et al. 1994b; Young et al. 1995b) were
reduced by mGluR antagonists as was behaviour induced by peripheral injection of the
algogen carrageenan (Young et al. 1995a). However, formalin induced nociceptive
behaviour was only slightly reduced by a mGluR antagonist whilst it was significantly
facilitated by an agonist (Fisher and Coderre, 1996). This action may reflect an interaction
between metabotropic and ionotropic glutamate receptors. Co-operation between these types
of receptors has been previously demonstrated in isolated dorsal horn neurones (Bleakman et
al. 1992) and in in vivo preparations (Bond and Lodge, 1995), but the relative contributions
of specific cellular mechanisms versus increases in general excitability may complicate the
data (Jones and Headley, 1995). Interestingly, Mellar et al. have suggested that mechanical
hyperalgesia requires an interaction between mGluRs and AMPA receptors whilst thermal
hyperalgesia relies on NMDA receptor activity alone (Meller et al. 1993).
The role of mGluRs in nociceptive processing appears to be confined to situations of spinal
cord sensitisation and they have only a minimal role in transmitting innocuous or brief
noxious inputs. This is in direct contrast to the AMPA and kainate group of glutamate
receptors.
1.8.2 AMPA and Kainate Receptors
The first glutamate receptors to be characterised were ligand-gated ion channels.
Pharmacological identification of these receptors divided them into the NMDA, AMPA and
kainate subtypes named after their respective agonists. However, no glutamate receptor
antagonist clearly distinguished between AMPA and kainate receptors, hence they were
often collectively referred to as non-NMDA receptors.
Recent advances in molecular biology have now determined the structural composition of
non-NMDA receptors and using expression cloning, a total of 9 receptor subunits have been
identified. These are divided into 3 groups of closely related receptor genes comprising of
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AMPA (GluRl-GluR4 each with a flip and flop splice variant) (Hollmann et al. 1989;
Bettler et al. 1990; Boulter et al. 1990), low-affinity kainate receptors (GluR5-GluR7)
(Bettler et al. 1990; Egebjerg et al. 1991; Bettler et al. 1992) and high-affinity kainate
receptors with subunits KA1 and KA2 (Werner et al. 1991; Herb et al. 1992). These subunits
form functional homomeric and heteromeric receptor configurations with distinct functional
2-(-
properties. For example, the Ca permeability of AMPA receptors is regulated via the
GluR2 subunit and receptors consisting of this type are not permeable to Ca2+ (Hume et al.
1991) Likewise, co-expression of GluR6 with KA2 increases the response to AMPA, and
heteromeric AMPA receptors are responsive to kainate (Herb et al. 1992). However, there is
little data on the configuration of native receptors in vivo although there is evidence that the
subunits GluRl-GluR4 can form heteromeric complexes with each other and GluR6 and
GluR7 form native heteromeric complexes with KA2 but not with GluRl-GluR4 (Hollmann
and Heinemann, 1994).
The structure of non-NMDA receptors was believed to be similar to the nicotinic
acetylcholine receptor, however there is no sequence homology between these receptors or
with any other ligand-gated ion channel, including GABA, 5-HT3 or glycine receptors and a
revised model proposed some significant differences. The topology of non-NMDA receptors
is currently believed to contain the usual 4 transmembrane domains, however domain 2 does
not cross the membrane and is located close to the cytoplasmic side (Wo and Oswald, 1994).
As with other ligand gated ion channels, non-NMDA receptors form pentameric structures
(for review see Bettler and Mulle, 1995).
1.8.2.1 Non-NMDA Receptors and Sensory Processing
Due to the functional organisation of DRG cells and of dorsal horn laminae, the distribution
patterns of non-NMDA receptors can give important information on their prospective
sensory processing roles. Whilst there is plenty of data on the location of AMPA receptors,
that for kainate receptors is relatively sparse.
Ligand-binding studies showed that non-NMDA receptors were present in the superficial
dorsal horn extending from laminae I-III (Wrathall et al. 1992; Henley et al. 1993).
Immunohistochemical experiments supported this evidence and gave further information on
subunit distribution. The immunolabelling of the spinal cord revealed that GluRl, GluR2 and
GluR3 subunits were seen predominantly in laminae I,II and III indicating that they may well
receive input from A5 and C fibre nociceptors (Furuyama et al. 1993; Tachibana et al. 1994;
Popratiloff et al. 1996). Furthermore, these receptors were upregulated following peripheral
nerve injury and could therefore contribute to hyperalgesia (Harris et al. 1996). However,
other groups have reported the existence of AMPA subunits in laminae III, in which case
they could mediate Ap fibre input (Kiyama et al. 1993; Martin et al. 1993). At the electron
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microscope level, it has been suggested that GluRl receptors face synapses from
unmyelinated primary afferents and GluR2/3 receptors synapse with fine myelinated fibres
(Popratiloff et al. 1996). This would imply that different subtypes might mediate different
types of sensation.
In situ hybridisation studies broadly agreed with the immunohistochemical data. Generally,
GluRl/2 mRNAs predominated in the dorsal horn and GluR3-4 in the ventral horn
(Furuyama et al. 1993; Henley et al. 1993; Tolle et al. 1993). The cells that expressed GluRl
and GluR2 were mainly in laminae I, II and the upper part of lamina III. GluR2 had a much
higher intensity of expression compared to GluRl and interestingly GluRl expression was
reduced even further following unilateral arthritis with no change to any other subunit
(Pellegrini-Giampietro et al. 1994).
Kainate receptor mRNA was also seen in the superficial dorsal horn using in situ
hybridisation. GluR6 was not expressed, GluR5/7 and KA-1 were weakly detectable and
KA-2 had a stronger signal (Tolle et al. 1993).
Non-NMDA receptor mRNA and immunoreactivity has been seen in DRG cells and
peripheral sensory axons (Sato et al. 1993; Tachibana et al. 1994). There was a marked
distribution in unmyelinated sensory axons suggesting a nociceptive role for these receptors,
however both small and large DRG cells expressed AMPA receptors whilst kainate subtypes
were restricted to small cells. This would imply that AMPA may be involved in the
presynaptic regulation of A(3, A5 and C fibres whereas kainate might regulate just smaller
neurones.
Electrophysiological and behavioural experiments gave a more accurate picture of the role of
non-NMDA receptors in sensory processing. By measuring the latency of different
components of synaptic transmission it become apparent that AMPA and kainate receptors
were involved in monosynaptic pathways in the spinal cord and were therefore believed to
mediate fast synaptic transmission (Jahr and Jessell, 1985; Gerber and Randic, 1989). In
agreement with this, a variety of electrophysiological and behavioural tests demonstrated a
prominent role for these receptors in the transmission of brief noxious inputs. For example,
the non-NMDA antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) reduced dorsal
horn neuronal responses to C-fibre, A5 and AP inputs (Alford and Grillner, 1990; Yoshimura
and Jessell, 1990; Paleckova et al. 1992), innocuous and noxious mechanical stimulation
(Dougherty et al. 1992; Neugebauer et al. 1993), initial and prolonged firing evoked by
peripheral formalin injection (using the antagonist y-D-glutamylglycine) (Haley et al. 1990)
and the development of arthritis induced hyperexcitabiliy (Neugebauer et al. 1993a). In
agreement, peripherally and intrathecally administered non-NMDA agonists (AMPA and
kainate) resulted in behaviour indicative of nociception, and CNQX reversed this effect
(Aanonsen and Wilcox, 1987; Kitto et al. 1992). CNQX also reduced behavioural responses
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to formalin-induced irritation (Nasstrom et al. 1992), carrageenan-induced hyperalgesia (Ren
et al. 1992b) and thermal hyperalgesia elicited by peripheral nerve injury (Mao et al. 1992a)
or by noxious thermal stimulation of the tail. However, there are some reports that non-
NMDA receptors do not mediate the transmission of noxious stimulation. Radhakrishnan
and Henry (1993 a) found that CNQX blocked dorsal hom responses to innocuous hair
movement and not noxious thermal stimulation, and in behaving animals Coderre et al.
(1992) reported that non-NMDA antagonists did not alter responses in the formalin test.
Non-NMDA ionotropic receptors therefore play a complicated role in spinal sensory
transmission, but the majority of evidence has implicated these receptors in the processing of
nociceptive information particularly that of rapid onset and short duration.
1.8.3 NMDA Receptors
The NMDA receptor is a complex molecular entity that represents a class of ionotropic
receptor with unique functional properties (Figure 1.3).
The pioneering work of Moriyoshi et a/. (1991), using expression cloning of a rat forebrain
library, led to the isolation of the first cDNA clone of an NMDA subunit and this was termed
NMDAR1. However, whilst this formed homomeric channels with NMDA receptor
properties in Xenopus oocytes, when expressed in mammalian cells no functional channels
were created. This led to a search for other NMDA receptor subunits, and using low-
stringency hybridisation screening, four more NMDAR cDNAs were isolated (Monyer et al.
1992). These have been called NMDAR2A, NMDAR2B, NMDAR2C and NMDAR2D and
when expressed with NMDAR1, functional receptors are formed in mammalian expression
systems.
Like the nicotinic acetylcholine receptor, NMDA receptor subunits are believed to consist of
four transmembrane domains and form pentameric structures. The subunit stoichiometry of
these ion channels is unknown, but natively expressed receptors are likely to comprise of
NMDAR1 subunits and at least one member of the NMDAR2 class or occasionally two. The
properties of NMDA receptors are altered by different subunit compositions (see below) and
indeed the conformation of each subunit may be influenced by other subunits associated with
it (for review see Sucher et al. 1996). Furthermore, the expression of NMDA mRNAs is
different throughout the brain implying that distinct subunit combinations might contribute
to altered function between anatomical locations. These distribution studies have also
provided evidence that there may be additional NMDA receptor subunits that are
undiscovered at this time. Using in situ analysis it has been shown that the expression of
NMDAR 1 and NMDAR2 do not have a complete overlap in some brain areas (Monyer et al.
1992) and the recent cloning of a homologous novel NMDA receptor-like subunit (Ciabarra
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et al. 1995; Sucher et al. 1995) suggests that the molecular structure of this receptor is more
complex than was originally thought.
The complexity of the NMDA receptor is also reflected in its pharmacology (Figure 1.3). It
is a ligand-gated ion channel, but unlike most other ionotropic receptors, it is permeable to
Na+, K+ and Ca2+ ions (MacDermott et al. 1986) and has a number of distinct recognition
sites for endogenous and exogenous ligands (for review see Scatton, 1993). These include a
2+
recognition site for glutamate, divalent cation binding sites for Mg (Nowak et al. 1984)
2+
and Zn (Westbrook and Mayer, 1987), a binding site for dissociative anaesthetics called
the PCP site (Anis et al. 1983) and modulatory sites for the amino acid glycine (Johnson and
Ascher, 1987) and polyamines such as spermine (Scott et al. 1993). NMDA receptors also
have proton-binding sites (Tang et al. 1990), a redox site (Aizenman et al. 1989) and
2+
consensus phophorylation sites for protein kinase C (PKC) (Greengard et al. 1991), Ca -
calmodulin kinase II (CaM-KII) (Kolaj et al. 1994) and tyrosine kinases (Wang and Salter,
1995).
2+One of the unique properties of the NMDA receptor is its regulation by Mg ions. These
bind in the channel pore in a voltage-dependent fashion and block ionic entry at resting
membrane potential (Nowak et al. 1984). This means that NMDA receptors are generally
relatively quiescent and can only be activated after strong or repetitive stimuli that cause a
relative depolarisation of the nerve cell. It also subserves a function of the receptor as a
logical 'and' gate due to its requirement for both presynaptic release of agonist and
postsynaptic depolarisation, hence it has been used as molecular evidence for Hebb's (1949)
model of synaptic modification (Coan and Collingridge, 1984). This has functional relevance
in area CA1 of the hippocampus where activity-dependent synaptic plasticity may underlie
long term potentiation (Collingridge et al. 1983) and in the developing visual cortex where
synaptic modifications strengthen the stability of simultaneously active inputs (Artola and
Singer, 1987) and weaken the connections between asynchronously active afferents
(Kleinschmidt et al. 1987) leading to ocular dominance. Both of these examples of plasticity
have been shown to be NMDA-dependent by application of selective antagonists.
It would therefore appear that the Mg2+ block would in effect limit NMDA
involvement in normal synaptic events, but since Curtis and Watkins (1960) applied NMDA
to cat spinal interneurones it has been known that NMDA potently activates most central
neurones in vivo. If it is assumed that the voltage-dependence remains constant, this may be
attributed to neurones in vivo having different resting potentials, yet at potentials predicting
2+
maximum Mg block, NMDA can still evoke activity (Headley and Grillner, 1990). Thus in
certain cases, no prior depolarisation is necessary for NMDA-mediated synaptic
transmission, although removal of Mg2+ would presumably amplify the signal. The
importance of the voltage dependence of the block has been further qualified by observations
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2+
that intracellular transduction systems can modulate the extent of Mg binding. Chen and
Huang (1992) reported that in whole cell trigeminal neurone recordings, the action of PKC
2+
increased the dissociation constant for Mg block by nearly fourfold and consequently
NMDA currents were generated at more negative membrane potentials.
Another unusual property of NMDA receptors is their modulation by glycine and this has
particular importance for the present study. The glycine site of the NMDA receptor
(GlyNMDA) was first discovered by Johnson and Ascher in 1987. In Xenopus oocytes
expressing NMDA receptors from the mRNA, the NMDA receptor could not be activated by
glutamate in a glycine-free solution (Johnson and Ascher, 1987). Kleckner and Dingledine
(1988) confirmed that glycine was an essential requirement for NMDA activation and hence
it was termed a co-agonist rather than a positive modulator. The mechanism of interaction
between the glycine site and the EAA site has remained unclear. Electrophysiological data
supports a role in minimising desensitisation of the EAA site, because at low glycine
concentrations NMDA responses are very transient (Mayer et al. 1989), whereas radioligand
binding studies show that a positive allosteric relationship exists (Monahan et al. 1990). In
support of both of these ideas Kemp and Priestley (1991) demonstrated that the GlyNMDA
antagonist 7-chlorokynurenic acid increased NMDA desensitisation in cultured cortical
neurones and binding of the partial agonist (+)-HA966 to the glycine site produced an
allosteric reduction in the affinity of agonists for the glutamate recognition site. The most
recent model reviewed by Corsi et al. (1996) agrees with this data and shows how co-
agonism can affect the potency as well as the efficacy of agonist and antagonist interactions
within the NMDA receptor.
The generation of modulating influences such as Mg2+ block and glycine co-agonism at
NMDA receptors is not constant throughout the nervous system and it is likely that the
subunit conformation regulates these properties. For example, distinct pharmacological
effects can be seen for different subunit combinations such that NMDAR1/NMDAR2B-D
receptors have significantly higher affinities for glycine than the NMDAR1/NMDAR2A
heteromer (Priestley et al. 1995). This is also reflected in CNS cells where there are
differences in glycine binding affinities between cultured cerebellar granule and cerebral
cortex cells (Priestley and Kemp, 1983; O'Shea et al. 1991). Indeed, in a recent study by
Bovetto et al. (1997) it was reported that chronic application of the GlyNMDA partial agonist
ACPC induced changes in the subunit expression of NMDA receptor subunit mRNAs in the
hippocampus and cerebral cortex, such that NMDA receptors developed reduced affinities
for glycine and glutamate. Interestingly, NMDAR1/NMDAR2A-C receptors can be activated
by glycine alone without glutamate binding (Kutsuwada et al. 1992). However, this may
highlight an important discrepancy between recombinant and native NMDA receptors, as
this effect has not been reported in vivo (Scatton, 1993).
26
Very few investigations have questioned the release and dynamics of endogenous ligands to
the GlyNMDA site. In addition to glycine, D-serine (Hashimoto et al. 1992) possesses similar
affinity for the site, but both ligands are present at physiological concentrations (p.M) that
would saturate the GlyNMDA site (nM) (Nagata et al. 1994). Nevertheless, there is evidence
that the site operates in a dynamic range relevant to normal physiology. In the dorsal horn in
vivo, application of glycine potentiated NMDA responses (Budai et al. 1992), in
hippocampal slices NMDA receptors at CA1 synapses were potentiated by increased glycine
concentrations (Minota et al. 1989) and in the cerebellum, NMDA-dependent increases in
cGMP levels were blocked by tetrodotoxin (TTX) in a D-serine-reversible fashion,
suggesting an important presynaptic component that exerts its effect through the GlyNMDA
site (Southam et al. 1991). Furthermore, D-serine-LI was located on glial cells in close
proximity to NMDA receptors (Kehlet, 1995; Schell et al. 1995) and glutamate was shown
to stimulate its release from these cells (Snyder S.H. 1997). These data indicate that
endogenous ligands for the GlyNMDA site must therefore be under the close control of local
clearance mechanisms to reduce concentrations at the level of the synapse (see section
1.10.2).
1.8.3.1 Location ofNMDA Receptors in the Spinal Cord
NMDA receptors are distributed within the superficial dorsal horn from laminae I-III. Thus,
radiolabeled ligands for the NMDA receptor bind in this area (Greenamyre et al. 1984;
Jansen et al. 1990; Mitchell and Anderson, 1991; Shaw et al. 1991) and Co2+, which can be
visualised histochemically, enters laminae I-III cells when NMDA receptors are activated
(Nagy et al. 1994b). This data is also supported by immunohistochemical experiments,
where at the electron microscope level NMDA receptors are localised predominantly on
postsynaptic densities and occasionally in presynaptic terminals (Liu et al. 1994c). The
demonstration that these receptors are also present in DRG cells and peripheral sensory
axons indicates that many of these presynaptic receptors arise from primary afferent
terminals. Indeed, 70% of these cells contain high concentrations of glutamate and therefore
NMDA receptors may be acting as autoreceptors (Liu et al. 1994c).
In situ hybridisation studies have also located NMDA receptor mRNA in the dorsal horn.
One study found NMDAR1 expressed at low levels throughout the grey matter with stronger
hybridisation in the deeper layers (Furuyama et al. 1993). However there are many reports
of abundant signal in almost every dorsal horn cell with increased expression in laminae I-III
(Tolle et al. 1993; Watanabe et al. 1994). NMDAR2 subunits are expressed differentially in
the dorsal horn. Tolle et al. (1993) reported detectable levels of NMDAR2D in the rat
superficial dorsal horn with no NMDAR2A-C labelling. In the mouse, Watanabe et al.
(1994) showed that NMDAR2A (el) was expressed in all laminae except lamina II and
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NMDAR2B (s2) by cells in only laminae II, whereas NMDAR2C (e3) was not expressed in
the dorsal horn and NMDAR2D (s4) was present only early in development.
Substantial evidence therefore exists for the presence of NMDA receptors in the superficial
dorsal horn and since primary afferents terminate in this area NMDA receptors are likely to
play an important role in sensory processing.
1.8.3.2 Role ofNMDA Receptors in Sensory Processing
Whereas AMPA and kainate receptors are believed to be essential components of fast
synaptic transmission bought about by glutamate release, the latency of NMDA-mediated
synaptic transmission suggests that this receptor contributes towards prolonged changes in
excitability evoked by polysynaptic inputs (Davies and Watkins, 1983; Peet et al. 1983;
Schneider and Perl, 1985; Schouenborg and Sjolund, 1986; King et al. 1988; Gerber and
Randic, 1989; Morris, 1989). Nevertheless, electrophysiological and behavioural
experiments have demonstrated a role for NMDA receptors in brief noxious inputs as well as
sustained nociception.
From electrophysiological observations, application of NMDA readily excited dorsal horn
neurones (Anis et al. 1983; King et al. 1988; Sher and Mitchell, 1990; Dougherty and Willis,
1991) with a preferential selectivity for nociceptive types (Aanonsen et al. 1990) and
potentiated neuronal responses to noxious mechanical and thermal inputs (Aanonsen et al.
1990; Dougherty and Willis, 1991). Similarly, in behavioural experiments, intrathecal
injection of NMDA receptor agonists evoked scratching and biting behaviour evocative of
pain (Aanonsen and Wilcox, 1987b; Raigorodsky and Urea, 1987b; Coderre and Melzack,
1991b) and shortened the tail flick withdrawal time to noxious thermal stimulation (Kolhekar
et al. 1993). NMDA receptor antagonists (2-amino-5-phosphonovalerate (APV), 2-amino-7-
phosphonoheptanoic acid (AP7) and 3-(2-carboxypiperazine-4-yl)propylphosphonate (CPP))
also reduced nociceptive responses in a variety of electrophysiological and behavioural tests
investigating noxious thermal and mechanical modalities (Cahusac et al. 1984; Raigorodsky
and Urea, 1990; Nasstrom et al. 1992). However, many groups have reported that a
sensitising stimulus appears to be necessary to evoke an NMDA receptor component and
NMDA receptor antagonists are often ineffective antinociceptive agents during brief noxious
stimuli.
Perhaps the most extensively studied electrophysiological model of sensitisation is the
"wind-up" phenomenon (Mendell, 1966). This is a progressive increase in the excitability of
dorsal horn neurones caused by repeated electrical stimulation of the peripheral receptive
field. The stimulus must have frequencies greater than 0.3Hz and be strong enough to excite
C-fibres and the sensitisation appears to originate centrally since it occurs in the absence of
any increase in the size of the incoming volley. "Wind-up" has at least two components, an
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initial transient phase (that is thought to be A-fibre mediated and is NMDA-insensitive) and
a longer-lasting second phase (that is evoked by C-fibre activity and is blocked by NMDA
antagonists) (Davies and Lodge, 1987; Dickenson and Sullivan, 1990; Thompson et al.
1990). Headley and Grillner (1990) have also suggested a third phase and they reported that
this was likely to be mediated by another neurotransmitter such as a neuropeptide.
NMDA receptor antagonists are also effective at reducing the responses of other
experimental models thought to reflect sustained nociception. Many of these models induce
peripheral inflammation and corresponding increases in the sensitivity of dorsal horn
neurones. For example, topical application of the algogen mustard oil selectively activates C-
fibres and NMDA receptor antagonists blocked reflex facilitation evoked in this model
(Woolf and Thompson, 1991). Similarly, subcutaneous injection of the inflammatory agents
complete Freund's adjuvant (CFA) or capsaicin brings about hyperexcitability of dorsal horn
neurones and this was blocked by both competitive (AP-7) (Dougherty et al. 1992) and
channel-blocking NMDA receptor antagonists (MK-801) (Ren et al. 1992a). Joint
inflammation also sensitises dorsal horn neurones and the NMDA receptor antagonists APV
reduced increased neuronal responsiveness to innocuous and noxious stimuli of the inflamed
knee (Schaible et al. 1991a; Neugebauer et al. 1994a) and the hyperexcitability induced by
acute arthritis (Neugebauer et al. 1993a). Finally, subcutaneous injection of formalin causes
a biphasic increase in neuronal excitability and APV (Haley et al. 1990) did not block the
first transient stage but did inhibit the longer-lasting second stage indicative of sustained
nociception.
Behavioural experiments support the electrophysiological data. Several similar models are
used such as subcutaneous injection of CFA or formalin and behaviours thought to reflect
nociceptive responses are monitored. Coderre et al. have investigated the effects of agents
acting at different sites of the NMDA receptor complex on behavioural responses to
formalin. They reported that much more potent analgesia could be produced by combinations
of channel blockers (such as MK-801) and polyamine site agonists than application of the
same antagonists alone (Coderre and Van Empel, 1994a) and these results help confirm the
allosteric nature of interactions occurring between NMDA receptor binding sites.
Meller et al. (1993) have suggested that the modality of brief noxious inputs is regulated by
different EAA receptors. They reported that brief mechanical nociceptive behaviours were
inhibited only by combinations of AMPA and metabotropic antagonists whilst brief noxious
thermal stimulation was blocked by NMDA antagonists. Following sustained nociception,
such a clear-cut pharmacological definition of these classes of pain is not seen. For example,
peripheral inflammation such as that induced by subcutaneous injection of carrageenan or
CFA leads to both thermal and mechanical hyperalgesia. Ren et al. found that after induction
of inflammation, intrathecally applied MK-801 consistently reduced behavioural responses
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to noxious heat (Ren et al. 1992b) and noxious pinch (Ren and Dubner, 1993). However
Smith et al. (1994) reported that mechanical hyperalgesia was not affected by the same
compound after CFA injection.
NMDA receptors may also play an important role in neuropathic pain resulting from nerve
injury. NMDA antagonists were effective at reducing both thermal hyperalgesia (Davar et al.
1991; Mao et al. 1992) and mechanical allodynia (Smith et al. 1994) associated with loose
ligation of the sciatic nerve. This form of pain is often insensitive to morphine treatment in
humans and the potential effectiveness of NMDA antagonists as analgesics in these
situations is currently being explored. The availability of several clinically tested NMDA
antagonists such as ketamine (a dissociative anaesthetic) and memantine (an adamantane
derivative used for treating spasticity associated with Parkinson's disease) has speeded this
process as the safety profile of these drugs has already been evaluated. Indeed, ketamine
reduced ongoing and touch-evoked allodynia in neuropathic pain (Felsby et al. 1996) and
decreased these symptoms in phantom limb pain (Stannard and Porter, 1993; Rawal, 1995;
Nikolajsen et al. 1996) and neuropathic cancer pain (Mercadante et al. 1995). NMDA
antagonists were also shown to reduce both primary and secondary hyperalgesia in humans
(Ilkjaer et al. 1996) and trials have been performed to assess their effectiveness in reducing
post-operative pain. These compounds were shown to alleviate pain without narcotic-like
side effects (Islas et al. 1985; Chung et al. 1986) although some groups reported that they
produced only marginal and short-term analgesia (Bars and Hanna, 1987; Wong et al. 1995).
Nevertheless, NMDA antagonists have been used in combination with more conventional
opioid treatments where they reduced the requirement of opioids and the danger of
respiratory depression (Wong et al. 1995; Yang et al. 1996).
Most of the NMDA antagonists currently under clinical trials such as ketamine and
memantine are non-competitive channel blockers acting at the PCP site. Alternative
therapies may perhaps result from the use of antagonists acting at other NMDA binding sites
such as the polyamine site or the glycine site; indeed GlyNMDA antagonists are effective
analgesics in a number of animal models of nociception.
1.8.3.3 Role ofthe GlyNMDA site in Sensory Processing
Blockade of the GlyMMDA site alters nociceptive transmission in both electrophysiological and
behavioural protocols. The selective GlyNMDA antagonist, 7-chlorokynurenate inhibited
repetitive stimulus-induced 'wind-up' and late stage formalin responses in dorsal horn
neurones (Dickenson and Aydar, 1991) and reduced the amplification of Ap fibre-induced
responses which occurred after UV burn and was used to model the development of
inflammatory allodynia (Chapman and Dickenson, 1994). In behavioural tests, both normal
tail flick reflexes to noxious heat and those facilitated by NMDA were reduced by intrathecal
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application of the GlyNMDA antagonist ACEA-1021 (Lutfy and Weber, 1996). Partial agonists
and antagonists at the GlyMMDA site (L687,414, D-cycloserine, (+)-HA966, ACEA-1021,
MDL29951, DCPQ) also inhibited pain induced behaviour induced behaviour induced
behaviour induced behaviour induced behaviour induced behaviour induced behaviour
evoked during the second stage of the formalin model in mice and rats (Coderre and Van
Empel, 1994b; Millan and Seguin, 1994b; Lutfy and Weber, 1996b). Furthermore, Laird et
al. (1996) have shown that a GlyNMDA partial agonist (L687,414) and an antagonist
(L701,324) blocked mechanical hyperalgesia associated with the subcutaneous application of
carrageenan.
These observations provide evidence that the GlyMMDA site is occupied in vivo and serves as
an essential modulator of NMDA mediated events in the dorsal horn of the spinal cord.
31
Figure 1.3
Schematic representation of a NMDA receptor
Schematic representation of a NMDA receptor, indicating sites for various agonists,
antagonists, modulators for modifying its activity. The sub-unit drawn on the left
schematically indicates the coiling of the protein required to produce four transmembrane
domains as well as extracellular N- and C-termini. Only two of the five subunits required for














The tachykinins are a family of structurally related peptides characterised by their common
carboxyl terminal sequence Phe-X-Gly-Leu-Met (Figure 1.4). The family includes substance
P (SP), neurokinin A (NKA, also known as substance K), neurokinin B (NKB, also known as
neuromedin K), neuropeptide K (NPK) and neuropeptide y (NPy). These ligands are
distributed widely in the CNS and peripheral tissues and evoke a variety of biological
activities including neuronal excitation, vasodilatation and smooth muscle contraction.
The mammalian tachykinins are derived from two peptide precursor genes designated
preprotachykinin A (PPT-A) and PPT-B which are likely to have evolved from a common
ancestor gene (Nawa and et al. 1983; Kotani et al. 1986; Krause et al. 1987). Alternative
RNA processing gives rise to multiple forms of mRNA for both genes (Nawa and et al.
1984). PPT-A produces 3 variants termed a-PPT-A, P-PPT-A and y-PPT-A. SP is encoded
by all three genes, NKA by P and y-PPT-A, NPK by P-PPT-A and NPy by y-PPT-A (Nawa
and et al. 1983). PPT-B gives rise to two variants, both of which code for NKB (Kotani et al.
1986). Since the proportion of a-PPT-A expression in the CNS is very low (0.5% of total
PPT-A expression), SP should therefore almost always be expressed in combination with
other p and y-PPT-A gene products.
The tachykinins exert their effects through three receptors called the neurokinin] (NK]), NK2
and NK3 receptors. Radioligand binding displacement assays (Yokota et al. 1989; Shigemoto
et al. 1990) have shown that SP preferentially activates the NK] receptor at two orders of
magnitude higher than NKA and NKB. Similarly, the NK2 receptor is activated by NKA one
order of magnitude higher than NKB and two orders of magnitude higher than SP and the
NK3 receptor shows preferential binding of NKB two orders of magnitude higher than NKA
and SP. This evidence implies that there is a degree of interaction between different ligands
and receptors. However in most physiological situations, NK, receptors will be activated by
SP, NK2 receptors by NKA and NK3 receptors by NKB.
Tachykinin receptors were initially isolated in 1987 using expression cloning of the bovine
NK2 receptor (Masu et al. 1987). This led to the cloning of cDNAs for rat NK] and NK3
receptors using a similar functional assay combined with cross-hybridisation to the bovine
NK2 receptor (Sasai and Nakanishi, 1989; Yokota et al. 1989; Shigemoto et al. 1990). These
three receptors show considerable sequence homology, share the common structure of seven
transmembrane domains and are linked via G proteins to phosphoinositide metabolism
(Watson and Downes, 1983; Nakajima et al. 1992) (Figure 1.4). They also have significant
sequence similarities to other G protein-coupled receptors such as muscarinic acetylcholine




The mammalian tachykinin system consists of three distinct peptides: substance P,
neurokinin A and neurokinin B, that bind to NKi, NK2 and NK3 receptors respectively and
share the common carboxyl-terminal sequence, Phe-X-Gly-Leu-Met-NH2 (A). Tachykinin
receptors possess seven transmembrane domains with extracellular amino termini and
cytoplasmic carboxyl termini and are linked via G proteins to phosphoinositide metabolism
(B). Red circles in (C) indicate the conserved amino acids of the three tachykinin receptors
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1.9.1 Substance P and NKj Receptors
SP has traditionally been regarded as the classical spinal pain transmitter and there is
abundant evidence supporting this role. However, despite the availability of selective NK,
receptor antagonists, the therapeutic value of this receptor to analgesia has not been realised
and this is reflected in the experimental data. Investigations into the precise nature of SP and
NK! receptor involvement in nociceptive processing have revealed varied and sometimes
inconsistent results emphasising the complexity of SP and NKi receptor function in sensory
transmission.
1.9.1.1 Location ofSP and NKj receptors in the Spinal Cord
SP-LI and PPTA mRNA has been detected in dorsal root fibres and laminae I, II, V-VII and
X using immunohistochemistry, immunocytochemistry and in situ hybridisation (Hokfelt et
al. 1975; Hokfelt et al. 1977; Hokfelt et al. 1980; Gibson et al. 1981; Warden and Young,
3d, 1988; Harlan et al. 1989). Nerve section and dorsal rhizotomy largely but not entirely
reduced this distribution, hence it is likely that the SP-LI was derived from primary afferents,
intrinsic neurones and descending fibres (Jessell et al. 1979; Ogawa et al. 1985). In
agreement with this, neonatal capsaicin application destroyed most C-fibres and also reduced
SP-LI by approximately 55% (Moussaoui et al. 1992).
At the electron microscope level, Weiya et al. (1996) have analysed the types of neurone that
SP-LI boutons are apposed to. They reported that high threshold dorsal horn neurones
received most SP-LI appositions followed by WDR and then low threshold neurones and that
one third of all appositions displayed a synaptic contact. This data indicates that a direct
correlation exists between the amount of SP-LI input and the nociceptive nature of the cell
and importantly suggests that SP can act at NK, receptors close to the site of release.
Changes in dorsal horn and primary afferent SP-LI and mRNA have been observed
following peripheral injury. For example, nerve injury decreased PPT-A gene expression
(Marchand et al. 1994; Sommer and Myers, 1995; Munglani et al. 1996) whereas increases
in mRNA were seen after subcutaneous formalin or CFA injection (Minami et al. 1989;
McCarson and Krause, 1995). Similarly, adjuvant-induced arthritis increased the number of
SP-immunoreactive fibres in the dorsal horn (Kar et al. 1994). In agreement with this data,
studies investigating the release of SP have also reported increases following peripheral
stimulation.
Experiments using spinal cord perfusion as a method of measuring SP release have shown
that it was released following electrical stimulation of high threshold primary afferent fibres
and noxious heat applied to the hind limbs (Go and Yaksh, 1987). However this method has
limitations in its accuracy and a clearer picture can be seen from studies using push-pull
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cannulae and microdialysis. With this technique it was found that noxious mechanical and
severe thermal stimuli increased SP release (Kuraishi et al. 1989), but greater increments in
SP levels were measured following stimuli that caused damage to peripheral tissue.
Accordingly, injection of formalin also increased release of SP in the dorsal horn (Kuraishi
et al. 1989). However, McCarson and Goldstein (1991) have reported decreases in SP-
immunoreactivity using this model and they suggested that this was due to intrinsic
antinociceptive systems inherent to more sustained nociception.
SP release has also been measured in the spinal cord using the antibody microprobe
technique to give both spatial and temporal discrimination. SP was detected in the superficial
dorsal horn following peripheral noxious heat, mechanical or chemical stimulation or
electrical stimulation at C-fibre strength (Duggan et al. 1988). However, it was again
apparent that tissue damage is a much more effective stimulus and after the development of
peripheral inflammation such as that produced by arthritis (Schaible et al. 1990),
compression or flexion of the injured area produced a massive release of SP over a wide
area. Interestingly, a similar distribution of SP-LI was also reported after microinjection of
the peptidase inhibitor kelatorphan (Duggan et al. 1992) or of calcitonin gene related peptide
(CGRP) (Schaible et al. 1992), which can both slow the degradation of SP. This highlights
an important component of SP function. If it can spread away from its release site after
sustained nociception, possibly under the endogenous control of CGRP, then both the gain
and the duration of incoming signals might be increased. Furthermore, neurones receiving
inputs from adjacent tissue may also be affected and these could potentially contribute to
secondary hyperalgesia. Therefore it is likely that under certain conditions, the primary
function of SP is not to transmit brief noxious information, but to alter the response
properties of dorsal horn neurones to subsequent inputs.
The distribution of NK) receptors has also been studied in detail. Radiolabeled SP bound to
postsynaptic cells in laminae I and II (Quirion et al. 1983; Helke et al. 1986; Yashpal et al.
1991; Nasstrom et al. 1992) and this was altered by peripheral stimulation. Brief noxious
inputs decreased the binding after 1 minute due to competition by the endogenous ligand
(Yashpal et al. 1994) whereas sustained forms of nociception such as inflammation or
peripheral nerve injury raised levels of bound SP presumably as a result of postsynaptic
receptor upregulation (Yashpal et al. 1991 a; Aanonsen et al. 1992a; Kar et al. 1994a).
Immunohistochemical observations of NKi receptor distribution do not agree with the
autoradiographic data. In these studies, NKj receptor-LI was located in laminae I and III-V
but not in laminae II (Bleazard et al. 1994; Liu et al. 1994; Nakaya et al. 1994). This lack of
staining was quite striking, but is supported by physiological and in situ hybridisation
observations where few lamina II cells respond to or make the NKi receptor (Kiyama et al.
1993; Bleazard et al. 1994). Nevertheless, at the electron microscope level, NK] receptor-LI
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outlines somata and major dendrites of dorsal horn neurones in laminae III, IV and to some
extent V, which have dendrites that extend into laminae II and presumably act as targets for
SP released in this area (Brown et al. 1995; Nairn et al. 1997). Furthermore, many of these
cells are likely to project via the STT to the thalamus and may be nociceptive in nature
(Marshall et al. 1996). Liu et al. (1994a) reported that these heavily labelled membranes
make direct synaptic contact with SP terminals in only about 15% of cases indicating that
much of the transmission in this area could be due to diffusion of the ligand. However Nairn
et al. (1997) observed a higher proportion of synaptic contact and they suggested that whilst
some of this might be important in maintaining a degree of secure synaptic contact with
deeper neurones, much could be attributed to glutamatergic transmission as glutamate is
often co-localised with SP.
Upregulation of NK] receptors after inflammation and nerve injury was also seen with
immunohistological techniques (Abbadie et al. 1996). Interestingly, this did not necessarily
correlate with alterations in SP levels which were reduced after nerve injury. Furthermore,
increases in NKi receptor-LI occurred over a wide area and extended into the contralateral
side of the cord (Abbadie et al. 1996). NK] receptor upregulation may therefore contribute to
the central sensitisation of dorsal horn neurones under conditions of persistent pain.
The activation of NK] receptors by endogenous ligand, or exogenous agonist has recently
been visualised in vivo using confocal microscopy. This is dependent upon the phenomenon
of receptor endocytosis, exhibited by all G protein-linked receptors. Activation of the
receptor leads to rapid internalisation from the membrane into endosomes with a resulting
desensitisation during which time the receptor is recycled. Mantyh et al. (1995a) first
demonstrated this phenomenon for NK] receptor immunoreactive receptors in rat striatum in
vivo. They found that injection of SP bought about massive internalisation of NK] receptor-
LI and reorganisation of the morphological characteristics of NK] receptor immunoreactive
dendrites. This occurred after one minute and recovered within sixty minutes. The technique
has also been applied to the dorsal horn where noxious stimuli evoked a marked endocytosis
on dendrites in laminae II that was graded with respect to the intensity of the stimulus (Pook
et al. 1993; Mantyh et al. 1995). Furthermore, peripheral inflammation increased the degree
of receptor internalisation such that near-maximal endocytosis was induced in cells in
laminae I and III-VI following mechanical stimulation after inflammation (Abbadie et al.
1997).
In situ hybridisation localisation of mRNA for NK] receptors showed a low distribution in
the superficial dorsal horn and lamina III (Elde et al. 1990; Kiyama et al. 1993). However
CFA or formalin-induced inflammation caused a considerable upregulation of NK, receptor
mRNA throughout the superficial and deeper layers (Schafer et al. 1993; McCarson and
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Krause, 1994) that was blocked by prior administration of opioid agonists (McCarson and
Krause, 1995).
Evidence concerning the location of NK, receptors on primary afferent is contradictory. NK]
receptor-LI did not decrease in the dorsal horn after dorsal rhizotomy, and DRG cells did not
label for NKt receptor-LI, NK! mRNA or radioactive SP binding (Brown et al. 1995).
However, a significant number of cutaneous sensory axons were immunolabelled for the
NKi receptor (Carlton et al. 1996b). This contradiction has not been resolved (for review see
Coggeshall and Carlton, 1997).
1.9.1.2 Role ofSP and NKt receptors in Sensory Processing
There is a large body of both behavioural and electrophysiological evidence implicating SP
and NK| receptors in sensory processing in the dorsal horn.
Ionophoresis of SP into the dorsal horn evoked neuronal activity (Henry, 1976;
Zieglgansberger and Tulloch, 1979) and selectively activated high threshold and WDR
laminae I and II neurones (Randic and Miletic, 1977) resulting in a characteristic slow
postsynaptic depolarisation (Urban and Randic, 1984; Randic et al. 1988). In agreement,
intrathecal application of SP was shown to evoke scratching and biting behaviour indicative
of pain in a number of studies (Hayes and Tyers, 1979; Hylden and Wilcox, 1981; Piercey et
al. 1981). However, NKi antagonists were generally not effective at reducing responses to
brief noxious stimuli (Fleetwood-Walker et al. 1987b; Fleetwood-Walker et al. 1990b). They
did not alter baseline nociceptive reflex activity (CP96345 and RP67580) (Laird et al. 1993),
single C-fibre volleys (CP96345) (De Koninck and Henry, 1991; Chapman and Dickenson,
1993) and in some cases sustained C-fibre stimulation in normal animals (CP96345 and
RP67580) (Thompson et al. 1994). Similarly, behaviour induced by SP and neuronal and
behavioural responses to more natural stimuli, such as brief noxious pinch and acute noxious
thermal stimulation of the tail or paw, were generally not affected by NK, antagonists
(CP96345, CP99994, RP67580, SR140333, WIN51708 and WIN62577) (Malmberg and
Yaksh, 1992; Yamamoto and Yaksh, 1992; Couture et al. 1993; Garces et al. 1993; Picard et
al. 1993; Seguineta/. 1995).
Nevertheless some groups do report effective NK! mediated analgesia in these tests. For
example, Radhakrishnan and Henry (1991) and De Koninck and Henry (1991) found that
CP96345 reduced dorsal horn responses to brief noxious stimuli and Holland and Goldstein
(1994) showed that NKi receptor desensitisation (through administration of high doses of
SP) reduced phasic but not tonic pain behaviours. In these situations though, the difficulties
in maintaining standardised experimental procedures is highlighted. For instance the
intensity and duration of brief noxious stimuli may differ between groups, and antagonist
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specificity is often questioned, especially as CP96345 has Ca channel blocking effects that
could interfere with any direct NK, receptor antagonism (Seguin et al. 1995).
It has become apparent that SP and NK] receptors may have a more prominent role in
sustained nociception. From behavioural experiments, a number of models have been used to
test for NK! receptor involvement. These include the measurement of pain induced
behaviours evoked by intraperitoneal injection of acetic acid (Garret et al. 1991; Seguin et
al. 1995) and intraplantar injection of capsaicin (Sakurada et al. 1993a; Sakurada et al.
1993a), carrageenan (Nagahisa et al. 1992; Yamamoto et al. 1993; Traub, 1996) or formalin
(Charriaut-Marlangue et al. 1991; Murray et al. 1991; Yamamoto and Yaksh, 1991; Yashpal
et al. 1993; Seguin et al. 1995). NK, antagonists (CP96345, CP99994, PR67580, SR140333,
WIN51708, WIN62577, GR82334 and D-pro-SP) were usually antinociceptive in these more
sustained tests. However, these antagonists were found to be ineffective at increasing paw
withdrawal latencies to noxious mechanical and thermal stimuli following chronic
constrictive nerve injury (Yamamoto and Yaksh, 1992) or carrageenan-induced hyperalgesia
(Young et al. 1995a).
Sluka et al. (1997a) and Traub (1996) investigated the differential contribution of NK,
receptors to the development and maintenance of hyperalgesia. Using intraarticular injection
of carrageenan and kaolin as a model, Sluka et al. (1997a) demonstrated that spinal NK,
receptors were essential for the maintenance of thermal hyperalgesia whereas peripheral
receptors were involved in the development of this state. However, Traub (1996) reported
that spinal NK, receptors were also important during the initial stages of thermal and
mechanical hyperalgesia evoked by subcutaneous carrageenan or, spontaneous pain
behaviours induced by formalin. He suggested that NK, receptors could contribute to the
generation of hyperalgesia but the additional presence of NMDA receptor activation was
needed to maintain the sensitisation. The variability between these studies probably reflects
the differences in the models used.
In electrophysiological protocols, SP enhanced the responses of WDR and high threshold
neurones to repetitive C-fibre strength stimulation (Kellstein et al. 1990) and paralleled the
increase in duration and magnitude of the flexor reflex evoked by C-fibre conditioning
stimuli (Wiesenfeld-Hallin, 1986). Furthermore, NK, antagonists ([D-Pro2,D-Trp7'9]-SP,
CP96345 and RP67580) blocked both the SP-induced (Wiesenfeld-Hallin, 1986; Kellstein et
al. 1990) and electrically-conditioned elevated responses of these tests (De Koninck and
Henry, 1991; Xu et al. 1992; Laird et al. 1993), reduced an NK, receptor-mediated
component of wind-up (Kellstein et al. 1990b; Thompson et al. 1993b) and blocked the high
frequency, high intensity induction of C-fibre evoked LTP (Liu and Sandkuhler, 1997).
Similarly, Thompson et al. (1994) reported that whilst CP96345 did not affect ventral root
41
potentials in an in vitro hemisected spinal cord preparation taken from normal rats, it did
reduce this response in animals sensitised by a UV burn to the cutaneous receptive field.
NK, receptor antagonists are also effective at reducing neuronal responses to inflammatory
stimuli. Dorsal horn activity evoked during the second stage of response to subcutaneous
formalin injection was blocked by NK, antagonists (RP97580) (Chapman and Dickenson,
1993) as was the in vivo sensitisation of primate STT neurones by peripheral application of
capsaicin (GR82334 and CP96234) (Dougherty et al. 1994). However NKi antagonists did
not reduce capsaicin-induced sensitisation in an in vitro spinal cord preparation (CP96234)
(Urban et al. 1993) or neuronal responses to cutaneous application of the algogen mustard oil
(GR82334 and L668169) (Munro et al. 1993). Therefore, like the behavioural data, both the
intensity and mode of nociceptive model may be crucial in defining an NKi receptor
involvement in sustained nociception.
In addition to the above pharmacological approaches of addressing the role of spinal NK,
receptors in nociception, two recent studies have used new methods to explore NK, receptor
function. Hua et al. (1998) investigated the effects of intrathecally administered NK,
receptor antisense oligonucleotides on nociception and Mantyh et al. (1997) assessed
nociceptive responses in rats following ablation of lamina I neurones expressing SP
receptors. Hua et al. (1998) reported that there was no reduction of pain behaviour or
immunostaining of NKi receptors after repeated intrathecal treatment with antisense
oligonucleotides. However, spinal application of SP in these animals caused a reduction in
the behavioural response to formalin and in NK, receptor immunoreactivity. These results
suggested that under quiescent conditions the half-life of NK, receptors was relatively long
and unless the receptors were challenged by a stimulus of sufficient strength to cause
internalisation (and subsequent degradation) then reduction in the ability to synthesise new
protein by antisense oligonucleotides would not be apparent. Similarly, Mantyh et al. (1997)
demonstrated that by infusing a conjugate of SP and the ribosome-inactivating protein
saporin into the spinal cord, receptor internalisation allowed the toxin to enter cells and
inactivate and ultimately kill lamina I neurones expressing SP receptors. This treatment left
responses to mild noxious stimuli unchanged but markedly attenuated responses to highly
noxious stimuli and thermal and mechanical hyperalgesia induced by capsaicin application.
Both of these investigations therefore support a role for NK, receptors in the transmission of
sustained or severe stimuli and show that mild pain can be dissociated from severe or
hyperalgesic pain by the apparent lack of NK, receptor involvement.
Much of the reviewed evidence implicates the NK, receptor as a sensitising agent rather than
a pain transmitter. Dirig and Yaksh (1996) directly tested this assumption by examining the
change in nociceptive threshold under three different thermal stimuli after intrathecal
administration of SP. They found that an NK, receptor antagonist increased paw withdrawal
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latencies to noxious thermal stimulation at all intensities, but that this change remained
directly proportional to the withdrawal latency of untreated animals for each stimulus
intensity investigated. They therefore suggested that SP was not acting through an additive
mechanism via a fixed increase in excitation, but elevated the gain of spinal nociceptive
neurones and thus functioned as a sensitising agent.
SP and agonists at NKi receptors have also been demonstrated to have inhibitory affects.
Ionophoresis of SP or the NKi agonist SP methyl ester (SPOMe) into the superficial dorsal
horn inhibited non-nociceptive responses of deeper dorsal horn SCT cells whilst leaving
nociceptive responses unaffected (Fleetwood-Walker et al. 1988b; Fleetwood-Walker et al.
1990b). Davies and Dray (1980) reported that administration of SP into laminae II initially
inhibited and then enhanced responses to noxious thermal stimuli in two thirds of laminae I,
IV and V neurones whilst depressing the activity of the remaining neurones and not affecting
innocuous stimulation. Mixed effects were also reported in primate STT cells where SP
caused excitation and inhibition of glutamate driven activity, background activity and
noxious pinch stimuli (Willcockson et al. 1984), and in rat and cat laminae IV-V WDR
neurones where a GABAergic inhibitory interneurone was suggested to mediate SP
inhibitory actions (Ryall and Pini, 1987).
Intracellular recordings from in vitro spinal cord slice preparations support the in vivo data.
Murase and Randic (1984) have shown that bath-applied SP evoked a hyperpolarising
response in one third of dorsal horn neurones that was blocked with either TTX or high
2+ 2+
Mg , low Ca solutions. This suggests that the action of SP was either indirect though an
inhibitory interneurone or involved presynaptic inhibition of primary afferents, however the
lack of anatomical evidence for presynaptic NKi receptors supports the former hypothesis.
An alternative mechanism for SP inhibition has been proposed by Larson et al. (1994). They
reported that a metabolite of SP, the N-terminal fragment (1-7) (SP(i_7)), had inhibitory
actions on dorsal horn neuronal responses to nociceptive stimuli. This compound had
opposite properties to SP and was demonstrated to inhibit C fibre evoked-flexor reflexes
(Goettl et al. 1994), reduce acetic acid-evoked writhing behaviour (Kreeger et al. 1994),
inhibit amino acid release (Skilling et al. 1990) and initially decrease and then facilitate
NMDA receptor-evoked activity (Hornfeldt et al. 1994). Furthermore, SP(1.7) down-regulated
NKi receptor binding via an mechanism not directly associated with NIG receptor activation
(Yukhananov and Larson, 1994). SP(i.7) is a potential candidate for SP induced inhibition,
but the ability of selective NKi agonists to also inhibit neuronal responses suggests that the
mechanism probably occurs directly via NKj receptor activation.
The main role of SP and NKi receptors in sensory processing therefore appears to be as a
modulator of nociceptive transmission. A wide variety of studies including behavioural,
electrophysiological, anatomical, and investigations into the release of SP, support this
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function and provide little evidence for a direct role in the transmission of brief noxious
inputs. However, it is not yet known how the NK| receptor sensitises neurones to subsequent
inputs and what mechanisms limit its involvement to this process. This study is concerned
with those mechanisms and they will be discussed with respect to positive interactions
between NKi and NMDA receptors and inhibitory regulation via strychnine-sensitive glycine
receptors.
1.9.2 Other Tachykinins
There is only a small body of evidence on the distribution and role of other tachykinins in the
dorsal horn and this is effectively limited to investigations on NKA and NKB and their
respective receptors, NK2 and NK3.
NKA and NKB have both been located in the spinal cord. NKA coexists with SP (Dabgaard
et al. 1985) but concentrations of NKA have been shown to be significantly higher in the
central terminals of primary afferents than SP (Bakhle and Bell, 1995). Furthermore, levels
were reduced by half following neonatal capsaicin treatment supporting its role as a primary
afferent neurotransmitter (Moussaoui et al. 1992).
The release of NKA has been investigated using the antibody microprobe technique. Duggan
et al. (1990) reported that NKA was released following noxious thermal and mechanical
stimuli but unlike SP, NKA was relatively resistant to enzyme degradation. Therefore it was
detected widely in the spinal cord and persisted for sixty to ninety minutes following
peripheral nerve stimulation (Hope et al. 1990a). Additionally, NKA has been detected
immediately after joint injection with carrageenan and kaolin when it again had a widespread
presence in the spinal cord (Hope et al. 1990b).
Very few studies have examined the precise localisation of NKB in the dorsal horn. It is not
present in DRG cells and the distribution of PPT-B mRNA is restricted to laminae I-IV and
X (Ogawa et al. 1985; Moussaoui et al. 1992). Furthermore, neonatal capsaicin or sectioning
of the dorsal roots did not alter NKB-LI suggesting that it is not a primary afferent
neurotransmitter (Ogawa et al. 1985; Meldrum, 1992).
NK2 and NK3 receptors are also present in the spinal cord and are located postsynaptically
from primary afferents (Yashpal et al. 1991a). Radioligand binding studies have located NK2
receptors in a thin band across the dorsal part of the dorsal horn (Yashpal et al. 1990) and
NK3 receptors in laminae I-III (Ninkovic et al. 1984). MRNA for NK2 receptors was
detected in spinal cord using blot hybridisation analysis but as yet, no results on NK2
receptor expression have been reported from in situ hybridisation studies (Takeda and
Krause, 1991). In contrast, mRNA for NK3 receptors has been localised in spinal cord using
in situ hybridisation (Tsuchida et al. 1990) and this was reported to increase following
adjuvant or formalin induced nociception (McCarson and Krause, 1994).
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Ionophoresis ofNKA into the dorsal horn evoked a slow and prolonged increase in the firing
rate of all types of dorsal horn neurones including low threshold cells (Salter and Henry,
1991). NKA also depolarised spinal neurones in in vitro preparations (Matsuto et al. 1984)
and Nagy et al. (1993) reported that only capsaicin-sensitive laminae II-IV neurones were
affected by NK2 agonists. Furthermore, capsaicin-induced responses in these neurones were
inhibited by NK2 antagonists (MEN10376) (Nagy and Hunt, 1982; Nagy et al. 1993).
Thresholds of behavioural responses to noxious thermal stimuli were also reduced by
intrathecal application of NK2 agonists (Picard et al. 1993a) and Yashpal et al. (1996)
demonstrated that this elevation was blocked by antagonists of NK2 (SR4896) but not NK,
receptors and similarly, SP-evoked behavioural changes were only blocked by NK,
antagonists (CP96345). Therefore NKA appears to act only at NK2 receptors in the spinal
cord and SP is specific for NKi receptors.
Experiments with NK2 antagonists (MEN10376, MEN10207, GR103537 and R368) suggest
that these receptors mediate both brief and sustained nociceptive transmission, especially
that of a thermal nature (Santucci et al. 1993a; Yamamoto et al. 1993a; Seguin et al. 1995a;
Sluka et al. 1997a). Many studies have investigated the effects of NK2 antagonists on
electrically-evoked activity. Otsuka et al. (1995) and Nagy et al. (1994a) showed that slow
prolonged ventral root potentials induced by C-fibre stimulation were sensitive to NK2
antagonists and Thompson et al. (1993a and 1994) reported that unlike the NK, receptor,
NK2 antagonists reduced C-fibre potentials both before and after a UV-induced burn to the
cutaneous receptive field. The nociceptive flexor reflex has also been studied extensively as
a model for NK2 receptor involvement and it has been reported that adjuvant-induced
increases in the reflex were reduced by NK2 antagonists (Jia and Seybold, 1997) as was the
development of mechanical allodynia caused by muscle (and not cutaneous) C-fibre
conditioning stimuli (Ma and Woolf, 1995).
NK2 receptors are also important in the spinal transmission of more natural stimuli. For
example NK2 antagonist (SR48968) reduced dorsal horn neuronal responses to noxious and
innocuous stimulation of the normal and inflamed joint (Neugebauer et al.
1996).Furthermore NKA facilitated (Fleetwood-Walker et al. 1990a), and an NK2 antagonist
(L659874) inhibited (Fleetwood-Walker et al. 1993) activity evoked by cutaneous noxious
heat and not mechanical stimulation of the skin. Unlike NKi antagonists these antagonists
were also effective at blocking neuronal responses to peripheral application of mustard oil
(Munro et al. 1993).
Behavioural experiments support the electrophysiological evidence and NK2 receptors have
been implicated in models exploring thermal nociception (Fleetwood-Walker et al. 1990a),
the second phase of formalin evoked behaviour and responses induced by intraperitoneal
acetic acid (Seguin et al. 1995). Additionally, Sluka et al. (1997a) showed that whilst NK]
45
receptors were involved in the maintenance of heat hyperalgesia caused by intraarticular
injection of kaolin and carrageenan, spinal NK2 receptors were essential for its development.
This evidence supports a role for NKA and NK2 receptors in nociceptive processing in the
dorsal horn, but unlike SP that may act as a sensitising agent, NK2 receptors are likely to
mediate the transmission of brief noxious inputs.
1.10 Glycine as a Neurotransmitter
Glycine is an amino acid with many metabolic functions throughout the nervous system. It is
also a neurotransmitter in the vertebrate CNS where it serves two distinct functions, an
excitatory modulatory role via NMDA receptors (section 1.8.3) and an inhibitory action at
the strychnine-sensitive glycine receptor.
This inhibitory function was first demonstrated in the late 1960s by Curtis et al. (1967) who
showed that glycine depressed spinal neurones when applied ionophoretically. Initial
disagreement as to the specificity of glycine and the inhibitory amino acid y-aminobutyric
acid (GABA) for their selective receptors came for the work of Davidoff and Aprison
(Davidoff and Aprison, 1969; Davidoff et al. 1969). However Curtis et al. (1969) maintained
that glycine bound specifically at the strychnine-sensitive receptor. It has since been
confirmed that glycine is released in a calcium-dependent manner (Hopkin and Neal, 1970)
and acts at postsynaptic sites to generate IPSPs through an increased CI" conductance that
can be antagonised competitively by strychnine (Barker and Nicoll, 1973).
1.10.1 Glycine Transporters
Like the EAA glutamate, rapid termination of the synaptic actions of glycine is achieved by
the uptake of transmitter into surrounding presynaptic terminals and glial cells.
Two types of glycine transporter belonging to the GABA transporter gene super-family have
been cloned to date (Liu et al. 1993): GLYT1, which exists as two variants GLYTla and
GLYTlb, and GLYT2 that shares approximately 50% amino acid homology with GLYT1.
Both transporters share similar mechanisms of glycine uptake which involves the transfer of
Na+ and CI" ions with a stoichiometry of 2 Na+:1 CI": 1 glycine (Aragon et al. 1987). This
transfer can also be modulated by PKC, which leads to a decrease in glycine uptake
(Gomeza et al. 1995; Sato et al. 1995).
Interestingly, GLYT1 and GLYT2 have different distributions throughout the CNS. GLYT1
is located in glial cells in the spinal cord, brainstem, cerebellum, thalamus, hypothalamus
and hippocampus (Zafra et al. 1995a; Zafra et al. 1995a) whereas GLYT2 is expressed in
presynaptic terminals and glia exclusively in the spinal cord, brainstem and cerebellum
(Luque et al. 1995; Zafra et al. 1995; Zafra et al. 1995). Furthermore, GLYT1 protein has
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been localised with NMDA receptors in the hippocampus and is often found in areas devoid
of inhibitory glycinergic transmission (Smith et al. 1992; Zafra et al. 1995; Zafra et al.
1995). This raises the possibility that GLYT1 regulates glycine concentrations at NMDA
receptors and GLYT2 is associated with inhibitory strychnine-sensitive receptors.
1.10.2 Strychnine-Sensitive Glycine Receptors
The strychnine-sensitive glycine receptor (GlyR) is a pentameric structure consisting of two
types of transmembrane subunit, the 48KDa a subunit and the 58KDa p subunit. These
subunits have significant sequence homology with those of the nicotinic acetylcholine
receptor and consequently the GlyR is classified as a member of the superfamily of ligand
gated ion channels (Betz et al. 1994).
To date, three different genes encoding a subunits of this receptor have been cloned in rats
with a variety of splice variants and these form functional receptors in Xenopus oocytes of
variable stoichiometrics. In contrast, incorporation of the P subunit usually generates a
stoichiometry of 3a:2p (Kuhse et al. 1993) which may reflect the endogenous situation in
vivo. It is proposed that the a subunit contributes to the ligand binding site of GlyRs
(Langosch et al. 1994) whereas the P subunit may have more of a prominent role in ion
channel function (Pribilla et al. 1992). Furthermore, P subunits have been shown to co-
distribute with the protein gephyrin in the CNS (Kirsch et al. 1993a). This protein is believed
to anchor the GlyR to both microfilaments and microtubules (Kirsch and Betz, 1995), and its
association with the P subunit suggests that both polypeptides may interact in vivo. Indeed
inhibition of gephyrin expression by antisense oligonucleotides prevented the formation of
GlyR clusters (Kirsch et al. 1993b) and this correlates with the mouse mutant spastic that
lacks synaptically-located receptors due to incorrectly spliced P mRNA (Becker, 1990).
Therefore the P subunit and gephyrin may be essential for the correct placement of glycine
receptors in the neuronal membrane. However it has become apparent that gephyrin is not
exclusively associated with GlyRs and may also localise with GABA receptors at non-
glycinergic synapses (Todd et al. 1995).
2+
GlyRs can be modulated by a number of other agents as well as glycine. Zn ions have been
shown to have a biphasic effect and potentiate CI" entry at low concentrations and inhibit at
high concentrations (Bloomenthal et al. 1994). GlyRs are also phosphorylated by a number
of compounds including enhancement of response by protein kinase A (PKA) (Vaello et al.
1994) and (CaM-KII) (Wang and Randic, 1996) and inhibition by PKC (Vaello et al. 1994).
This underlies the plasticity of these receptors in many physiological and pathological
processed including spinal nociceptive transmission.
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I.10.2.1 Location ofGlycine and GlyRs in the Spinal Cord
Glycine is involved in metabolic as well as transmitter functions in the CNS. However it
appears to be present in higher concentrations in those areas important to synaptic
transmission, especially in the spinal cord, strengthening evidence for its role as a
neurotransmitter.
In the rat dorsal horn, glycine-LI has been located in laminae I-III with predominant staining
in laminae III (Todd, 1990). At the subcellular level glycine-LI was observed, co-localised
with GABA (Spike and Todd, 1992; Mitchell et al. 1993; Todd et al. 1996) presynaptically
at axodendritic and axosomatic synapses and also at axo-axonic synapses where the
postsynaptic boutons appeared to be on myelinated primary afferents (Todd, 1990; Todd et
al. 1991). Furthermore, many immunoreactive dendrites were postsynaptic to type II
glomeruli that are usually associated with myelinated axons (Todd, 1996). This evidence
implies that glycine may be involved in monosynaptic processing of Ap type afferents.
In the monkey however, the situation appears to differ slightly. Carlton et al. (1996a) have
demonstrated that glycine-LI is distributed mainly in laminae III-VII with some light
staining in laminae I and II. Importantly, they also found no evidence of axo-axonic type
glycinergic synapses indicating that whilst primary afferents can activate glycine systems,
there is little presynaptic control by glycine on monkey primary afferents.
Radioligand binding studies indicate that GlyRs are distributed throughout the CNS but are
concentrated in the spinal cord and brainstem. In the dorsal horn, binding occurs in laminae
II, III and V (Zarbin et al. 1981). Immunocytochemical observations broadly agree with the
binding data and GlyR-LI has been reported in laminae II, HI, IV and V with a noticeable
absence in the predominantly nociceptive laminae I (Araki et al. 1988; Basbaum, 1988). At
the electron microscope level, GlyR-LI is almost always confined to synaptic locations
associated with axodendritic and axosomatic synapses. Interestingly, and in contrast to
reports of axo-axonic distribution of glycine-LI (Todd, 1990; Todd et al. 1991), GlyR
labelling has not been observed on axo-axonic connections or on primary afferent
membranes (Mitchell et al. 1993) indicating that is does not appear to function as an
inhibitory auto-receptor on these neurones.
In situ hybridisation studies have localised mRNA for a and p subunits of GlyRs in laminae
II-VIII (Fujita et al. 1991; Malosio et al. 1991; Sato et al. 1991) and much of this
hybridisation occurs on glial cells (Kirchhoff et al. 1996). In contrast with binding and
immunocytochemical studies, GlyR mRNA has also been detected in DRG cells. These
neurones are mostly large diameter and also contain mRNA for GABA receptors (Furuyama
etal. 1994).
Physiological and pathological alterations to dorsal horn neuronal morphology have been
associated with glycinergic transmission. For example, noxious stimulation evoked by
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peripheral subcutaneous formalin injection evoked increases in c-fos immunoreactivity in
many glycinergic neurones (Todd et al. 1994), and trans-synaptic degeneration of the
superficial dorsal horn associated with peripheral nerve injury was increased by strychnine
application (Sugimoto et al. 1989; Sugimoto et al. 1990). Furthermore, ALS induced
motorneurone cell death dramatically decreased GlyR binding in the anterior grey matter and
this may further accelerate the symptoms of this disease (Flayashi et al. 1981).
1.10.2.2 The role ofGlycine and GlyRs in Sensory Processing
In addition to its excitatory effect at NMDA receptors, ionophoretic application of glycine is
known to reduce spinal neuronal responses in vivo (Curtis et al. 1967) and in vitro (Barker
and Nicoll, 1973). Consistent with this data, intrathecal application of strychnine, a specific
inhibitory glycine receptor antagonist, evoked scratching and biting behaviour indicative of
pain in rats (Beyer et al. 1985) and strychnine poisoning in humans is known to evoke
intense pain that is paralleled by significant increases in sensitivity to innocuous stimuli
(Perper, 1985).
An increased sensitivity to innocuous mechanical stimuli, or allodynia, forms the basis of a
model of hyperalgesia developed by Sosnowski and Yaksh (1990) where intrathecal
administration of strychnine brings about allodynia and receptive field expansion in rats.
Characterisation of this model revealed that strychnine caused an enhanced neuronal
response to hair deflection, enlargement of the low threshold receptive field and an increased
neuronal afterdischarge. Moreover, these changes only occured in dorsal horn cells activated
by both hair deflection and by high intensity mechanical stimuli, suggesting that the
inhibitory modulation was associated with large fibre-mediated nociceptive states which
resulted from removal of tonic inhibition of hair afferent input onto convergent neurones
(Yaksh, 1989; Sherman and Loomis, 1995; Sherman and Loomis, 1996; Sorkin and Puig,
1996).
The pharmacology of strychnine induced allodynia (and presumably of the convergent
neurones that receive glycinergic input) has been investigated extensively. Importantly, this
model of hyperalgesia was insensitive to morphine and p-opiate receptor agonists (Yaksh,
1989; Sorkin and Puig, 1996) but it was blocked by NMDA and AMPA antagonists, nitric
oxide synthase inhibitors, guanylate cyclase inhibitors and adenosine agonists (Sosnowski
and Yaksh, 1989; Onaka et al. 1996). The lack of effect of conventional analgesic agents on
this form of nociception has important implications for the therapy of morphine-intractable
pain and suggests that removal of inhibitory circuits may contribute to these states.
Glycine has also been implicated in other nociceptive systems. For example, Sivilotti and
Woolf (1994) have demonstrated that intrathecal strychnine increased the nociceptive flexor
reflex in a similar way to C-fibre conditioning stimuli, suggesting that the reflex was under
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the control of segmental inhibitory mechanisms. Furthermore, Peng et al. (1996) and Lin et
al. (1994) have shown that periaquaductal grey-induced descending inhibition of STT
neurones involves a glycinergic mechanism that was reduced during central sensitisation by
PKC-mediated phosphorylations (Lin et al. 1997).
Inhibitory control may also be an important component of neuropathic pain. Autotomy, a
behavioural response that is associated with injury discharges from damaged sensory fibres
was significantly increased by application of strychnine (Seltzer et al. 1991) and following
sciatic nerve constriction injury, glycine levels (measured by HPLC) increased in the dorsal
hom (Satoh and Omote, 1996). Intrathecal application of glycine also attenuated mechanical
and thermal hyperalgesia in this model (Simpson et al. 1996; Simpson et al. 1997) whereas
strychnine enhanced responses (Yamamoto and Yaksh, 1993; Sorkin and Puig, 1996).
Interestingly, Simpson et al. (1994 and 1997) have reported that inhibition of thermal and
mechanical hyperalgesia by glycine was differentially blocked by NMDA antagonists. They
have shown that NMDA antagonists failed to block the antinociceptive effects of glycine on
mechanical allodynia whereas they did block the influence of glycine on thermal responses.
Inhibitory glycine receptors may therefore be important regulators of excitatory input during
normal transmission. However, removal of this tonic inhibition can unmask inappropriate
connections and contribute to an increase in spinal cord excitability.
1.11 Receptor Interactions and Spinal Sensory Processing
Interactions between different receptor systems and their signalling mechanisms form the
basis of our current understanding of plasticity in somatosensory processing. Anatomical
studies on the co-localisation of different agents and behavioural and electrophysiological
analysis of these distributions has revealed that both negative and positive influences
modulate incoming signals and exert rapid and profound effects on the excitability of the
dorsal horn. The present study has addressed the role of NKi receptors in spinal nociception
and their participation in a series of interactions involving the release of glycine. The actions
of this amino acid at either inhibitory GlyRs or excitatory NMDA receptors may therefore
differentially regulate the role of NKt receptors during nociceptive events.
1.11.1 Interactions Between NKj Receptors and Glycine
Most evidence on the role of NKi receptors in sensory transmission suggests that they play
little part in mediating responses to brief inputs but act as sensitising agents to increase the
gain of dorsal horn neurones after sustained nociception (see section 1.9.1.2). It is not yet
known if a specific mechanism exists to exclude their involvement from acute nociception or
whether this latency of action can be attributed to slow degradation or slow spread of SP to
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NK] sites some way from the release site. However, brief inputs were not enhanced by the
application of agonists directly onto dorsal horn cells (Fleetwood-Walker et al. 1987; De
Koninck and Henry, 1991; Malmberg and Yaksh, 1992; Yamamoto and Yaksh, 1992;
Couture et al. 1993) indicating that NK, receptors might be under some form of regulation.
This is also supported by observations that NKi agonists often inhibited neuronal responses
both in vivo (Davies and Dray, 1980; Willcockson et al. 1984; Ryall and Pini, 1987;
Fleetwood-Walker et al. 1988; Fleetwood-Walker et al. 1990) and in vitro (Murase and
Randic, 1984) and that intrathecally-applied SP was actually antinociceptive at low doses
(Masuyama et al. 1996). The apparent lack of NKj receptor involvement in acute responses
may therefore be due to the co-activation of an inhibitory mechanism by SP.
Littlewood et al. (1995) have investigated the extent of GABA and glycine-LI in neurones
expressing NK! receptors. They reported that in lamina I, none of these cells were GABA or
glycine-immunoreactive although some cells in laminae III-V did stain for both receptor and
inhibitory ligand. They concluded that most neurones that were activated by SP were
excitatory in the dorsal horn. However, this evidence does not preclude the existence of an
inhibitory mechanism activated by SP. Indeed increased glycine release was detected
following bath application of SP in vitro (Kangrga and Randic, 1990; Maehara et al. 1995)
and after microdialysis of SP into the spinal cord in vivo (Smullin et al. 1990b). Furthermore,
intrathecal administration of glycine has been shown to inhibit SP-evoked scratching and
biting behaviour (Beyer et al. 1989). Taken together this data indicates that an inhibitory
interneurone may well be activated at some point down line of NK, receptor activation,
presumably after SP acts on an excitatory neurone.
This model therefore predicts that NK) receptor activation of a glycine interneurone would
initially obscure an NKi excitatory input. However, the accumulation of lasting intracellular
changes such as phosphorylations and NMDA receptor activation would eventually
overcome the acute inhibitory modulation. Consequently, effects of NKi antagonists would
not be apparent following brief noxious stimuli but in those situations where the stimulus
was more severe and led to sensitisation, the combination of intracellular changes and
increased SP release would eventually lead to a direct, measurable NKi receptor effect.
1.11.2 Interactions Between NK, Receptors and NMDA Receptors
NMDA and NKi receptors have been shown to play important individual roles in sensory
processing, but there is also evidence that during sustained nociception a synergistic
interaction develops between them. It is probably the most extensively studied receptor
interaction in the dorsal horn and stems from observations that glutamate and SP coexist in
DRG cells (Battaglia and Rustioni, 1988b) and primary afferent terminals in the superficial
laminae (De Biasi and Rustioni, 1988). This led to suggestions that they are co-released
following noxious stimulation and act together at NK, and NMDA receptors to contribute to
neuronal sensitisation.
A facilitation of glutamate-evoked activity in dorsal horn neurones by SP was first reported
by Zieglgansberger and Tulloch in 1979 (1979). Randic et al. (1990) demonstrated a similar
phenomenon in isolated dorsal horn neurones in vitro and showed that SP both reduced and
potentiated NMDA responses without affecting AMPA or kainate current. Furthermore,
Dougherty and Willis (1991a and 1995) found that NMDA-induced activity in identified
STT cells was facilitated by SP administration in vivo for a number of hours and this
paralleled an enhancement of responses to mechanical stimulation of the skin indicative of
sensitisation. Later studies by the same group (Dougherty et al. 1993a) also reported
excitation and inhibition of NMDA and AMPA responses by SP and whilst NMDA
alterations could be blocked by NK, antagonists, reductions in AMPA-evoked activity were
unaffected by these antagonists.
Experiments investigating behavioural responses have also described an interaction between
NMDA and NK, receptors. For example, kainate, AMPA and NMDA all evoked caudally
directed biting and scratching when applied intrathecally, but this was significantly increased
by co-administration with SP, especially responses to NMDA (Mjellem-Joly et al. 1991).
Similarly NK] receptor agonist-induced facilitation of the tail flick reflex was blocked by
NMDA antagonist (APV) (Yashpal et al. 1991b), although Okano et al. (1993) reported that
NMDA-evoked biting and scratching behaviour was not inhibited by NK] antagonists
(CP96345) even though NK] receptor agonist evoked behaviour was reduced by NMDA
antagonists (APV).
Several studies have addressed the role of the NMDA and NKj receptor interaction in a
number of different models of nociception. For example, behavioural responses to a variety
of stimuli including subcutaneous formalin (Murray et al. 1991; Mjellem-Joly et al. 1992) or
capsaicin injection (Okano et al. 1994), and hyperalgesia caused by repeated cold stress
(Okano et al. 1995) were blocked more significantly by co-administration of NMDA (APV)
and NK] receptor antagonists ([D-Pro2,D-Trp7'9]-SP, [D-Pro4,D-Trp7'9'10,Phe11]-SP(4.ii) and
CP96345) than application of these antagonists alone. Furthermore, subthreshold doses of
NK, (CP96345) and NMDA (MK-801) receptor antagonists reduced the electrically-evoked
flexor reflex and in the same study SP facilitation of this reflex was blocked by NMDA
antagonists (Xu et al. 1992a). Co-administration of NMDA and SP also facilitated A8-
evoked dorsal horn responses and the development of wind-up (Chapman et al. 1994) and
slow nociceptive ventral root potentials have been shown to rely on both NMDA and NK,
receptors to generate a full response (Woodley and Kendig, 1991).
There is also evidence against a specific synergistic NMDA/NK, interaction and some
investigations have reported only an additive effect. Cumberbatch et al. (1995 a) addressed
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this question by cycling the ionophoresis of selective NK, and EAA agonists into spinal
cord. They reported that application of an NK, agonist (GR76362) enhanced responses to
AMPA, kainate and NMDA equally whilst an NK2 agonist (GR64349) reduced AMPA
evoked activity and did not change NMDA responses. It was suggested that the NK, receptor
mediated facilitation was simply due to a general increase in excitability (hence the similar
increase in AMPA-evoked activity). Nevertheless, they argued that in a physiological
situation, co-release of NKA with SP would reduce AMPA receptor activity and bias
transmission towards NMDA receptors. However, the data they presented showed that NKi
agonist facilitation of NMDA responses was still clearly greater than facilitation of AMPA
and kainate activity indicating that the NMDA/NK, interaction could be fully accounted for
by a simple additive process. Cumberbatch et al. (1995) also investigated the effects of
ionophoreses of NK, receptor antagonists on EAA responses to assess the importance of
tonic facilitation. They found that NK, receptor antagonists (CP99994 and GR82334)
preferentially reduced kainate, AMPA and then NMDA responses whilst the NK2 receptor
antagonist GR159897 increased kainate evoked activity. These results implied that there was
a tonic release of endogenous tachykinins that could modulate glutamatergic transmission in
the spinal cord, furthermore the effects of the NK, antagonists appeared to resemble the
actions of NK2 agonists on EAA-evoked responses. It was suggested that this effect could be
attributed to the limited selectivity of tachykinin receptors for their ligands. Since SP and
NKA could theoretically act at both NK, and NK2 receptors, by blocking the NK,
component, synaptically released SP and NKA might have acted at the NK2 receptor and
mimicked the effects of NK2 agonists.
Baranauskas et al. (1995) have reported a similar additive interaction between NMDA and
NK, receptors in the ventral horn. Recording intracellularly from motorneurones following
dorsal root stimulation they showed that in this population of cells, NK, receptor antagonist
(SR140333) reduction of NMDA receptor activity could only be attributed to excitability
changes and not to a specific co-operation. Behavioural investigations by Ren et al. (1996)
also supported this data. They used isobolographic analysis of drug effects where a
theoretical additive line for a combination of the two drugs was calculated and compared
with individual and combined administrations. It was found that co-application of NMDA
and NK, antagonists reduced thermal hyperalgesia induced by CFA but that this was no
different from the predicted additive value.
These experiments have demonstrated that the NMDA/NK, interaction may not always be a
synergistic process. However there is a large body of evidence on the mechanisms of this
interaction that indirectly support co-operation between the receptors. Much of this data
involves the possible participation of intracellular signalling systems and the
phosphorylation of NMDA receptors. One known consequence of activating an NK, type
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receptor is the activation of PKC and both Rusin et al. (1993a) and Urban et al. (1994a) have
shown that this 2nd messenger activated enzyme contributes to NKi receptor agonist-induced
facilitation of NMDA receptor activity. Furthermore PKC has been implicated as a
sensitising agent for dorsal horn neurones (Munro et al. 1994; Peng et al. 1997; Sluka and
Willis, 1997) emphasising the important physiological consequences of co-activation of
NMDA and NKi receptors. Other 2nd messengers may also be involved in the NMDA/NK,
interaction. Blockers of nitric oxide production (Radhakrishnan and Henry, 1993b;
Bjorkman et al. 1994b; Coderre and Yashpal, 1994b) and arachidonic acid (Malmberg and
Yaksh, 1992b; Coderre and Yashpal, 1994b) reduced both behavioural and
electrophysiological responses to co-administration of NMDA and NK, agonists.
Many investigators have considered enhanced release of ligand as a mechanism for receptor
co-operation and SP has been shown to increase concentrations of glutamate both in vitro
(Kangrga et al. 1990; Kangrga and Randic, 1990) and in vivo (Smullin et al. 1990a) where
release is further enhanced following nerve injury (Skilling et al. 1992). Liu (1997) have
investigated NMDA receptor regulation of SP release from primary afferents. They
demonstrated that injection of NMDA into the cerebrospinal fluid enhanced NKi receptor
internalisation, which was significantly reduced by an NK] receptor antagonist. They
therefore suggested that activation of presynaptic NMDA receptors and increased release of
SP was the mechanism for co-operation between NMDA and NKi receptors. In support of
this hypothesis, Marvizon et al. (1997) showed that NK! receptor internalisation produced by
high frequency stimulation of the dorsal roots was also blocked by NMDA receptor
antagonist whilst AMPA and kainate antagonists had no effect. Nevertheless, much of this
evidence is circumstantial. For example, SP release could be the result of an indirect action
of NMDA receptors and there is little anatomical evidence for the existence of functional
presynaptic NMDA receptors on primary afferent nociceptors. Indeed, in a recent study by
Aicher et al. (1997) it was reported that the NMDA receptor was usually postsynaptic to SP-
containing axons (252/324 neurones). Furthermore a postsynaptic locus of interaction is
supported by the experiments of Randic et al. (1990) who demonstrated a facilitation of
NMDA activity by SP in isolated single postsynaptic dorsal horn neurones.
This study has addressed the role of the GlyNMDA site in the NMDA/NK! interaction. It is
proposed that an NK! induced increase in glycine concentration (see section 1.11.1) may
activate the GlyNMDA site and this hypothesis and the effects of PKC-mediated
phosphorylations on GlyNMDA function have been tested.
A potential role for glycine in the FTG/NMDA receptor interaction has previously been
investigated using anatomical, behavioural and electrophysiological protocols. Chapman et
al. (1996) showed that inflammation induced increases in spinal C-fos expression were
reduced by co-application of NKi (RP67580) and GlyNMDA antagonists ((+)-HA 966) and in
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behavioural responses to subcutaneous injections of formalin, the GlyNMDA partial agonist
(+)-HA 966, promoted the antinociceptive effects of NK receptor antagonists RP 67580 and
CP99994 (Seguin and Millan, 1994). Furthermore, Rusin et al. (1993c) reported that in
isolated dorsal horn neurones the presence of glycine greatly enhanced NMDA responses
and this prevented a SP facilitation of NMDA evoked inward currents. This data is consistent
with the idea that SP potentiation of NMDA receptors may be dependent on the status of the
GlyNMDA site and emphasises the potential importance of this site in the development and
maintenance of central sensitisation.
1.12 Leukaemia Inhibitory Factor
Leukaemia inhibitory factor (LIF) is a hematopoietic cytokine that has recently been shown
to function in neuronal tissue. Initially characterised on the basis of its capacity to induce the
differentiation and death of a mouse myeloid leukaemic cell line Ml (Metcalf et al. 1988),
LIF is now known to exert a variety of effects on immune system and nervous system cells
including actions in development, hematopoiesis, bone metabolism, inflammation and
cachexia (for review see Gearing, 1993). This functional diversity is reflected in the number
of different names ascribed to LIF and through discovery and rediscovery it has been known
as D-factor, differentiation-inducing factor, cholinergic nerve differentiation factor (CDF)
and hepatocyte stimulating factor III amongst others. However, the purification of murine
LIF in 1987 (Hilton et al. 1988) and the subsequent isolation of its encoding cDNA (Gearing
et al. 1987) has now revealed that all of these molecules are identical to LIF.
Due to its many functions in the immune and nervous systems, LIF has been grouped with a
number of similar proteins termed the neuropoietic cytokines. This family includes
interleukin-6 (IL-6), IL-11, ciliary neurotrophic factor (CNTF), oncostatin M and
cardiotrophin-1 and whilst these proteins have little sequence homology they share a
common secondary structure (Bazan, 1991; Rose and Bruce, 1991) (Figure 1.5) and exert
similar actions on a variety of tissues. Indeed there is a large functional overlap between
members of the neuropoietic cytokine family that is revealed by gene knockout studies
(Stewart et al. 1992) and these have shown that this redundancy is most easily accounted for




Despite the limited homology of neuropoietic cytokines they are all predicted to share a four
antiparallel helix bundle secondary structure, a prediction that is borne out by the structure of
LIF as determined by single crystal X-ray diffraction (from the Brookhaven protein databank
at ftp ://ftn ,pdb .bnl, gov (Robinson et al. 1994)).
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1.12.1 LIF Signal Transduction
The first neuropoietic cytokine receptor to be identified was the IL-6 receptor (IL-6R)
(Yamasaki et al. 1988). However, transfection with the cDNA for IL6-R conferred mostly
low-affinity IL-6 binding, while native IL-6 responsive cells showed both high and low
affinity sites (Hibi et al. 1990). This led to the search for a molecule associated with IL-6R
and immunoprecipitation of IL-6 stimulated cells revealed this protein to be the 130-kDa
membrane glycoprotein gpl30 (Taga et al. 1989).
It has now become apparent that gpl30 is critical for the signal transduction of IL-6 and the
other members of the neuropoietic cytokine family, with IL6-R conferring specificity to IL-6
and IL-11, LIF-receptor (LIF-R) binding LIF and cardiotrophin-1, CNTF-receptor (CNTFR)
binding CNTF, and oncostatin M-receptor (OSM-R) binding oncostatin M. These subtypes
then form gpl30 receptor complexes either by inducing homodimerisation of two gpl30
subunits in the case of IL-6R or by forming heterodimers consisting of the relevant low-
affinity receptor associated with gpl30 (for review see Taga and Kishimoto, 1997).
Dimerisation initiates signal transduction via activation of a Janus kinase (Jak). This
phosphorylates tyrosine residues on the distal part of gpl30 and provides a docking site for a
transcription factor termed STAT3 (Signal Transducer and Activator of Transcription 3).
Tyrosine phosphorylated STAT3 proteins form homodimers and are translocated to the
nucleus where they initiate transcription through a cytokine response element (CRE) (Taga,
1996; Taga and Kishimoto, 1997) and induce the expression of a number of peptides
including VIP, somatostatin, CGRP, SP and Glial Fibrillary Acidic Protein (GFAP) (Frank
and Greenberg, 1996). Additionally, gpl30 has been demonstrated to activate a RAS/MAPK
(mitogen activated protein kinase) pathway and this also induces an upregulation of
transcription, particularly of acute phase proteins (Taga, 1996; Taga and Kishimoto, 1997).
The mechanism that underlies cytokine redundancy therefore appears to lie in the nature of
the receptor. This is reflected in experiments examining knockout of the gpl30 receptor,
where removal of this element is lethal early in development (Ware et al. 1995; Yoshida et
al. 1996). However, specific biological functions of neuropoietic cytokines can still be
maintained in vivo. A combination of regulated expression of the individual cytokine and
limited cellular expression of the ligand-specific receptor component will serve to define the
actions of the cytokine.
1.12.2 Location of LIF in the Nervous System
Most investigations on neuronal LIF have addressed its location in the peripheral nervous
system where it was primarily regarded as a sympathetic neuronal factor, however more
recent studies have also demonstrated actions of LIF in sensory neuronal function.
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Expression of LIF in the uninjured nervous system is normally very low (Yamamori, 1991)
but this is dramatically upregulated by axotomy or explantation. In the sympathetic system
the process occurs in Schwann cells at the site of injury and in the ganglion, whilst in
sensory nerves it is restricted to the nerve trunk both proximal and distal to the injury
(Banner and Patterson, 1994; Curtis et al. 1994; Kurek et al. 1996; Sun et al. 1996).
Nevertheless, sensory fibres retrogradely transport LIF and a study by Thompson et al.
(1997) defined the population of fibres that undertook this task. They reported that
biotinylated LIF (and not IL-6) was transported by peptide and non-peptide small diameter
neurones, many of which were immunopositive for the high affinity nerve growth factor
(NGF) receptor tyrosine kinase A (trk A). They therefore suggested that this subpopulation
was associated with predominantly nociceptive innervation and reflected a role for LIF in
pain signalling.
Few studies have investigated the distribution of LIF in the central nervous system. Using
reverse transciption-polymerase chain reaction (RT-PCR), Yamamori (1991) detected LIF
mRNA in the visual cortex and superior cortex. However spinal cord expression was not
examined. More investigators have addressed the central location of the related cytokine IL-
6. This is upregulated in the spinal cord by both central injury such as HTLV-I-associated
myelopathy (Umehara et al. 1994) and by peripheral injury such as sciatic cryoneurolysis
neuropathy where it produced mechanical and thermal behavioural hypersensitivity (DeLeo
et al. 1996). These data support a role for the neuropoietic cytokines in central neuronal
function.
1.12.3 Role of LIF in the Nervous System
LIF has important functions in both the developing and adult nervous systems. There is
evidence that LIF promotes the differentiation of sensory fibres from progenitor cells of
neural crest origin (Murphy et al. 1991) and later in development (from E14 and E15), acts
as a target derived survival factor in gut and skin for a small population of DRG neurones
(Murphy et al. 1993). More relevant to this study are its effects in the adult nervous system
where it rescues both motorneurones (Cheema et al. 1994b) and sensory neurones (Cheema
et al. 1994a) from axotomy-induced cell death and induces alterations in the chemical
phenotype of axotomised sympathetic and sensory fibres (Zigmond et al. 1996).
Neuronal injury such as axotomy or explantation brings about changes in the DRG of injured
nerves that are collectively called the cell body reaction (Zigmond et al. 1996). This was
originally characterised as a morphological reaction that reflected a change in neuronal
function from synaptic transmission to regeneration (Grafstein and McQuarrie, 1978). Thus
the expression of structural proteins such as tubulin, actin and GAP-43 increased in
axotomised nerves whilst proteins associated with neurotransmission such as tyrosine
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hydroxlase in sympathetic neurones decreased (Koo et al. 1988; Hoffman, 1989). This was
accompanied by alterations in peptide synthesis such that SP, galanin and VIP were
upregulated whilst NPY was decreased in sympathetic neurones (Hyatt-Sachs et al. 1993;
Schreiber et al. 1994) and in sensory neurones, galanin, neuropeptide Y (NPY) and
vasoactive intestinal peptide (VIP) expression were increased whilst SP and CGRP were
decreased (Hokfelt et al. 1994). Initial experiments to find the induction factor that caused
this process revealed that non-neuronal cells were essential mediators and by pretreating the
conditioned medium with an antiserum that immunoprecipitated LIF, the active agent was
removed (Shadiack et al. 1993; Sun et al. 1994). It has now become apparent that LIF is
involved in the induction of a number of peptides in both sympathetic and sensory neurones.
From in vitro studies, LIF has been demonstrated to increase levels of substance P, VIP,
galanin and NKi receptor in sympathetic neurones (Rao et al. 1993; Shadiack et al. 1993;
Fann and Patterson, 1994; Sun et al. 1994; Ludlam et al. 1995). Furthermore, knockout of
the LIF gene prevents axotomy-induced upregulation of galanin in sensory neurones
(Corness et al. 1996; Sun and Zigmond, 1996) and reduces the expression of galanin,
neurokinin A and VIP in sympathetic neurones in vivo (Rao et al. 1993). This process
appears to be dependent upon the activation of STAT proteins, which have been
demonstrated to act at the cytokine response element in the promoter region of VIP, SP and
other peptides and activate gene transcription (Symes et al. 1994; Rajan et al. 1995; Frank
and Greenberg, 1996). The evidence therefore places LIF as an essential mediator in the
cascade of events leading to increased gene expression. Indeed it has been reported that
axotomy induced changes in neuropeptide expression involve the sequential induction of
tumour necrosis factor (TNF) followed by IL-1 and then LIF (Shadiack et al. 1993; Ding et
al. 1995; Ludlam et al. 1995). However, Zigmond et al. (1994a) have recently identified a
novel 50kDa protein that also leads to LIF induction. They have called this factor LIF-
induction factor (LIF-IF) and its release could represent one of the earliest biochemical
changes associated with axotomy.
Peripheral nerve axotomy brings about changes in the structure of damaged neurones.
Postganglionic sympathetic fibres are known to sprout into the DRG and form noradrenergic
pericellular basket structures around damaged sensory neurones (McLachlan et al. 1993).
Thompson et al. (1998) have recently shown that LIF may induce this process. Following
intrathecal administration of LIF, varicose tyrosine hydroxylase-immunoreactive (TH-IR)
sprouts penetrated deeply into the parenchyma of the DRG and formed TH-IR baskets in the
absence of peripheral injury. It was suggested that this might lead to a coupling between
sympathetic and sensory activity and contribute to sympathetically-maintained neuropathic
pain. Indeed, systemic or local injection of LIF brought about an enhanced mechanical
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sensitivity in behaving rats (Thompson et al. 1996) indicative of the allodynia seen following
nerve injury.
A potential consequence of LIF-induced increases in neuropeptide synthesis by primary
sensory neurones is a facilitated release of these substances at their central terminals and
enhanced spinal neuronal excitability. However, changes in gene expression within central
nervous system cells also contribute to spinal hyperexcitability and the factors that regulate
these central changes are unknown. The present study investigated the role of centrally
applied LIF on gene expression in the spinal cord. Using in situ hybridisation, alterations in
spinal LIF expression evoked by peripheral nerve injury and inflammation were examined.
Since this may have led to alterations in the synthesis of factors involved in central
sensitisation, the effects of intrathecally-applied LIF on dorsal horn gene expression were
then examined. An important component of central sensitisation is the co-activation of
neuropeptide and EAA neurotransmitters. Therefore as a marker for neuropeptide
expression, NK] receptors were chosen as they are upregulated by both nerve and tissue
injury (Abbadie et al. 1996) and for the EAA system, glutamate transporter EAAT2 was
considered. EAA transmission can occur via ionotropic AMPA, kainate and NMDA
receptors or metabotropic receptor subtypes, therefore changes in expression of glutamate
transporter mRNA could reflect altered EAA activity at any of these receptor types.
Furthermore, the distribution of EAAT2 has been extensively characterised in the spinal cord
where it is located on glial cells in laminae I-III and in the ventral horn (Rothstein et al.
1994) suggesting that it may regulate glutamatergic transmission in this area. Finally the
effects of intrathecally-applied LIF on behavioural sensitivities to thermal and mechanical
stimulation were considered.
These experiments addressed for the first time the role of LIF in the central mediation of
spinal neuronal hyperexcitability and established its function as a regulatory factor in the
spinal cord.
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CHAPTER 2: FUNCTIONAL INTERACTIONS INVOLVING NK,
RECEPTORS AND GLYCINE
2.1 Aims
There is little evidence to support a direct role of spinal NK] receptors in mediating brief
noxious cutaneous inputs. These experiments have addressed that lack of action and tested a
novel mechanism that describes an apparently covert role for NKi receptors during acute
nociceptive events. It was proposed that an inhibitory intemeurone might mask the NK!
component during acute nociception. Since SP is known to increase concentrations of
glycine in the dorsal hom, the actions of this amino acid at its inhibitory receptor (GlyR) and
subsequent regulation of NKi receptor activity were investigated.
2.2 Methods
2.2.1 Animals
Wistar rats were purchased from Charles River UK Ltd, Margate, Kent, UK. They were
housed in groups of 3 or 4 in standard rat cages on a 12 hour light/12 hour dark cycle, with a
room temperature of 19-23°C. Food and water were available ad libitum.
2.2.2 Surgical Procedures
62 Male Wistar rats (210g-400g) (Charles River) were anaesthetised with halothane (Zeneca
Pharmaceuticals, Macclesfield, UK) followed by intravenous a-chloralose (60mgkg-')
(Sigma, Poole, UK) and urethane (1.2gkg_1) (Sigma). Subsequent doses of a-chloralose were
given when required (as determined by testing the blink reflex). The trachea was cannulated
and a light flow of oxygen passed over the cannula. Body temperature was maintained at 37°
C using a thermostatically controlled heat blanket.
The animal was placed in a stereotaxic frame, with stability provided by jaw and ear bars.
The spinal column was exposed and supported with 3 pairs of swan-necked clamps and a
laminectomy (LrL4) was performed. Agar was injected under the most rostral vertebra and
over the exposed area to provide stability. This was removed from the recording area and the
dura was cut. Paraffin at 37°C was poured onto the exposed surface.
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2.2.3 Electrophysiological Recording and Ionophoresis of Drugs
Extracellular recordings were made from single multireceptive lamina III-V neurones in the
exposed dorsal horn using the central barrel of a 4-5pm tipped 7-barrelled glass
microelectrode filled with 4M NaCl (pH 4.0-4.5) (Figure 2.1). Recording locations were
assessed from micro-manipulator depth readings which were adjusted in 2 or 6pm steps via a
microdrive and were well correlated with the position of Pontamine Sky Blue dye spots
when ejected from a side barrel.
Recordings were amplified though a recording amplifier with a bandwidth of 1Hz to 7KHz,
discriminated through a D.130 spike processor and monitored on an oscilloscope
(Tektronix). Discriminated neuronal firing rate was continuously plotted on line on an IBM
PS/2-70-121 computer using SCAP90, a customised analysis programme (M. Dutia,
Department of Physiology, University of Edinburgh) that allowed event markers to be added
as data was collected.
Drugs were ionophoresed from the side barrels of the electrode. A retention current of lOnA
to 15nA was applied to each barrel and resistance was monitored regularly; electrodes were
rejected if values exceeded 35MQ. One of the remaining barrels contained 1M NaCl (pH4.0-
4.5) for automatic current balance using a Neurophore BH2 Ionophoresis system (Medical
systems Corporation) and for current controls. Ionophoresis of vehicle (0.5% DMF, pH4.5 or
pH8) or 1M Na+ had no detectable effect on any responses. Wherever investigated in detail,
the magnitude of drug effects was dependent on ionophoretic currents.
2.2.3.1 Drugs for Ionophoresis
Glycine receptor antagonists: phenylbenzene-co-phophono-a-amino acid (PMBA) (Research
Biochemicals International), ImM in 77mM NaCl, pH8.5 (Saitoh et al. 1994); strychnine
(Sigma), ImM in 77mM NaCl and 0.05% dimethylformamide (DMF), pH 4.5.
NK, receptor antagonist: GR82334, ImM aqueous, pH 4.5 (Hagan et al. 1991).
NMDA channel blocker: MK-801 maleate (Tocris Cookson), 200pM aqueous, pH 4.65
(Wong et al. 1986).
All compounds were ejected with positive current except for PMBA, which was ejected at
negative current.
2.2.4 Quantification of Neuronal Responses to Cutaneous Sensory Stimuli
Neurones were located by simultaneously lowering the electrode into the spinal cord and
manually brushing the hind limb. Once an appropriate electrode position had been found,
spikes were carefully discriminated and the location of neuronal receptive fields was
checked by light brushing of the ipsilateral hind limb. The multireceptive nature of the cell
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was then established by assessing responses to noxious pinch and 48°C heat. Recording was
started to determine the basal firing level.
2.2.5 Quantification of Neuronal Responses to Application of Mustard Oil
Following location and identification of a neurone, mustard oil was applied to the receptive
field. Mustard oil is a chemical irritant that can be applied topically, intramuscularly or intra-
articularly to selectively activate C-afferent fibres (Woolf and Wall, 1986; Harris and Ryall,
1988). It induces a 2-3°C increase in skin temperature, oedema and an increase in plasma
extravasation at the site of application (Lippe et al. 1993) and sensitises central neurones to
subsequent inputs (Woolf and Wall, 1986). Application of mustard oil therefore brings about
enhanced nociceptive responses such that it causes an intense burning sensation in man
(Woolf, 1984), prolongs nociceptive reflexes in the rat (Woolf and Wall, 1986) and when
applied repetitively, evokes a sustained and incremental level of C-fibre activation analogous
to electrically evoked wind-up (Woolf and King, 1990).
In this study, mustard oil (7.5-10% in paraffin) was applied topically to the receptive field at
5 minute intervals until a steady elevated neuronal firing rate (5-30Hz) was maintained
(usually after 5-7 applications). The NKi receptor antagonist GR82334 was then ejected at a
current of 50nA for 2 minutes. Following a 2-minute recovery time, glycine receptor
antagonists strychnine or PMBA were applied alone at 3 OnA for greater than 1 minute and
then with 50nA of GR82334. The ejection current of the glycine antagonists was then
increased by increments of lOnA at 1-minute intervals. When a reduction in the firing rate
occurred, application of GR82334 was stopped and the cell was tested for recovery in the
absence of the NK, receptor antagonist.
To investigate the specificity of this inhibitory mechanism to NKj receptor activation, the
protocol was repeated with the NMDA channel blocker MK801 and like the NK] receptor
antagonist GR82334, this was tested alone and in combination with increasing ejection
currents of glycine antagonists.
2.2.6 Analysis of Results
Analysis was carried out off-line using the SCAP90 programme. The mean evoked activity
was assessed for each drug and corresponding control over a constant period of 30 seconds
of stable representative activity before and after application. The change in activity was
expressed as a percentage for each cell and then pooled to find the mean+SEM. The




Schematic representation of the protocol utilised in electrophysiological
recording experiments
Schematic representation of the spinal cord exposed in the region of L1-L4 and stabilised
using 3 pairs of swan necked clamps. The surrounding area was covered with agar except for
the recording region which was protected with paraffin at 37°C. Extracellular recordings
were made via a 7-barrelled glass microelectrode and discriminated spikes plotted onliine as










In agreement with previous data (Munro et al. 1993) the NKj antagonist GR82334 did not
alter the activity evoked by mustard oil (100±4% of control) in any of the 19 cells tested
(Figures 2.2 and 2.4). Similarly, at the ejection currents used the glycine receptor antagonists
were without significant effects (strychnine: 96±4%, PMBA: 113±9%) (Figures 2.2 and 2.4).
However, when GR82334 was ejected together with strychnine or PMBA it caused a
significant (P<0.05) inhibition of the mustard oil activity to 43±7% and 68±7% respectively
until application of the glycine receptor antagonists was stopped at which time values
returned to baseline (Figures 2.2 and 2.4).
In contrast to the NKi receptor antagonist, the NMDA channel blocker MK801 readily
inhibited mustard oil evoked activity when ejected alone (69±4%) and importantly,
strychnine did not alter this reduction (69±14%) (Figures 2.3 and 2.4).
Changes brought about in neuronal firing which were within 15-20% of pre-drug controls
were not considered to be of likely functional importance as they were within (or close to)
the range of natural variability brought about by vehicle or current controls.
2.4 Discussion
These results demonstrate new evidence for an endogenous inhibitory control over
influences of the NK, receptor and describe a mechanism where this receptor is prevented
from having a direct excitatory effect during acute nociception.
Topical application of mustard oil to the cutaneous receptive field was used as an in vivo
model of short term but sustained activation of C-fibres. This led to an elevated-firing rate of
dorsal horn neurones to which antagonist responses could be tested. Mustard oil application
is known to sensitise dorsal horn neurones to subsequent inputs and this is often
accompanied by an increase in the receptive field size (Woolf and King, 1990). A similar
change was observed in this study indicating that mustard oil might be inducing central
sensitisation. However, there was a degree of variability in the time and extent of neuronal
"wind-up" that may reflect a lack of access of mustard oil to pertinent sites. Harris and Ryall
(1988) demonstrated that application of mustard oil to glabrous skin resulted in poor
penetration and no neuronal activation. Observations from the present study are in agreement
with this and accordingly, topical application was restricted to receptive fields of
multireceptive neurones located over hairy skin.
The current evidence from both electrophysiological and behavioural studies implicates a
role for NK, receptors in spinal pain transmission only after sustained or prolonged
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conditioning stimuli. For example NK, receptor antagonists were ineffective at reducing
responses to single C-fibre volleys (De Koninck and Henry, 1991) or brief noxious stimuli
(Garces et al. 1993) but did inhibit electrically-evoked activity and behaviours evoked by
more severe models such as subcutaneous formalin injection (Charriaut-Marlangue et al.
1991) or sensitisation of STT neurones by capsaicin (Dougherty et al. 1994). Indeed Dirig
and Yaksh (1996) proposed that SP is a sensitising agent and not a pain transmitter and
functions to lower nociceptive thresholds rather than directly evoke pain induced behaviours.
The precise nature of the stimulus required to elicit an NKi mediated response is not clear,
but it is apparent from this experiment and previous data (Munro et al. 1993) that topical
application of mustard oil does not evoke a direct NK, component in the activation of dorsal
horn neurones. In this model, mustard oil application reflects a relatively brief form of
sustained nociception that does not require NKi receptor activation. However in agreement
with Dirig et al. (1996) the sensitisation of dorsal horn neurones by mustard oil may be NK,
receptor dependent (S.M. Fleetwood-Walker, unpublished observations). When neuronal
responses to brief noxious thermal and mechanical stimulation of the receptive field were
tested during mustard oil application, the NKi antagonist RP67580 was effective at reducing
sensitised activity supporting a role for NK! receptors in central sensitisation but not acute
nociceptive transmission.
The mechanism that prevents NKj receptors from engaging in brief noxious inputs is not yet
known. It is possible that a large release of SP, such as that seen after sustained nociception,
is required to enable spreading to distant receptors. However direct application of NK,
agonists onto dorsal horn neurones did not enhance responses to brief inputs (Fleetwood-
Walker et al. 1987; De Koninck and Henry, 1991; Malmberg and Yaksh, 1992; Yamamoto
and Yaksh, 1992; Couture et al. 1993) but often inhibited evoked activity (Davies and Dray,
1980; Willcockson et al. 1984; Ryall and Pini, 1987; Fleetwood-Walker et al. 1988;
Fleetwood-Walker et al. 1990). Murase and Randic (1984) have investigated this inhibitory
phenomenon using an in vitro spinal cord slice preparation and they reported that a SP-
2+ 2+
evoked hyperpolarising response could be blocked with TTX or high Mg and low Ca
solutions indicative of an indirect mechanism. Similarly, Masayama et al. (1996) addressed
an antinociceptive effect of low doses of SP on behavioural responses to intrathecally-
applied NMDA and proposed that this occurred via an opioidergic inhibitory interneurone.
However, SP is known to increase levels of glycine in the dorsal horn and this has inhibitory
effects via its strychnine-sensitive receptor. It is therefore possible that the activation of an
inhibitory glycine interneurone precludes the actions of NK, receptors during brief
nociceptive transmission.
Glycine has been previously implicated in nociception. Intrathecal application of the glycine
receptor antagonist strychnine increased the nociceptive flexor reflex (Sivilotti and Woolf,
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1994) and induced allodynia and receptive field expansion (Sosnowski and Yaksh, 1990).
Indeed glycinergic inhibitory modulation may be an essential mechanism for regulating
spinal neuronal hyperexcitability and removal of this tonic inhibition could unmask
inappropriate connections and contribute to pathological pain states (Sosnowski and Yaksh,
1990).
In this study, ionophoresis of strychnine or the selective glycine receptor antagonist PMBA
did not alter mustard oil-evoked activity at the current used. Since the aim of these
experiments was to unmask an inhibitory regulation of NK, receptor activity, very low
concentrations of these antagonists were ejected at currents just below the threshold required
to potentiate ongoing activity. Therefore, when the NK, antagonist was co-applied any
excitatory effects of strychnine would not mask potential GR82334 inhibition.
Glycinergic inhibition of NK, excitatory inputs has recently been considered. Littlewood et
al. (1996) investigated the anatomical arrangement of a NK!/glycine circuit and reported that
very few cells were doubled labelled for NK! receptors and glycine-LI. However, glycine
levels were increased in the dorsal horn following SP application (Kangrga and Randic,
1990b; Smullin et al. 1990b; Maehara et al. 1995b) and intrathecally-administered glycine
inhibited SP-evoked biting and scratching behaviour (Beyer et al. 1989) indicating that NK,
receptors could still activate a glycinergic inhibitory mechanism, albeit indirectly. Data from
the present study shows that co-application of GR82334 and glycine receptor antagonists
significantly reduced activity evoked by mustard oil and that this inhibition increased with
incrementing ejection currents of glycine receptor antagonist and recovered when application
of these antagonists was stopped. It is important to note that at the same ejection current
GR82334 alone did not reduce mustard oil activity and that the additional presence of the
glycine receptor antagonists caused the inhibition. One possible interpretation of these
results is that by blocking the glycine receptor, inhibitory regulation of NK, receptors was
removed. Therefore antagonism of the glycine receptor may have unmasked a covert
contribution by NK, receptors to mustard oil-evoked activity and allowed NK, antagonists to
exert their inhibitory effects (Figure 2.5).
In contrast, ejection of the NMDA antagonist MK801 in the presence of strychnine had a
quite different effect. Ionophoresis of MK801 inhibited the mustard oil activity to 69±4% of
control and then this was not altered by the addition of strychnine. Thus dorsal horn neuronal
activity evoked by mustard oil application had a direct measurable NMDA receptor
component as shown by the action of MK801 and there was no regulatory glycinergic
inhibitory mechanism as demonstrated by the lack of effect of strychnine. This would imply
that the inhibitory control of NK, receptors by strychnine/PMBA-sensitive glycine receptors
is not a general phenomenon but is specific to the NK, receptor.
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Data from this study helps explain the apparent lack of action of NK, receptors in brief
nociception. NKi antagonists are known to be ineffective at reducing neuronal responses to
acute stimuli (Charriaut-Marlangue et al. 1991; De Koninck and Henry, 1991; Garces et al.
1993; Dougherty et al. 1994; Dirig and Yaksh, 1996) but the mechanism that precludes their
involvement from short-term nociception yet allows them to act as sensitising agents after
prolonged input is not known. The present study demonstrates that NKj receptor activation
may be under the control of a regulatory mechanism where increased release of glycine
obscures any direct NKi mediated excitatory input. However during more sustained
nociception the accumulation of other factors such as increased SP release and intracellular
phosphorylations will outweigh this inhibitory modulation and contribute to the sensitising
effect of NK] receptors (Figure 2.5). Therefore the actions of NKi receptors in spinal
nociception may occur via a series of time-dependent interactions that help define the
physiological response to the stimulus. NK] mediated sensitisation will only occur if the
stimulation is severe enough to outweigh the inhibitory control. This would suggest that if
NK] receptors are essential for the initiation of central sensitisation, this balance of inhibitory




Effects of ionophoretically applied NK, receptor and glycine receptor
antagonists on a single dorsal horn neurone.
Individual records of ongoing firing frequency are displayed as action potentials per second
(A/s) plotted against time for a single neurone. Record A shows the lack of effect of
GR82334 when applied alone or with strychnine vehicle compared to its inhibitory action
when ejected in combination with strychnine. Record B shows a similar lack of effect of
GR82334 when applied alone compared to inhibition when ejected with an alternative

























Effects of ionophoretically applied NMDA and glycine antagonists on a single
dorsal horn neurone
Individual records of ongoing firing frequency are displayed as the action potentials per
second (A/s) plotted against time for a single neurone. The record shows the inhibitory







Effects ofNK, and NMDA receptor antagonists tested alone and in combination
with glycine receptor antagonists on mustard oil-evoked activity
The NKi receptor antagonist GR82334 (|) (n=19) or the glycine antagonists PMBA ([Q])
(n=6) or strychnine (H) (n=17) did not alter activity when ejected alone. However
combined application of GR82334 and PMBA (gj) (n=6) or GR82334 and strychnine (151)
(n=17) produced a significant reduction in mustard oil-evoked activity. The NMDA
antagonist MK801 (n=6) significantly reduced mustard oil evoked activity when applied
alone (Q ) and in combination with strychnine (^ ) the activity remained at this level. All
data are expressed as percentages of mean±SEM mustard oil-evoked activity. The statistical
significance of differences from control mustard oil activity was determined using a one way
repeated measures analysis of variance and * represents a significance of P<0.05.
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A hypothetical model of the actions of SP during acute nociception
SP is known to increase concentrations of glycine in the dorsal horn. During brief noxious
inputs this may act via a network of interneurones at the inhibitory glycine receptor and
mask any direct effects of NKi receptors. However, in more prolonged situations, a
combination of increased SP release coupled with an accumulation of intracellular








CHAPTER 3: FUNCTIONAL INTERACTIONS INVOLVING NK,
RECEPTORS, NMDA RECEPTORS AND GLYCINE
3.1 Aims
This series of experiments examined the role of the GlyNMDA site in the NMDA/NK, receptor
interaction. Since SP increases concentrations of glycine in the dorsal horn, it was proposed
that this could act at the GlyNMDA site and facilitate NMDA receptor-evoked activity. The
possible contribution of PKC mediated phosphorylations to this interaction was also assessed
using selective PKC inhibitors.
3.2 Methods
3.2.1 General Methods
Please refer to section 2.2 for methods regarding animals, surgical procedures,
electrophysiological recording techniques, quantification of neuronal responses to cutaneous
sensory stimuli and analysis of results.
3.2.2 Drugs for Ionophoresis
AMPA receptor agonist: a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA),
lOmM aqueous, pH8 (Krogsgaard-Larsen et al. 1980).
GI}>nmda site agonist: 1-aminocyclopropanecarboxylic acid (ACPC), 150pM in 0.5% DMF,
pH8 (Nadler et al. 1988).
NKf receptor agonist: acetyl-[Arg6,Sar9,Met(02)1' ]-SP6-n (Sar9-SP ), lOOpM in 0.5% DMF,
pH4.5 (Regoli et al. 1988).
NMDA receptor agonist: 1-ammocyclobutane-cA-l ,3-dicarboxylic acid (ACBD), lOOpM
aqueous, pH8 (Allan et al. 1990).
AMPA receptor antagonist: 6-nitro-7-sulphamoylbenzo[f]quinoxaline-2,3-dione (NBQX),
100pM in 0.5% dimethylformamide (DMF), pH8.5 (Sheardown et al. 1990).
GlyNMDA site antagonists: 2-carboxy-4,6-dichloro-(lH)-indole-3-propanoic acid (MDL
29951), lOOpM in 0.5% DMF, pH4.5 (Salituro et al. 1992).
7-chloro-3-(cyclopropylcarbonyl)-4-hydroxy-2(lH)-quinoline (L701,252), lOOpM in 0.5%
DMF, pH4.5 (Rowley et al. 1993).
5,7-dinitroquinaxoline-2,3-dione (MNQX), lOOpM in 0.5% DMF, pH4.5 (Sheardown et al.
1989).
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7-chlorothiokynurenic acid (7-CTK), 50pM aqueous, pH5.5 (Moroni et al. 1991).
Non-competitive NMDA receptor antagonist: MK801 maleate, 200p.M aqueous, pH 4.65
(Wong et al. 1986).
PKC inhibitors: chelerythrine, ImM aqueous, pH4.5 (Herbert et al. 1990).
GF109203X, 200pM in 0.2%DMF, pH4.5 (Toullec et al. 1990).
Polyamine site antagonist: arcaine sulphate, 25mM aqueous, pH4.3 (Reynolds, 1990).
All compounds were from Tocris Cookson (Bristol, UK) except Sar9-SP from Sigma and the
PKC inhibitors which were from Calbiochem (Nottingham, UK). ACBD, ACPC, AMPA,
MDL 29951 and NBQX were ejected with positive current and all others were ejected with
negative current.
3.2.3 Quantification of Neuronal Responses to Ionophoresis of Agonists
3.2.3.1 NMDA/NK, Interaction
In order to determine the effects of GlyNMDA site antagonists and PKC inhibitors on the
NMDA/NK
j receptor interaction, NMDA and NKi receptor agonists were ionophoresed to
establish facilitated activity.
NK] receptor agonist Sar9-SP was initially ionophoresed at 20nA for 2 minutes. Then
following a recovery time of 5 minutes, the NMDA receptor agonist ACBD was applied at
15nA. After a response the ejection current was decreased until a steady firing rate of
approximately 15Hz had been reached. Following 3 minutes of regular activity, Sar9-SP was
applied at 5nA or greater and the firing was allowed to stabilise at a constant rate.
3.2.3.2 Effects ofGlyNMDA site antagonists
The status of the GlyNMDA site during the NKj/NMDA interaction was investigated by
comparing the effects of GlyMMDA antagonists on the facilitated activity occurring in the joint
presence of both NMDA and NK! receptor agonists with antagonism of activity evoked by
an NMDA receptor agonist alone.
GlyNMDA site antagonists MDL29951, 7-CTK, MNQX or L701,252 were tested on the
ACBD and Sar9-SP evoked activity at a range of currents from 2nA to 60nA and then
ionophoresis was discontinued to check for recovery. In 33 cases, following a recovery time
of 10 minutes, the compounds were tested on ACBD-evoked activity in the absence of Sar9-
SP. Sar9-SP was also applied alone at 20nA for 4 minutes before ACBD (n=10) to assess its
direct action. A recovery time of 10 minutes was allowed before ACBD was tested.
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3.2.3.3 Effects ofa GlyNMDA site agonist
Substituting Sar9-SP with the GlyNMDA site agonist ACPC further assessed the importance of
the GlyNMDA site in the NK,/NMDA interaction. Sar9-SP was applied at 15-30nA,
superimposed on stable ACBD-evoked activity (n=24) and then when a steady firing rate had
been attained L701, 252 was ejected (n=12). ACPC was also applied alone at 30nA for 4
minutes (n=l 1) with 10 minutes recovery time before further experiments.
3.2.3.4 Specificity of the NMDA/NK/ receptor interaction and the influence of GlyNMDA
site antagonists
To demonstrate the specificity of the NMDA/NK, interaction and of blockade of the
GlyNMDA site, effects of the antagonists were examined on control AMPA-evoked activity.
AMPA was applied at 15nA (n=10) and the current then decreased to maintain a stable firing
rate. For five of these neurones, Sar9-SP was ejected at 20nA. The remaining cells were
tested with the selective AMPA receptor antagonist NBQX (20-40nA) and GlyNMDA site
antagonist L701,252 (20-50nA). Following a recovery time of 5 minutes, activity was
evoked from these cells by the combined application of ACBD and Sar9-SP and then NBQX
was applied at a range of currents from 20nA to 60nA.
3.2.3.5 Effects ofother NMDA antagonists
Controls for the involvement of other regulatory sites on the NMDA receptor complex were
carried out by applying the non-competitive NMDA receptor antagonist MK801 (n=5) and
the polyamine site antagonist arcaine (n=5) during activity evoked by ACBD alone and
(following a recovery time of 10 minutes) to facilitated Sar9-SP/ACBD-evoked activity.
3.2.3.6 Effects ofPKC inhibitors
The role of PKC in the NMDA/NK! interaction was investigated by testing the effects of
PKC inhibitors on facilitated and non-facilitated NMDA receptor-evoked activity. The PKC
inhibitors chelerythrine and GF109203X were ionophoresed at a range of currents from 2nA
to 60nA and inhibitions of activity evoked by NMDA and NKi receptor agonists versus
activity evoked by NMDA receptor agonist alone were compared.
3.3 Results
3.3.1 Effects of NMDA and NKi receptor agonists and GlyNMDA site antagonists
The majority of tested neurones had basal firing rates lower than 1Hz and responded
vigorously to ACBD at an ejection current of 15nA. A steady rate of firing was maintained
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by decreasing the current to less than 5nA until a stable activity was observed over a 3
minute time period. The mean firing rate for this stable ACBD-evoked activity was 12±lHz.
g
Sar -SP (which had no effect alone (Figure 3.1 A)) was then applied, causing the ACBD
response to be facilitated in 80 out of 89 cells by an average of 227±37% (Figure 3.IB); the
g
remaining cells remained unaffected by Sar -SP. The facilitation usually occurred over 5 to
10 minutes at a current of 5nA for Sar9-SP and took up to 15 minutes to fully stabilise. A
steady firing rate was attained and this was then resistant to further increases in the current of
g
Sar -SP. Application of the GlyNMDA site antagonist MDL 29951 produced an inhibition of
g
the Sar -SP plus ACBD-evoked activity in 14 out of 19 cells; completely reversing the
facilitation due to Sar9-SP and inhibiting activity to 49±21% of that evoked by ACBD alone.
MDL 29951 was active at a range of 5-20nA and inhibition occurred within 20 seconds to 5
minutes. The activity of 7 out of 14 cells recovered to that previously seen in the presence of
ACBD plus Sar9-SP 15 minutes after ionophoresis of the antagonist was stopped. L701,252
had a similar action with the activity of 19 out of 22 cells being inhibited to 111±30% (5-
35nA) of ACBD-evoked control activity (Figure 3.2A) and 13 out of 19 of these showed
recovery following discontinuation of L701,252 ionophoresis. MNQX and 7-CTK reduced
the Sar9-SP-enhanced ACBD-evoked activity in 7 out of 11 cells (2-50nA) and 16 (7-65nA)
out of 26 cells respectively to 129±62% and 102±29% of ACBD-evoked activity. 4 out of 7
and 13 out of 16 cells of these respective populations recovered within 15 minutes. Figure
3.3 illustrates the mean reduction of Sar9-SP potentiation of ACBD-evoked activity by the
GlyNMDA site antagonists and also shows that at currents matching those used to demonstrate
marked inhibition of Sar9-SP plus ACBD-evoked activity, none of the GlyNMDA site
antagonists caused reductions in activity evoked by ACBD alone, although they were
effective when ejected at significantly higher currents (see below). The small (and not
statistically significant) depression of Sar9-SP and ACBD-evoked activity below the level
due to ACBD alone that was apparently caused by MDL 29951, was not reproduced when
the antagonist was tested on ACBD alone at the same current.
12 neurones were tested with MDL 29951 (n=4), L701,252 (n=4) (Figure 3.2B) or 7-CTK
(n=4) on activity evoked by ACBD alone following at least 15 minutes recovery from
inhibition in the presence of Sar9-SP and showed only marginal inhibition at currents up to
double those required to inhibit ACBD plus Sar9-SP-evoked activity. At higher currents, the
ACBD-evoked activity was reduced in all cases by the GlyNMDA site antagonists. A further 61
separate cells were also tested with MDL 29951 (n=14), L701,252 (n=19), 7-CTK (n=16) or
MNQX (n=12) solely on ACBD-evoked activity and the current range for inhibition (MDL
29951: mean 30±7nA, L701,252: mean 38±7nA, MNQX: mean 41±6nA, 7-CTK: mean 44±
6nA) was again significantly higher (P<0.05) than that required for inhibition in the
additional presence of Sar9-SP (MDL 29951: mean 14+lnA, L701,252: 16±2nA, MNQX:
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18±6nA, 7-CTK: 25±4nA). These results indicate that structurally diverse GlyNMDA site
antagonists do not uniformly depress all evoked activity at the currents effective on Sar9-SP
facilitation of ACBD activity and the effect is therefore likely to be specific. Furthermore
they underline the point that the facilitation due to Sar9-SP is outstandingly sensitive to
blockade of the GlyNMDA site.
For the 10 neurones first tested with Sar9-SP alone, 8 out of 10 were not excited by Sar9-SP
(20nA) and of these cells, all showed a potentiation of ACBD-evoked activity by the NKt
receptor agonist. 2 out of 10 cells were directly excited by Sar9-SP (20nA) from a basal level
of less than 1Hz to 15-20Hz; this activity was further potentiated in the additional presence
of ACBD (l-10nA), but L701,252 (5-40nA) or MDL 29951(50-50nA) had no inhibitory
effect.
3.3.2 Effects of the GlyNMDA Site Agonist ACPC
The GlyNMDA site agonist ACPC (15-30nA) had no effect on basal firing rates when applied
alone (n=25) (Figure 3.4A). Following a recovery time of 10 minutes, ACBD was applied,
and ACPC at the same current range (15-30nA) significantly increased the firing rate by 88±
11% in 24 out of 25 neurones (Figure 3.4B) (P<0.05). The facilitation consistently took less
than 5 minutes to stabilise at this level and did not show any further increase (up to 35nA).
Application of L701,252 (n=12) reduced this activity to 79+17% of ACBD-evoked control
activity for all 12 neurones (Figure 3.4C) and the average current for inhibition was 18±4nA.
This current was significantly lower (P<0.05) than that required to inhibit activity evoked by
ACBD alone and resembled the low currents required to inhibit the Sar9-SP facilitation of
ACBD-evoked activity.
3.3.3 Effects of AMPA and the AMPA Receptor Antagonist NBQX
Application of AMPA caused excitation in 10 out of 10 neurones and this was maintained at
a stable rate (15-30Hz) by reducing the ejection current to below 5nA (Figure 3.5A). Sar9-SP
(20nA) (Figures 3.5A amd 3.5B) or L701,252 (50nA) (Figure 3.5C) caused only minimal
alteration in the steady AMPA-evoked activity in 5 out of 5 of the tested neurones (107±5%
and 104±5% respectively) whereas NBQX (n=5) significantly inhibited the firing rate in all
cases to an average of 52±13% (P<0.05) (Figure 3.5D). Following a recovery time of 5
minutes, the combined application of Sar9-SP and ACBD evoked a steady activity of 34+
7Hz and ejection of NBQX at up to 50nA did not alter the firing rate of these 5 neurones
(101 ±21 % of control) (Figure 3.5E).
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3.3.4 Effects of MK801 and the Polyamine Site Antagonist Arcaine
MK801 (n=5) and arcaine (n=5) (Figures 3.6A and 3.6B) significantly reduced both the Sar9-
SP facilitated ACBD-evoked activity (to 63±4% and 73±9% respectively) and ACBD-
evoked activity alone (to 66±7% and 70±9%) to similar levels. Unlike the GlyNMDA site
antagonist and PKC inhibitors, facilitated activity was not more sensitive to antagonism by
these compounds than activity evoked by ACBD alone (Figure 3.7): Mean effective currents
for 50% inhibition were 31±6nA and 19±5nA respectively for MK801 and 46±7nA for both
activities with arcaine.
3.3.5 Effects of PKC Inhibitors
The PKC inhibitors, chelerythrine and GF109203X (Figure 3.8A), significantly reduced the
Sar9-SP facilitation (411±81%) of ACBD-evoked activity to 111+26% (10 out of 14
neurones) and 76+34% (8 out of 10 neurones) of control respectively (P<0.05). When
applied to ACBD-evoked activity alone, the PKC inhibitors had only marginal effects in all
tested neurones; chelerythrine reduced the ACBD-evoked activity to 87+9% (n=12) and
GF109203X increased the activity to 114+24% of control (n=7) (Figure 3.8B); these small
changes were not significant.
3.4 Discussion
The present investigation provides further evidence for an NK receptor-mediated facilitation
of NMDA receptor agonist-evoked activity in the dorsal hom. Furthermore this facilitation
was blocked by the application of several different GlyNMDA site antagonists and PKC
inhibitors and the blockade occurred more potently than blockade of activity evoked by
NMDA receptor agonist alone. This is further support for a key role of the GlyNMDA site in
sensory processing in the dorsal horn and implicates its occupation as a crucial regulatory
mechanism in the influence of NMDA receptors on dorsal horn neurones. In particular the
GlyNMDA site and PKC appear to be important mediators of the interaction between the NK
and NMDA receptors and these may therefore serve as important components in
sensitisation of dorsal hom neurones following sustained input.
An essential requirement for NMDA-agonist evoked activity is occupation of the GlyNMDA
site. This is supported by data from the experiments where GlyNMDA antagonists were applied
to ACBD-evoked activity and reduced the firing rate. The effects are consistent with
evidence that glycine binding to its allosteric site on NMDA receptors is a critical regulator
of their function (Kleckner and Dingledine, 1988). In Xenopus oocytes and in cortical
neurones in vitro, the presence of added glycine seems to be an absolute requirement for the
function of NMDA receptors (Johnson and Ascher, 1987; Kleckner and Dingledine, 1988)
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and although cerebellar granule cells and spinal cord neurones in vitro and cerebral cortex
neurones in slices do show responses to NMDA in the absence of added glycine, these are
greatly enhanced by glycine addition (Fletcher and Lodge, 1988; Murase et al. 1989;
Thomson et al. 1989; D'Angelo et al. 1990). The incomplete reversal of the ACBD-evoked
activity by the GlyNMDA antagonists may reflect failure to reach adequate concentrations,
non-selective actions of the drugs or residual channel activity continuing in the absence of
glycine occupation. The present results do however confirm that NMDA receptor agonist
responses of dorsal horn neurones can be inhibited by GlyNMDA site antagonists, indicating an
endogenous partial tone due to glycine.
For the GlyNMDA site to be functionally utilised in SP modulation of the NMDA receptor
complex, ambient concentrations of glycine must presumably be below saturation levels for
this site. Application of the selective GlyNMDA site agonist ACPC facilitated ACBD-evoked
activity clearly whilst having no effect when applied alone. This is consistent with other
studies which showed that exogenously applied glycine potentiated NMDA receptor
responses (Larson and Beitz, 1988; Salt, 1989; Budai et al. 1992; Rusin et al. 1992),
suggesting that the resting concentration of glycine is low. Maehara et al. (1993) provided
evidence that SP increases the release of glycine in the rat spinal cord by two fold and may
therefore increase extracellular glycine concentrations enough to contribute to promoting
activation of the NMDA receptor. On balance it appears that most NMDA receptors in vivo
appear to be normally subjected to a partial tone from glycine, corresponding to the pM
concentrations thought to be present in the extracellular space in the CNS in vivo (Skilling et
al. 1988). However, the extent of this tonic influence is likely to vary at different locations
because of differences in local glycine clearance mechanisms (Priestley and Kemp, 1983;
O'Shea et al. 1991) or in glycine sensitivity of NMDA receptor complexes which may
correspond to the presence of different subunit configurations (Nakanishi, 1992). Our results
confirm that the NMDA receptor agonist responses of dorsal horn neurones can be inhibited
by GlyNMDA site antagonists and be potentiated by GlyNMDA agonists, indicating an
endogenous partial tone but not complete saturation of the GlyNMDA site.
Ionophoretically-applied Sar9-SP facilitated ACBD-evoked activity in dorsal hom neurones.
This occurred gradually over several minutes, stabilised within 15 minutes and continued at
this level even after application of Sar9-SP was stopped. Furthermore, application of Sar9-SP
alone at greater than 5 times the potentiating current generally had no effect on background
activity demonstrating that the amplification of ACBD responses was dependant on NMDA
receptor function. By applying Sar9-SP after ACBD had evoked increased activity it can be
assumed that potentiation was not due to changes in membrane potential directly altering the
2_j_
extent of Mg block (although activation of PKC may account for a relative lifting of the
block) and this is further supported by the observation that at the ejection currents used, Sar -
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SP elicited no recorded increase in electrical activity. This data also precludes the possibility
of summation of the 2 activities and consequently the facilitation might therefore be due to a
direct alteration of the conductance of the NMDA channel, perhaps via the GlyNMDA site.
In support of this, Sar9-SP had no effect on AMPA-evoked firing, implying that under the
present circumstances, the facilitation was specific to NMDA receptor-mediated firing and
not due to a general increase in subthreshold excitability. This accords with other in vivo
investigations of the interaction. Dougherty and Willis (1990) found that SP facilitated the
action of quisqualic acid in only two out of eight macaque spinothalamic tract neurones
whereas combined application of SP and NMDA enhanced activity in six out of eight cells
and to a far greater extent. Cumberbatch et al. (1995b) reported facilitations of AMPA,
Kainate and NMDA receptor mediate responses by the NKi agonist GR7362, but the
facilitations of the NMDA receptor responses appeared clearly greater than those to AMPA
and Kainate. The selective facilitation by NK, agonist of NMDA but not AMPA responses
under the present conditions therefore verifies the specificity of the interaction apparently
mediated by the GlyNMDA site. Furthermore, the GlyNMDA antagonist L701,252 did not inhibit
AMPA-evoked activity and the AMPA antagonist NBQX did not affect NMDA plus Sar9-
SP-evoked activity. As well as demonstrating the specificity of the compounds these data
also confirm that responses were not due to any artefactual current coupling effects between
electrode barrels.
The present experiments suggest that the GlyNMDA site may additionally play a very specific
role in the facilitation of NMDA receptor-evoked activity due to NK( receptors, since the
facilitation of ACBD-evoked activity brought about by Sar9-SP was selectively blocked by
GlyNMDA site antagonists more potently than their inhibition of ACBD-evoked activity alone.
Four structurally different antagonists produced similar results in support of the idea that this
site was indeed the mediator of their common action. This data is also supported by previous
evidence on the role of the GlyNMDA site in nociceptive transmission. Both
electrophysiological and behavioural protocols have shown that blockade of spinal GlyNMDA
sites reduces dorsal horn neuronal activity (Dickenson and Aydar, 1991; Chapman and
Dickenson, 1994) and pain induced behaviours (Coderre and Van Empel, 1994; Millan and
Seguin, 1994; Laird et al. 1996; Lutfy and Weber, 1996) evoked by sustained nociceptive
stimuli.
Furthermore, Rusin et al. (1992) have shown that the GlyNMDA site is an important mediator
in the NMDA/NK, interaction. They reported that SP facilitation of NMDA-induced inward
currents in isolated dorsal horn neurones was not observed in cells continuously perfused
with glycine, i.e. saturation of the GlyNMDA site led to occlusion of any further effect of SP.
However, they also observed a restoration of SP facilitation of NMDA responses in the
presence of continuously perfused glycine plus GlyNMDA site antagonist (7-chlorokynuremc
86
acid) which does not accord with the present results. The experimental conditions differ
greatly between the two studies of course, and additional sites of action may well be present
in the in vivo rather than the isolated neurone preparation. Nevertheless one possible
interpretation of their results is a partial reversal by 7-chlorokynurenic acid of the GlyNMDA
site-mediated occlusion of SP effect, allowing the reappearance of some SP facilitation
perhaps as further glycine released by SP action overwhelms the influence of the GlyNMDA
site antagonist.
The greater sensitivity to GlyNMDA site antagonists of the NK receptor agonist-induced
facilitation of ACBD-evoked activity (rather than ACBD-evoked activity alone) in the
present experiments accords closely with recent behavioural observations. Kolhekar et al.
(1994) reported that the reduction in tail flick latency caused by the GlyNMDA site agonist, D-
serine, was blocked more potently and fully by 7-chlorokynurenate than the reduction caused
by NMDA, although both were equally sensitive to MK-801. This suggests that phenomena
directly elicited by stimulation of the GlyNMDA site are somewhat more sensitive to GlyNMDA
site antagonists than those elicited by stimulation of the excitatory amino acid site of the
NMDA receptor and an analogous situation could arise here if Sar9-SP was acting by
increasing glycine release. This hypothesis was tested using two approaches. Firstly the
effects of antagonists at other sites on the NMDA receptor were investigated and secondly
Sar9-SP was substituted with a GlyNMDA agonist ACPC to potentiate NMDA activity. From
the first protocol it became apparent that inhibitions by MK801 (acting as a non-competitive
channel blocker) and arcaine (a polyamine site antagonist) were no different on Sar9-SP
facilitated versus ACBD-evoked activity alone and that increased modulation of the NMDA
receptor complex by NK! receptor activation only involved functional changes in the
influence of the GlyNMDA site. Secondly, by mimicking the presumed action of Sar9-SP with
ACPC a similar facilitation was observed and this was also much more sensitive to blockade
by GlyNMDA antagonists than ACBD-evoked activity alone. These data would therefore
suggest that the allosteric nature of interactions between the GlyNMDA and EAA recognition
sites may produce a situation where activation of the channel by increasing glycine in the
face of a constant EAA level would be more sensitive to GlyNMDA site antagonists than
activation resulting from increased EAA levels in the face of a constant glycine level.
Furthermore, since this phenomenon appears to occur when NKi agonist is co-applied with
NMDA agonist, it supports the hypothesis that NKi receptors may facilitate NMDA receptor
function via the GlyNMDA site.
The data is also consistent with a postsynaptic effect of Sar9-SP. Dendrites of nociceptive
laminae III-V neurones have been shown to receive SP-immunoreactive terminals (De
Koninck et al. 1992) and a subpopulation of neurones, including spinothalamic tract cells, in
this region express immunoreactivity for the NK] receptor (Bleazard et al. 1994; Liu et al.
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1994; Nakaya et al. 1994; Marshall et al. 1996). Additionally, mRNAs for NMDA receptor
subtypes are widely expressed throughout dorsal horn neurones (Tolle et al. 1993; Luque et
al. 1994; Watanabe et al. 1994) consistent with the hypothesis of a postsynaptic interaction
between NK, and NMDA receptors occurring here. The possibility of a substantial
postsynaptic effect of Sar9-SP was directly investigated by applying Sar9-SP and ACPC
simultaneously to stable ACBD-evoked activity at currents that would not facilitate that
activity when applied individually. Although an excitation was observed when ejected
together, it was not possible to configure experimental conditions that enabled definitive
analysis of whether or not synergistic interactions were occurring. Other evidence however,
strongly suggests that functional responses to NMDA in isolated dorsal horn neurones can be
facilitated by activation of protein kinase C (Watson and Downes, 1983; Chen and Huang,
1992; Nakajima et al. 1992). One known consequence of activating an NK,-type receptor is
the activation of PKC (Rusin et al. 1993c), so the modulation of site-site interactions within
the NMDA receptor complex by a NIC receptor-induced event may occur via PKC-mediated
phosphorylation. Indeed PKC has been implicated as a mediator of spinal nociceptive
transmission. It augments neuronal activity when activated by phorbol esters (Cerne et al.
1992; Palecek et al. 1994), is translocated to the membrane compartment after sustained
noxious inputs (Mao et al. 1993; Munro et al. 1994; Yashpal et al. 1995) and PKC inhibitors
have been shown to reduce activity evoked by mustard oil (Munro et al. 1994) or capsaicin
(Sluka et al. 1997b and 1997c) as well as behaviours evoked by subcutaneous application of
formalin (Coderre, 1992; Coderre and Yashpal, 1994; Yashpal et al. 1995) and capsaicin
(Sluka and Willis, 1997). Furthermore, an isoform of PKC, PKCy is upregulated in the spinal
cord after peripheral inflammation (whilst NMDA receptor subunit expression remains
constant) (Berthele et al. 1996) and gene knockout of this variant produces mice that do not
display behavioural hyperalgesia following nerve injury or inflammation (Malmberg et al.
1997).
PKC has also been demonstrated to have an important function in the NMDA/NK!
interaction. PKC inhibitors block the SP-mediated facilitation of NMDA responses in
acutely isolated dorsal horn neurones (Rusin et al. 1993b), reduce ventral root potentials
evoked by subthreshold applications of NKi receptor agonist and NMDA (Urban et al.
1994a) and inhibit enhanced behavioural responses to subcutaneous formalin injection
induced by the co-application of SP and NMDA (Coderre, 1992; Coderre and Yashpal,
1994).
In agreement with these studies, we report that the PKC inhibitors chelerythrine and
GF109203X inhibited Sar9-SP facilitation of ACBD-evoked activity and propose that this
would be consistent with a postsynaptic mechanism of the NMDA/NK! interaction. Such an
event does not preclude the previous evidence on the role of the GlyNMDA site as this may
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occur additionally to any Sar -SP-induced increase in glycine release. It is also possible that
changes in the sensitivity of the GlyNMDA site seen during NK, and NMDA activation are
caused by a site specific PKC mediated phosphorylation initiated by the NKj receptor. This
is further supported by the observation that GlyNMDA site agonist does not facilitate ACBD-
evoked activity to the same extent as Sar9-SP, so a postsynaptic increase in the sensitivity of
the GlyNMDA site coupled with an increase in glycine access to the NMDA receptor complex
could explain the present results (Figure 3.9).
This investigation has addressed the role of NK] receptors in sustained nociception and
focused on their involvement in the NMDA/NK] interaction. By examining the effects of
antagonists at the GlyNMDA site on neuronal activity evoked by combined application of
NMDA and NKj agonists and comparing this to antagonism of NMDA activity alone, it has
become apparent that activation of NK] receptors results in an increased sensitivity of the
GlyNMDA site. This has been discussed with reference to SP-induced increases in local
glycine concentrations and PKC mediated phosphorylations of the NMDA receptor complex.
The relative importance of such a mechanism in the context of acute versus sustained
nociception will be considered in Chapter 5.
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Figure 3.1
Effects of ionophoretically-applied NK( and NMDA receptor agonists on a
single dorsal horn neurone
Individual records of ongoing firing frequency are displayed as the action potentials per
second (A/s), integrated over 700 millisecond bins, plotted against time for a single neurone.
Record A shows the typical lack of effect of Sar9-SP on background activity. Record B










Effect of ionophoretically applied GlyNMDA antagonist on activity evoked by
NMDA plus NKi receptor agonists compared to that evoked by NMDA receptor
agonist alone
Individual records of ongoing firing frequency are displayed as the action potentials per
second (A/s), integrated over 700 millisecond bins, plotted against time for a single neurone.
Record A shows the inhibitory effects of GlyNMDA antagonist L701,252 on ACBD plus NKt
receptor agonist-evoked activity and record B shows the lack of effect of L701,252 on
ACBD evoked activity alone until higher ejection currents.
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Effects of GlyNMDA site antagonists on neuronal activity evoked by NMDA
receptor agonists or by NMDA plus NKi receptor agonists
Activity due to ACBD Q ) and ACBD-evoked activity in the additional presence of Sar9-SP
(fl). Effects of the GlyNMDAsite antagonists were tested on either ACBD-evoked activity
(DM) or ACBD- and Sar9-SP -evoked activity Q): MDL29951 at 14±lnA in [[J andFffl
at 30±7nA in [1. L701.252 at 16±2nA in [ID and ES and at 38±7nA mES. MNQX at 18±6nA
in [0 and EH and at 41±6nA inES3 . 7-CTK at 25±4nA iifTH andffil and at 44±6nA iiH . All
data is expressed as percentage of mean control ACBD-evoked activity (for individual
drugs) and each value is the mean ± SEM. The statistical significance of differences was
assessed using the Mann-Whitney U-test (* represents a significant difference from ACBD




Effects of ionophoretically applied GlyNMDA site and NMDA receptor agonists
and a GlyNMDA site antagonist on a dorsal horn neurone.
Individual records of ongoing firing frequency are displayed as the action potentials per
second (A/s), integrated over 700 millisecond bins, plotted against time. Record A shows the
typical lack of effect of ACPC when applied alone. Record B shows the facilitatory effect of
the GlyNMDA agonist ACPC on ACBD-evoked activity (P<0.05, Mann-Whitney U-test) on
the same neurone following a sufficient recovery time. Record C is from a separate neurone























Effects of ionophoretically applied AMPA, NMDA and NK, receptor agonists
and GlyNMDA site and AMPA receptor antagonists on a dorsal horn neurone
Individual records of ongoing firing frequency are displayed as the action potentials per
second (A/s), integrated over 700 millisecond bins, plotted against time. Record A shows the
typical lack of effect of Sar9-SP when applied to AMPA-evoked activity. Record B shows
the inhibitory effect of NBQX on AMPA-evoked activity, record C shows the lack of effect
of NBQX on activity evoked by Sar9-SP and ACBD and record D shows the lack of effect of











































Effects of the polyamine site antagonist arcaine on activity evoked by NMDA
plus NKi receptor agonists and on NMDA receptor agonist-evoked activity
alone
Individual records of ongoing firing frequency are displayed as the action potentials per
second (A/s), integrated over 700 millisecond bins, plotted against time for a single neurone.
Record A shows the inhibitory effects of the polyamine site antagonist arcaine on ACBD
plus NK[ receptor agonist evoked activity and record B shows the inhibition of ACBD








Effectiveness of GlyNMDA site and other NMDA receptor antagonists at reducing
neuronal activity evoked by NMDA receptor agonist alone compared to activity
evoked by NMDA plus NKi receptor agonists.
Ejection current required to inhibit ACBD evoked activity alone by greater than 20 percent
(FFfl ) compared to that required to inhibit ACBD plus Sar9-SP evoked activity (JH ). Four
compounds acting at different sites on the NMDA receptor complex were considered:
GlyNMDA site antagonists L701,252 and 7-CTK, non-competitive channel blocker MK801
and polyamine site antagonist arcaine. The statistical significance of differences was
assessed using the Mann-Whitney U-test (* represents a significant difference from ACBD









Effect of ionophoretically applied PKC inhibitor on NMDA plus NKj receptor
evoked activity compared to NMDA receptor-evoked activity alone
Individual records of ongoing firing frequency are displayed as the action potentials per
second (A/s), integrated over 700 millisecond bins, plotted against time for a single neurone.
Record A shows the inhibitory effects of PKC inhibitor GF109203X on ACBD plus NKi
receptor-evoked activity and record B shows the lack of effect of GF109203X on ACBD-
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Figure 3.9
A hypothetical model of the actions of SP during prolonged nociception
SP-induced increases in dorsal horn glycine concentrations act at the GlyNMDA site of the
NMDA receptor during sustained nociception. Following a severe or prolonged noxious
stimulus, PKC mediated phosphorylations of the NMDA receptor increase the sensitivity of
the GlyNMDA site. Glycine now acts at this site, unmasks any direct excitatory NKi input and
contributes to the NMDA/NKi interaction. Additional factors may also play a role.
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CHAPTER 4: LIF AS A SPINAL NOCICEPTIVE MEDIATOR
4.1 Aims
LIF is a neuroactive cytokine that has been extensively characterised in the peripheral
nervous system where it acts as an injury-induced neuronal differentiation factor. Recent
investigations have explored the role of LIF in the sensory system and there is evidence that
it may act on a subset of small diameter neurones suggesting a nociceptive role for this
cytokine. This study has addressed the role of LIF as a nociceptive mediator in the spinal
cord. Firstly, using in situ hybridisation, the distribution of LIF mRNA was examined in the
spinal cord of normal animals compared to animals with peripheral inflammation or nerve
injury. Secondly the consequences of intrathecally applied LIF to mechanical and thermal
behavioural hypersensitivity were determined. Finally, the effects of LIF on the expression
of critical components in neuropeptide and excitatory amino acid transmission were
assessed. Since changes in behavioural hypersensitivity may reflect altered spinal neurokinin
and EAA transmission, expression of NKj receptor mRNA (which is upregulated by both
nerve and tissue injury) and EAAT2 mRNA (which may regulate synaptic glutamate
concentration and hence activation of any of the EAA receptor subtypes) were examined
before and after intrathecal LIF infusion. These data are discussed with reference to a
nociceptive role for LIF in the spinal cord.
4.2 Methods
4.2.1 Animals
Experiments were performed on male Wistar rats weighing 200-400g (please see section
2.2.1). LIF expression was assessed in spinal cords taken from normal animals, peripherally
inflamed animals and those with a peripheral nerve injury. The effects of LIF on the
expression of spinal cord neuropeptide and EAA transmitter components were determined by
examining the expression of NKi receptor and EAAT2 mRNA before and after intrathecal
LIF application.
4.2.1.1 Inflammation and Nerve Ligation
Inflammation (n=3) was induced under halothane anaesthesia with a single unilateral
intraplantar injection of 150pl of Complete Freund's Adjuvant (CFA; LCN, Thame, UK) and
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animals were left for 52 hours. Increase in paw circumference was measured as a guide to
the development of inflammatory oedema.
Peripheral nerve ligation was performed by S.W.N. Thompson: in a group of animals (n=3)
under pentobarbitone anaesthesia (40mg/kg i.p.), the L3 spinal nerve was tightly ligated with
5/0 Mersilk for 7 days and a 5mm distal portion of the nerve resected to prevent
regeneration.
A third control group (n=3) received no treatment.
Spinal cords comprising segments L2-L4 and injured spinal nerves were then removed from
these animals under halothane anaesthesia and snap frozen in isopentane at -40°C to -45°C.
Frozen transverse cryostat sections (15pm) were taken at -16°C, thaw mounted onto
polysine-coated microscope slides (Merck, Lutterworth, UK) and stored at -70°C.
At all times precautions were taken to avoid the risk of RNase contamination of the tissue.
This included wearing gloves, continually cleaning the cryostat blade with ethanol
throughout the cutting session and treating all aqueous solutions with the nuclease inhibitor
diethyl pyrocarbonate (DEPC).
4.2.1.2 Intrathecal LIF Infusion
Experiments were performed by S.W.N. Thompson on male Wistar rats weighing 200-250g.
A laminectomy was performed under pentobarbitone anaesthesia (40mg/kg i.p.) between T4
and T5 vertebrae using sterile precautions. The dura was cut and a silastic tube, external
diameter 0.6mm, passed intrathecally so that its tip lay approximately between the L2 and L3
dorsal root ganglia. The silastic tube was connected to a mini-osmotic pump (Alzet type
2001, Alza Corp, Palo Alto,) which delivered at a rate of 1 pl/hr. The pumps were filled with
either rat serum albumin (RSA, 5mg/ml) in phosphate buffered saline (PBS) (n=3) (sham
controls) or RSA in PBS plus recombinant human LIF (rhLIF, 0.4mg/ml, from J. Heath,
University of Birmingham, Birmingham, UK)) (n=3). Pumps were left in place for 7 days.
A control group of animals (n=3) received no treatment.
Sections from spinal cord segments L2-L4 were taken as described above.
4.2.1.3 Behavioural Testing
Behavioural testing was performed by S.W.N. Thompson on male Wistar rats (200-250g)
receiving intrathecal applications of LIF or saline and control animals receiving no
treatment. The sensitivity to noxious thermal stimuli was assessed by the method of
Hargreaves et al. {#12705} using a Ugo Basile testing apparatus (Ugo Basile, Comero,
Italy). Animals (n=4) were left to acclimatise for 15-20 minutes prior to testing and then the
time taken for hindpaw withdrawal was measured automatically. In each testing session the
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mean of 4 withdrawal latencies was determined for both hindpaws and these values were
averaged.
The hindpaw withdrawal response to a noxious mechanical stimulus was measured using a
Randall-Sellito apparatus (Ugo Basile, Comero, Italy). The animals (n=4) were gently
restrained and an increasing pressure was applied to the plantar surface of the hindpaw via a
pointed rod. The pressure required to elicit withdrawal was determined and the mean of three
measurements calculated.
Paws in both thermal and mechanical tests were measured in a pseudo-random order to avoid
sensitisation effects and withdrawal thresholds were represented as absolute values.
4.2.2 In situ hybridisation
In situ hybridisation histochemistry was carried out to investigate the spinal distribution of
LIF mRNA in normal and injured animals and of NK, receptor and EAAT2 mRNA before
and after intrathecal LIF infusion.
4.2.2.1 Probe Labelling
Complete gene sequences of the rat LIF, NK, receptor and EAAT2 genes were obtained
from the EMBL database at http://www.embl-heidelberg.de. Two oligonucleotide probe
sequences were chosen from each gene (complementary to bases 86-133 and 434-478 of the
rat LIF gene, bases 559-606 and 1075-1105 of the rat NK! receptor gene (Elde et al. 1990)
and bases 300-348 and 851-899 of the rat EAAT2 gene). These were designed to reflect
similar characteristics of length (45-50 bases) and CG content (60%) to maintain a
comparable affinity for hybridisation within the limits of the in situ hybridisation
methodology used. The specificity of these sequences was then confirmed using the BLAST
search programme at http://www.nih.gov and probes were synthesised by Oswel
(Southampton, UK).
35 35
Oligonucleotide probes were 3' end-labelled with deoxyadenosine [a- S]-triphosphate ( S-
dATP; specific activity <1250 Ci/mmol; NEN Dupont, Hounslow, UK) using terminal
deoxynucleotidyl transferase (TDT; Gibco, Paisley, UK). The reaction was carried out at 37
°C in an autoclaved Eppendorf tube containing the oligonucleotide (1.5pg), TDT buffer
(lOpl), TDT enzyme (15U/pl), 35S-dATP (4pi) and DEPC distilled water (to give a final
35volume of 52pl). Following an incubation time of 1 hour a further 2pl of S-dATP and 2pl
of TDT enzyme were added and the incubation was continued for a further hour. After this
time the reaction was stopped on ice for 15 minutes and the labelled probe was separated
from unincorporated nucleotide via a Nu-Clean D25 disposable spin column (Scientific
Imaging Systems, Cambridge, UK). Percentage incorporation was calculated for each probe
and labelling was confirmed by counting the P-emission from liquid scintillation for
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duplicate aliquots (lpl) of pre-spun and post-spun mixture. The labelled probe was then
stored at -20°C until it was used the following day.
4.2.2.2 Tissue Fixing
Slides were brought to room temperature, immediately fixed in 4% paraformaldehyde/0.1M
PBS (0.1M, pH 7.4) for 10 minutes and then rinsed in fresh PBS. Sections were acetylated in
ethanolamine (10%)/acetic anhydride (0.25%) for 10 min to reduce non-specific
hybridisation of the negatively charged probe to the positively charged glass before being
dehydrated in ascending concentrations of aqueous ethanol (50%, 70%, 80%, 90% and
100%) buffered with ammonium acetate (0.3M) followed by 100% ethanol and then air
dried.
4.2.2.3 Hybridisation
Labelled oligonucleotide probes were mixed with 40%formamide/60% hybridisation buffer
(0.1 % 5x Denhardt' s solution, 10% dextran sulphate, NaCl (600 mM), Tris pH 7.6 (10
mM), EDTA (1 mM), 0.01% salmon sperm DNA, 0.005% yeast tRNA, 0.0005% glycogen
and 50% deionised formamide) at a concentration of 750cpm/pl and the solution was heated
at 60-70°C for 10 minutes before being cooled on ice for 2-3 minutes. The addition of
formamide, which destabilises nucleic acid duplexes, and the heating process ensured that
the probe was maintained in a single stranded form and thus achieved a good fidelity of
hybridisation. This was further secured by adding dithiothreitol (lOmM) to break any
random S-S bonds and keep the 35S-dATP in a reduced form following cooling.
The solution was then hybridised with the sections in sealed containers saturated with a
solution of 50% de-ionised formamide/50% 4X standard sodium citrate (SSC) solution at 37
°C for 20 hours to give a final count of 1500cpm per slide. These conditions were chosen to
optimise the hybridisation reaction and reduce non-specific hybridisation and the ideal
temperature was determined from the calculated melting temperature (Tm) for the probes
(the temperature at which a hybrid population is half dissociated) to provide a temperature
high enough to disrupt random, intrastrand hydrogen bonds within denatured DNA, but not
high enough to interfere with intrastrand pairing of complementary bases.
4.2.2.4 Post-Hybridisation Washes
After overnight incubation, post-hybridisation washes were carried out to reduce non¬
specific binding. Slides were washed over 6 hours at 40°C in decreasing concentration steps
of SSC solution (2 x SSC, 1 x SSC and 0.5 x SSC all 2h each). This higher temperature and
reduced salt concentration increased the stringency of hybridisation.
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4.2.2.5 Emulsion Coating, Developing and Staining
Slides were dehydrated in ascending concentrations of aqueous ethanol (50%, 70%, 80%,
90% and 100%) buffered with ammonium acetate (0.3M) followed by 100% ethanol and
then thoroughly air dried overnight. The dried slides were then dipped in photographic
emulsion (LM1; Amersham, Chalfont, UK) at 40°C and sealed in light-tight Kartell boxes.
After 6-8 weeks exposure at 6°C they were developed at 16-18°C using Kodak D19
developer (4 min) and Ilford Hypam rapid fixer (5 min) and then counterstained in
haematoxylin/eosin (Sigma, Poole, UK), mounted and cover-slipped.
4.2.3 Controls
The specificity of the oligonucleotide probe mixture was confirmed by BLAST search, by
pretreating sections with RNAse A (Sigma) (lmg/ml in 0.1 M PBS) for 1 hour at 37°C prior
to hybridisation, by competition for the [35S]-labelled probes in the hybridisation medium
with a 100-fold excess of unlabelled probes and by repeating the protocol with
corresponding sense probes.
4.2.4 Analysis
Quantitative measurements of hybridisation were made in the lateral part of the superficial
dorsal horn and compared with contralateral and control data. Four sections were chosen
from each animal and cell counts and silver grain densities measured blind with respect to
the treatment groups.
Cell counts were made under the light microscope at X400 magnification over an area of
30625pm and were selected on the criterion that they expressed specific silver grain
labelling at five times greater than background levels.
Silver grain densities were measured with an automated image analysis system running
"Image vl.49 VDM" software (NIH). The number of silver grains within a standardised
■j
circular area of 78.5pm (representing the maximum extent of silver grain clustering over
expressing cells) was counted over 4 positively hybridised cells and 1 non-expressing cell
(representative of background) for each section and the net density calculated by subtracting
background measurements.
Data was pooled for each group and differences between animal means determined using the




4.3.1 Spinal expression of LIF mRNA
In situ hybridisation of 2 antisense oligonucleotide probes complementary to the LIF
nucleotide sequence revealed that LIF mRNA was expressed in the spinal cord of normal
and injured rats. In control animals, expression of LIF mRNA was highest in the superficial
laminae I-II of the dorsal horn with only light expression in the deeper laminae III-V. There
was also expression around the central canal that extended into the ventral horn where it was
observed on motorneurones (Figure 4.1). Peripheral injury profoundly altered levels of LIF
mRNA, especially in the lateral superficial dorsal horn.
Spinal nerve ligation increased LIF expression at the injury site and in the ipsilateral spinal
cord. In the spinal nerve, a dense band of positively hybridised cells was observed around the
ligation and this extended from the injury site by only 100-150pm (Figure 4.2). In the spinal
cord, increases in LIF expression were confined to the ipsilateral side and this was most
evident in the lateral areas of laminae I and II (Figures 4.3 D-F). Hence in this area, the
number of cells positively expressing LIF mRNA increased by 53±8% (mean±SEM, P<0.05)
compared to control, whereas contralateral to the injury, cell counts were not significantly
increased being only 8± 12% greater than control (P=0.61; Figures 4.3 A-C). Similarly, silver
grain densities were also significantly higher in the ipsilateral dorsal horn (64±13%, P<0.05)
and contralateral levels were unchanged (17±15%, P=0.23; Figure 4.4).
To test whether increases in LIF synthesis were associated only with nerve injury, levels of
LIF mRNA were also assessed after peripheral inflammation. Intraplantar injection of CFA
induced inflammation that was evident as an increase in the circumference of the injured
paw by 78±15% compared to contralateral. In the spinal cord, inflammation caused increased
synthesis of LIF mRNA throughout the grey matter of the ipsilateral and contralateral sides
(Figures 4.3 G-L). However, hybridisation was most dense in the ipsilateral side and was
consistently associated with a band of positively hybridised cells across lamina I. Cell counts
in this area showed that the number of cells specifically expressing mRNA for this cytokine
increased by 27±13% (P<0.05) compared to control whereas contralateral counts were
unaltered at 104±9% of control (P=0.63). Silver grain densities were also significantly higher
for ipsilateral (48±22%, P<0.05) but not contralateral sides (24±20%, P=0.17) although there
was no significant difference between these data (P=0.18) (Figure 4.4).
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4.3.2 Intrathecal LIF infusion
4.3.2.1 Behavioural testing
Intrathecal application of LIF produced both a thermal and mechanical hyperalgesia.
However the time course of developing sensitivity in thermal (Hargreaves) and mechanical
(Randall-Sellito) tests appeared to differ.
The onset of mechanical hyperalgesia appeared to be rapid and was significantly different
from baseline scores three days following initiation of LIF treatment (P<0.05). This
hyperalgesia persisted for the duration of intrathecal infusion (7 days) and at the end of the
infusion period withdrawal thresholds were substantially reduced (P<0.05). Furthermore,
partial reversal of withdrawal thresholds was evident five days following termination of LIF
delivery.
The onset of thermal hypersensitivity was delayed compared to mechanical hypersensitivity.
A significant difference in withdrawal thresholds was present five days following LIF
infusion. Thermal hypersensitivity was also prolonged with partial recovery five days
following cessation of treatment.
Intrathecal saline delivery did not significantly alter mechanical or thermal paw withdrawal
thresholds.
4.3.2.2 Expression ofNK, receptor and EAA T2 mRNA
In the spinal cord, intrathecal application of LIF altered the expression of EAAT2 and NK]
receptor mRNA.
NK] receptor mRNA was expressed diffusely through the superficial dorsal horn, laminae IV
and V and on motorneurones in the ventral horn of normal animals (Figures 4.5 A-C).
Intrathecal infusion of LIF caused a dramatic increase in NK] receptor expression throughout
the grey matter (Figures 4.5 D-F). This was quantified in the lateral superficial dorsal horn
where the number of hybridised cells rose by 51±15% (P<0.05) compared to control and the
silver grain density increased by 56± 11% (P<0.05; Figure 4.6) of control.
EAAT2 expression was normally most strongly associated with cells in laminae I and II,
around the central canal and in the ventral horn (Figures 4.5 G-I). In the dorsal horn,
intrathecal LIF application decreased the number of cells positively hybridising with the
EAAT2 probes by 26±6% (P<0.05; Figures 4.5 J-L)) and this was accompanied by a
decrease in silver grain density of 21±3% (P<0.05; Figure 4.6).
4.3.3 Controls
BLAST searches confirmed the specificity of the probes and sense probe, excess unlabelled
probe, or RNAse A-treated sections showed no hybridisation in any of the treatment groups.
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4.4 Discussion
4.4.1 LIF Expression in the Spinal Cord
In the peripheral nervous system, LIF has been characterised as a lesion-induced injury
factor that promotes the differentiation and regeneration of injured neurones (Zigmond,
1997). However, peripheral injury also alters the characteristics of spinal neurones (Cook et
al. 1987) and the hypothesis that peripheral challenges and trauma associated with
nociception may increase LIF synthesis in this area has not been previously considered. We
therefore examined the distribution of LIF mRNA in the dorsal horn of the spinal cord and
show for the first time that injury induces significant increases in the spinal expression of
LIF. Furthermore, this increase occurs after injury to both peripheral nerve and tissue,
indicating that LIF might be an important factor in the induction of central neuronal
sensitisation in both of these experimental models.
In normal animals, LIF was distributed at low levels in laminae I, II, IV and V of the dorsal
horn, around the central canal and on motorneurones in the ventral horn. This basal
expression of LIF appears to differ from the expression pattern seen in the peripheral
nervous system of uninjured animals. In the periphery, evidence suggests that LIF is not
expressed until the nerve is injured (Banner and Patterson, 1994). Kurek et al. (1996) have
demonstrated that expression occurs in Schwann cells and is confined to a proximal and
distal area close to the site of injury. In agreement with this data, we have reported that LIF
mRNA is expressed in ligated spinal nerve, only extends by approximately 100-150pm from
the injury site, and the remaining portion of nerve shows no detectable hybridisation. This
serves as an important control and implies that the oligonucleotide probes used were most
likely hybridising to LIF mRNA. However, these probes detected a basal expression of LIF
in the spinal cord of uninjured animals and this suggests that LIF expression may be
differentially regulated in peripheral versus central nervous tissue.
The expression of LIF was most prominent in the superficial dorsal horn and in lamina V.
This study did not address the types of cell that were producing LIF mRNA, but this area is a
major termination zone for small diameter AS and C-fibres transmitting nociceptive
information (Willis and Coggeshall, 1991). Furthermore, inflammation and nerve injury
increased LIF mRNA expression throughout the spinal cord, especially in the superficial
dorsal horn where a dense band of hybridisation extended across lamina I. The data therefore
indicate that LIF might have important actions on the regulation of nociceptive transmission
and this is supported by observations that the neuropoietic cytokine IL6 has also been shown
to be upregulated in the spinal cord in response to a peripheral nerve injury (DeLeo et al.
1996).
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If LIF does have a pro-nociceptive role in the central nervous system, it accords well with
aspects of its putative function in the periphery. Thompson et al. (1996; 1997) have shown
that both systemic and local administration of LIF increased nociceptive reflexes to
mechanical stimuli and that a subset of nociceptive sensory neurones retrogradely transport
LIF.
These observations imply that LIF may have important actions on central as well as
peripheral sensory nervous tissue and might be an essential regulator of neuronal
responsiveness to inflammation or nerve injury.
4.4.2 Intrathecal LIF infusion and NKj and EAAT2 expression
Injury-induced increases in the expression of LIF in the spinal cord might parallel the
neuronal hypersensitivity that occurs in the dorsal horn following sustained nociceptive
stimulation. This central sensitisation contributes to behavioural hyperalgesia and is partly
mediated by increased efficacy of neuropeptide and EAA transmission in the dorsal horn
(Urban et al. 1994b). The present study has investigated the role of intrathecally-applied LIF
in this process and addressed its function as a mediator of behavioural hypersensitivity and
as an induction factor in the regulation of NKj receptor and EAAT2 gene expression.
Intrathecal administration of LIF altered both thermal and mechanical behavioural
sensitivities without affecting motor responses. LIF was applied for 7 days and mechanical
thresholds were significantly reduced after 3 days with thermal paw withdrawal latencies
dropping after 5 days. Behavioural responses returned to normal after 12 days. This data is in
broad agreement with the effects of systemic application of LIF on behavioural reflexes
(Thompson et al. 1996). However, in contrast to that study, here LIF evoked changes in
thermal nociception. This could be due to differences in both the dosing regime and route of
administration. In the present study, LIF was applied over a chronic 7-day period compared
to a single acute injection. From the data, it is apparent that thermal hypersensitivity
develops later than mechanical changes indicating that a more prolonged exposure to LIF is
required for thermal sensitisation to develop. LIF was also applied intrathecally where it had
direct access to spinal cord tissue. Kerekes et al. (1997) have recently considered the effects
of different routes of application on drug efficacy in related models. They reported that
axotomy induced increases in DRG galanin expression were more sensitive to blockade by
NGF when this neurotrophin was applied via capsule form to the injured nerve, than in vitro
bath application or in vivo intrathecal administration. Although the effects of alternative
routes of application of LIF have not been considered, Thompson (S.W.N. Thompson
unpublished observations) has investigated the spreading of brain derived neurotrophic
factor-like immunoreactivity (BDNF-LI) after a chronic intrathecal application of BDNF.
The distribution of BDNF-LI extended around the spinal cord where it penetrated into the
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dorsal horn and importantly it was found around and within the DRG. Furthermore,
induction of DRG c-fos expression after intrathecal infusion of BDNF was too rapid to be
explained solely by retrograde transport from central terminals, indicating a direct effect on
DRG cells. If a similar spreading of peptide occurs following intrathecal administrating of
LIF, it is possible that the behavioural changes result from effects in only the DRG.
However, data from this study indicates that LIF mRNA is upregulated in the spinal cord
which makes it attractive to propose that LIF is have having at least some effect centrally.
Increased neuronal hyperexcitability in the spinal cord is known to contribute to behavioural
hyperalgesia and allodynia (Treede et al. 1992). This process may be dependent upon both
increased release of transmitter from primary afferent central terminals and increased
efficacy of postsynaptic receptor responses. A peripheral action of LIF may raise
neuropeptide synthesis in the DRG and enhance the release of these substances. However,
central actions of LIF could also alter postsynaptic elements in the spinal cord. Indeed
pretreatment of cerebellar granule neurones with IL-6 (a hematopoietic cytokine that shares a
similar signal transduction mechanism to LIF) has been demonstrated to selectively enhance
the intracellular calcium response of NMDA receptors (Qiu et al. 1995) and it is possible
that injury induced increases in LIF mRNA might have similar effects in the spinal cord.
Changes in behavioural sensitivity evoked by intrathecal application of LIF could therefore
be caused by a combination of peripheral and central effects where LIF induces changes in
the chemical phenotype of nociceptive primary afferents and alters gene expression and
neuronal excitability in the spinal cord.
In the periphery, LIF has been demonstrated to induce the synthesis of a number of peptides
involved in the cell body reaction to axotomy which are upregulated in the DRG in response
to nerve injury. These include SP, VIP, galanin and NIG receptor (Rao et al. 1993; Shadiack
et al. 1993; Fann and Patterson, 1994; Sun et al. 1994; Ludlam et al. 1995; Corness et al.
1996; Sun and Zigmond, 1996). In a recent study by Livesey et al. (1997), Reg-2 a Schwann
cell mitogen that is essential for neuronal regeneration, was also shown to be regulated by
LIF. Indeed DRG cells undergoing regeneration are sensitive to exogenous application of
this cytokine, such that the switch from a synaptically transmitting neurone to a regenerating
cell may be regulated by LIF in response to neuronal damage (Zigmond et al. 1996).
Furthermore, the induction of many of these factors has been demonstrated to be dependent
upon the existence of a 180 base pair cytokine response element on the promoter region of
the gene that can be activated by the LIF/JAK/STAT pathway and can initiate increased
transcription (Symes et al. 1994; Rajan et al. 1995; Frank and Greenberg, 1996).
This study has investigated the effects of LIF on gene expression in the central nervous
system. We report that LIF is upregulated in the spinal cord in response to peripheral injury
and may therefore induce alterations in neuronal chemical phenotype and indirectly increase
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spinal cord excitability. As markers for this process, NKj receptor and EAAT2 gene
expression were examined. Central sensitisation is believed to involve the synergism of a
number of factors, especially a positive co-operation between NKi and EAA transmission
(Urban et al. 1994b), therefore LIF induced changes in NK, receptor and EAAT2 expression
might contribute to this neuronal hyperexcitability. NKj receptor expression is known to be
upregulated by nerve and tissue injury (Schafer et al. 1993; Abbadie et al. 1996) and these
receptors may have crucial actions in the induction and maintenance of central sensitisation.
Furthermore, alterations in the expression of EAA transporters could have significant effects
on EAA transmission via changes in extracellular glutamate concentration and modified
activity at any of the EAA subtypes. There are currently four known EAA transporters and
all of these could contribute to the regulation of glutamate uptake in the nociceptive system.
However, EAAT2 has been located in the spinal cord and is extensively characterised in this
area (Rothstein et al. 1994). Therefore both NK] receptors and EAAT2 could represent
potential targets for intrathecally applied LIF and reflect important factors to study.
In untreated control animals NK! receptor mRNA was distributed in the superficial dorsal
hom and in laminae IV with a more diffuse hybridisation through the deeper dorsal hom.
Application of LIF brought about a marked increased in the number of positive neurones
throughout this area. This is in agreement with previous studies that have examined the
distribution of NKi mRNA in the spinal cord before and after peripheral injury. It has been
reported that NKj mRNA is upregulated following peripheral inflammation (Schafer et al.
1993) and NKi receptor-like immunoreactivity increases after inflammation and nerve injury
(Abbadie et al. 1996). Interestingly, these increases do not correlate with injury-induced
changes in the levels of substance P, the endogenous ligand for NK! receptors. Spinal
substance P gene expression has been demonstrated to increase after inflammation (Minami
et al. 1989) whilst substance P immunoreactivity and expression decreases after nerve injury
(Hokfelt et al. 1994; Sommer and Myers, 1995) indicating that ligand and receptor
expression is differentially regulated in these situations. However, injury-induced increases
in NKi receptor mRNA correspond to LIF-induced increases in NKi receptor expression and
represent evidence consistent with the hypothesis of a pro-nociceptive role for LIF.
EAAT2 is a member of a family of sodium-dependant glutamate transporters that rapidly
terminate glutamatergic synaptic transmission via high affinity uptake from the synaptic
cleft. There are 3 additional glutamate transporters termed EAAT1, EAAT3 and EAAT4
(Rothstein et al. 1994) but EAAT2 has been most extensively characterised in the spinal
cord. EAAT2-like immunoreactivity is distributed throughout the central nervous system and
is localised exclusively on astroglial cells (Milton et al. 1997). In the spinal cord this is
enriched in the grey matter and is particularly intense in laminae I-III (Rothstein et al. 1994).
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In agreement, we have shown that EAAT2 mRNA is expressed in laminae I-II of the dorsal
horn and furthermore, intrathecal LIF infusion decreases levels of its expression.
The functional consequences of a decrease in EAAT2 synthesis are unknown. The selective
loss of EAAT2-like immunoreactivity has been observed in the motor cortex and spinal cord
of human patients with ALS and has been shown to contribute to glutamate excitotoxicity
and the death of motorneurones (Rothstein et al. 1995). However, in axotomised hypoglossal
rat motorneurones, Kiryu et al. (1995) reported that the glutamate transporter EAAT3 was
upregulated compared to control. This transporter is located on glutamatergic nerve endings
and it was suggested that upregulation allowed these motorneurones to resist neurotoxic
glutamate accumulation during regeneration.
In the dorsal horn, a LIF-induced decrease in EAAT2 expression could regulate the neuronal
hypersensitivity associated with inflammation and nerve injury. Increased synaptic
concentrations of glutamate might raise the excitability of postsynaptic neurones and
contribute to this process. Furthermore, we have demonstrated that NKj receptors are
upregulated by intrathecal LIF infusion and interactions between these and glutamate
receptors have been shown to sensitise dorsal horn neurones (Dougherty et al. 1993b; Urban
etal. 1994b).
When considering the effects of LIF on gene expression in central compared to nervous
tissue, it is important to bear in mind the differences between the two situations. In the
peripheral nervous system, LIF expression is induced at the site of injury and in direct
response to the neuronal damage. It then induces changes in the chemical phenotype of these
neurones to promote cell survival and regeneration. However, evidence from the present
study suggests that in the central nervous system, LIF may act differently. It appears that LIF
is present at basal levels in the spinal cord of uninjured animals. Furthermore, peripheral
inflammation and injury of sensory neurones "upstream" of the spinal cord evoke changes in
LIF expression. Thus, whilst the spinal neurones are not injured per se, central tissue still
responds to peripheral injury by increasing LIF mRNA. This would suggest that LIF is not
acting as a regeneration factor for these neurones, but may be redefining their properties to
change the way in which they respond to subsequent inputs. However, the current
experiments do not exclude the possibility of indirect effects of LIF on NKj and EAAT2
expression. It is possible that intrathecally applied LIF may access peripheral sites such as
the nerve trunk and ganglion (sympathetic and sensory) as well as central sites in the dorsal
and ventral spinal cord. This could result in structural changes such as in the sympathetic
innervation of sensory ganglia (Thompson and Majithia, 1998) and the induction of a
number of factors both peripherally and centrally that could elevate dorsal horn excitability
and then contribute to secondary changes in NKi and EAAT2 gene expression. However, the
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upregulation of LIF in specific regions of the spinal cord suggests that it may have a defined
role in these areas.
LIF-induced regulation of neuropeptide and EAA systems in the spinal cord will presumably
have significant effects on sensory transmission. Correspondingly, we have demonstrated
that the same LIF treatment causes behavioural hypersensitivity and that this may be due to
the altered chemical phenotype of spinal neurones. Therefore the actions of LIF may
indirectly affect the excitability of central neurones and possibly contribute both to the




Photomicrographs showing expression of LIF mRNA in the spinal cord
LIF mRNA is normally expressed in the superficial laminae of the dorsal horn (A), around
the central canal and on ventral horn motor neurones (B). Part C shows a high power
photomicrograph of LIF distribution in the superficial dorsal horn. Roman numerals indicate
Rexed's laminae.
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Figure 4.2
Photomicrographs showing expression of LIF mRNA in a ligated spinal nerve
LIF mRNA is expressed solely at the ligation site of the injured nerve (A). Part B shows a




Photomicrographs showing expression of LIF mRNA in the spinal cord
following peripheral inflammation and nerve injury
Peripheral inflammation and nerve injury induce upregulation of LIF mRNA in the spinal
cord. Parts A-C indicate the expression of LIF in spinal cord contralateral to a peripheral
nerve injury and this is upregulated on the ipsilateral side (D-F). Parts G-I show the
expression of LIF in spinal cord contralateral to peripheral inflammation and this is also
upregulated on the ipsilateral side (J-L). (A, D, G and J represent dorsal horn, B, E, H and K





Quantification of silver grain density and number of cells expressing LIF in the
superficial dorsal horn
Histogram of the number of silver grains (representing hybridised probe) per expressing cell
(calculated as the mean number of silver grains per expressing cell (a standardised area of
2 _____
78.5pm ) minus the background density) against treatment groups of control animals (|£| )
(n-3), contralateral (§ ) and ipsilateral (fg| ) nerve injury (tv-3) and contralateral 0 ) and
ipsilateral (g| ) hindpaw inflammation (n=3). The inset shows the number of positively
hybridised cells (expression greater than 5 times background) per 30625pm for each
treatment. All measurements were made from the lateral superficial dorsal horn in laminae I-




Photomicrographs showing expression of NKj receptor and EAAT2 mRNA in
the spinal cord
Intrathecal LIF application induces alterations in NK] receptor and EAAT2 gene expression.
Parts A-C show the normal distribution of NK] receptor and this is increased by LIF
administration (D-F). Parts G-I show the normal distribution of EAAT2 and this is decreased
by LIF administration (J-L).
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FIGURE 4.6
Quantification of silver grain density and the number of cells expressing NKi
receptor or EAAT2 mRNA
Histogram of the number of silver grains (representing hybridised probe) per expressing cell
(calculated as the mean number of silver grains per expressing cell (a standardised area of
78.5pm ) minus the background density) against treatment groups of normal expression of
NKj receptor (§5]) and EAAT2 (Q ) compared to expression after intrathecal LIF infusion,
(NKj receptor = jj] , EAAT2 =§ ). The inset shows the number of positively hybridised
cells (expression greater that 5 times background) per 30625 pm2 for each treatment. All
measurements were made from the lateral superficial dorsal horn (laminae I-II). ★











CHAPTER 5: GENERAL DISCUSSION
The transmission of sensory inputs in the spinal cord relies upon a complex series of
interactions involving several classes of chemical mediator. These include classical
neurotransmitters such as EAAs and neuropeptides, neuromodulators such as growth factors
and compounds traditionally associated with the immune system such as inflammatory
cytokines. Recently it has become apparent that these systems do not act in isolation, but co¬
operate with varying degrees of interaction to modify spinal sensory processing.
This study has addressed the role of NK, receptors as spinal nociceptive mediators. There is
evidence that the involvement of these receptors in nociceptive transmission may be
dependent upon the duration and severity of the stimulus. Using an in vivo electrophysiology
protocol utilising ionophoresis and extracellular recording, a series of interactions involving
NK, receptors, glycine and NMDA receptors were investigated to determine a mechanism
for NK, receptor influence in sensory processing. The functions of the inflammatory
cytokine LIF were also considered. Using in situ hybridisation, the distribution of this factor
in the spinal cord and its effects on the expression of critical components in neuropeptide and
excitatory amino acid transmission were assessed. These data are discussed with reference to
injury induced alterations in dorsal horn processing of nociceptive information.
5.1 NK, Receptor Interactions With Other Mediators/Modulators of
Nociceptive Transmission
SP and NK, receptors are located in the superficial spinal cord where they are likely to play a
pro-nociceptive role. SP-LI boutons have been demonstrated to make appositions with high
threshold and WDR neurones (Weiya Ma et al. 1996) and many NK, receptor
immunoreactive dorsal horn neurones project via the STT to the thalamus and may be
nociceptive in nature (Marshall et al. 1996). Liu et al. (1994a) reported that few (15%) of
these neurones make direct synaptic contact with SP terminals indicating that much of the
transmission in this area could be due to diffusion of the ligand. Studies addressing the
release of SP are in agreement with this. Using the antibody microprobe technique it has
become apparent that a significant SP release is dependent upon a sustained and severe
stimulus such as tissue damage and this form of injury will produce a massive release of SP
over a wide area (Schaible et al. 1990). Diffusion of the ligand would therefore access
additional receptor sites raising the gain of the neurones and perhaps contribute to secondary
hyperalgesia by activating neurone populations that innervate tissue adjacent to the injury
site.
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Behavioural and electrophysiological investigations also support a role for NKj receptors in
spinal nociception. However their relative involvement may be dependent upon the duration
and severity of the stimulus. NKj receptors do not appear to mediate brief nociceptive inputs:
NK] antagonists don't reduce behavioural reflexes evoked by brief noxious pinch or acute
noxious thermal stimulation of the tail or paw (Malmberg and Yaksh, 1992; Yamamoto and
Yaksh, 1992; Garces et al. 1993) and in electrophysiological experiments they do not alter
baseline nociceptive reflex activity (Laird et al. 1993), single C-fibre volleys (De Koninck
and Henry, 1991; Chapman and Dickenson, 1993) or sustained C-fibre stimulation in normal
animals (Thompson et al. 1994). More evidence implies that NK| receptors are mediators of
sustained nociceptive inputs. For example, NK] antagonists reduce behavioural and dorsal
horn neuronal responses to severe stimulation such as intraplantar injection of capsaicin
(Sakurada et al. 1993; Dougherty et al. 1994), carrageenan (Yamamoto et al. 1993b) or
formalin (Charriaut-Marlangue et al. 1991; Chapman and Dickenson, 1993). Indeed, much
of this evidence suggests that SP does not function as a pain transmitter per se, but may be
more important in sensitising spinal neurones (Dirig and Yaksh, 1996).
The main role of SP and NK] receptors in sensory processing therefore appears to be as a
positive modulator of nociceptive transmission. This is supported by anatomical, behavioural
and electrophysiological studies with little evidence for a direct role of SP in the
transmission of brief nociceptive inputs. There are several feasible mechanisms for this
delayed mode of action of NK] receptors. One possibility is that the release of SP has to
accumulate enough to spread to pertinent receptor sites some way from the actual release
site. However, even when NK] agonists are applied directly onto dorsal horn cells, neuronal
responses to brief inputs are often not enhanced (Fleetwood-Walker et al. 1987; De Koninck
and Henry, 1991; Malmberg and Yaksh, 1992; Yamamoto and Yaksh, 1992; Couture et al.
1993) and in some cases are even inhibited (Davies and Dray, 1980; Murase and Randic,
1984; Willcockson et al. 1984; Ryall and Pini, 1987; Fleetwood-Walker et al. 1988;
Fleetwood-Walker et al. 1990; Masuyama et al. 1996). This would suggest that there might
be an endogenous regulatory mechanism that precludes NK] receptor involvement in acute
nociception, perhaps via the co-activation of an inhibitory mechanism.
In contrast, sustained nociceptive stimuli are believed to activate an overt NK] receptor-
mediated component and there is a large body of evidence to demonstrate that this occurs in
co-operation with NMDA receptors. This hypothesis stems from observations that glutamate
and SP coexist in primary afferent terminals in the superficial laminae (De Biasi and
Rustioni, 1988) and may be co-released following noxious stimulation. Furthermore, a
synergistic interaction between NK] and NMDA receptors has been demonstrated in a
variety of experimental models. For example, SP is known to potentiate NMDA evoked
neuronal responses in vivo (Dougherty and Willis, 1991; Dougherty et al. 1995) and in vitro
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(Randic et al. 1990), and combined applications of NMDA and NKj antagonists reduce
wind-up (Chapman et al. 1994) and block behavioural responses to inflammatory stimuli
more significantly than application of each type of antagonist alone (Murray et al. 1991;
Mjellem-Joly et al. 1992; Okano et al. 1994; Okano et al. 1995). This data emphasises the
importance of NIC receptors in the transmission of prolonged nociceptive inputs and also
gives an insight into the mechanistics of the central sensitisation phenomenon. If a situation
arises where co-release of SP and glutamate activates NMDA and NK, receptors, then co¬
operation between these receptors should increase the gain of the system and sensitise dorsal
horn neurones to subsequent inputs.
This study has investigated the role of NK) receptor activation in spinal nociceptive
processing. On the basis of a relationship between stimulus severity and NK) receptor
involvement, a hypothesis has been proposed that links preclusion of the NK, receptor
component during acute nociception with NMDA/NKi co-operation during sustained
stimulation. Since SP is known to increase levels of glycine in the dorsal horn (Kangrga and
Randic, 1990b; Smullin et al. 1990b; Maehara et al. 1995b), the dual actions of this amino
acid at either its inhibitory strychnine-sensitive receptor or its excitatory site on the NMDA
receptor have been investigated. The model (Figure 5.1) predicts that during brief noxious
stimuli the NKi receptor component is masked by SP-evoked glycine activity at its inhibitory
receptor. However, sustained nociception leads to increased SP release and NMDA receptor
activation. SP-evoked glycine release can now act at the allosteric GlyNMDA site, unmasking
the covert action of NK) receptors and further potentiating NMDA receptor activity.
To investigate the role of NK] receptors in brief nociception, the effects of NK| antagonists
on dorsal horn neuronal responses to the algogen mustard oil were investigated. This model
reflects a fairly brief nociceptive stimulus that is not affected by NKj antagonists (Munro et
al. 1993). However, in the present study, co-application of glycine receptor antagonists such
as strychnine, with NKi antagonist brought about a dose-dependent inhibition of the
neuronal activity. This could be interpreted as a lifting of an inhibitory control. If NK)
receptor influences are regulated via an inhibitory action of SP-evoked increases in glycine
concentrations, by blocking the negative modulation (with glycine receptor antagonists), the
regulatory aspect will be removed and an effect of the NK) antagonist will become apparent.
Longer duration nociceptive stimuli evoke NMDA receptor involvement in neuronal
responses and NK) receptors now exert a positive modulation (Urban et al. 1994b). The
effects on the this interaction of an NK)-evoked increase in glycine levels on this interaction
were investigated by testing GlyNMDA antagonists on dorsal horn neuronal activity evoked by
NMDA and NK) receptor agonists. Data from this study demonstrate that the interaction is
highly sensitive to blockade of the GlyNMDA site. Furthermore, it is accompanied by an
increase in the sensitivity of the GlyNMDA site that is not apparent at other sites on the NMDA
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receptor complex or when NMDA agonist is applied alone. Similarly, PKC inhibitors at low
ejection currents also block the interaction. This raises the possibility that site specific
phosphorylations within the NMDA receptor complex (as a consequence of NKj receptor
activation) may alter the sensitivity of the GlyNMDA site and when coupled with increased
activity at this site, contribute to the NKi/NMDA interaction.
The central concept of both of these series of experiments is the functional change of NK,
receptors from a covert activity during brief stimulation to a potentiating role during severe
or sustained nociception and the dual actions of glycine might account for this change. Such
arrangements of inhibitory and excitatory actions of glycine receptors have previously been
described. Budai et al. (1992) reported that ionophoretic application of high doses of glycine
inhibited the NMDA-evoked firing of nociceptive neurones in rat dorsal horn whereas low
doses increased activity. Furthermore Beyer et al. (1992) demonstrated that in behavioural
tests, combined intrathecal injections of glycine and the glutamate antagonist D-AP5
produced marked and prolonged analgesia compared to individual applications of these
compounds suggesting that activation of the strychnine-sensitive receptor produces analgesia
provided that the NMDA receptor is also blocked. Therefore, the actions of this amino acid,
either at its inhibitory strychnine-sensitive receptor or its positive modulatory site on the
NMDA receptor would determine the role of the NKi receptor.
When discussing such a mechanism it is important to consider what element switches the
negative actions of glycine to a positive effect and how this relates to the severity and
duration of the stimulus. Data from the present and other studies suggests that this might be
due to the accumulation of intracellular phosphorylations perhaps mediated via PKC. We
have demonstrated that the NK]/NMDA interaction is highly sensitive to inhibition by PKC
blockers and this accords well with other evidence. PKC inhibitors block the SP-mediated
facilitation of NMDA responses in electrophysiological preparations (Rusin et al. 1993a;
Urban et al. 1994a) and inhibit enhanced behavioural responses to subcutaneous formalin
injection induced by co-application of SP and NMDA (Coderre, 1992; Coderre and Yashpal,
1994). Furthermore PKC has been implicated as a sensitiser of dorsal horn neuronal
responsiveness (Munro et al. 1994; Yashpal et al. 1995; Peng et al. 1997) and Lin et al.
(1997) have demonstrated that this may be partly due to an attenuation of the inhibition of
(spinothalamic tract) neurones by glycine. They reported that during central sensitisation,
PKC desensitised glycine receptors and removed the inhibitory modulation. It is therefore
possible that a combination of glycine receptor desensitisation and phosphorylation of the
NMDA receptor complex diverts the action of glycine from an inhibitory function to an
excitatory role and helps initiate the process of central sensitisation.
This study shows that the effects of NK, receptors in spinal nociception may occur via a
series of time-dependent interactions. During acute situations the inhibitory glycine receptor
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reduces the role played by NKj receptors in pain transmission, presumably via an NKi
induced increase in glycine levels. However in more prolonged or severe models of pain
other factors may overcome this influence. Increased release of substance P coupled with the
accumulation of intracellular phosphorylations and changes in the sensitivity of the GlyNMDA
site (and perhaps also the strychnine-sensitive glycine receptor) reduce the inhibitory




A hypothetical model of the effects of SP-evoked increases in glycine
concentrations in the dorsal horn.
During brief noxious stimuli SP-evoked glycine acts at its inhibitory receptor to mask any
direct effects of NKj receptors. Following a more severe stimulus, PKC-mediated
phosphorylation of the NMDA receptor leads to changes in the sensitivity of the GlyNMDA
site. Glycine now exerts a greater action at this site and contributes positively to the
NMDA/NKi interaction while this cumulative potentiation of NMDA receptor effect
outweighs the acute inhibitory effect of strychnine-sensitive glycine receptors. Additional















5.2 LIF as a Regulator of Nociceptive Transmission
The first part of this study addressed short-term changes in dorsal horn processing of
nociceptive information. This form of plasticity may be important in initiating alterations in
neuronal responsiveness. However long term modifications of neuronal phenotype are also
known to occur via alterations in gene expression. These changes can lead to pathological
conditions where the dorsal horn remains in a sensitised state in the absence of peripheral
stimulation (Treede et al. 1992). Understanding the mechanisms of longer term plasticity in
the dorsal horn may therefore lead to the development of new pharmaceutical strategies for
the treatment of pain and sensory neuropathies.
LIF is a neuropoietic cytokine that has been demonstrated to have a function in the injured
sympathetic nervous system. LIF synthesis is upregulated at the site of injury and in the SCG
by Schwann cells (Banner and Patterson, 1994; Curtis et al. 1994; Kurek et al. 1996; Sun et
al. 1996) and participates in the cell body reaction to axotomy (Zigmond et al. 1996). This
may be considered as essentially a protective process reflecting a change in neuronal
function from synaptic transmission to regeneration (Grafstein and McQuarrie, 1978) and is
accompanied by increased production of a number of structural proteins and neuropeptides
(Koo et al. 1988; Hoffman, 1989; Hyatt-Sachs et al. 1993; Schreiber et al. 1994). LIF
induces the synthesis of many of these factors including SP, VIP, galanin and NKi receptor
(Rao et al. 1993; Shadiack et al. 1993; Fann and Patterson, 1994; Sun et al. 1994; Ludlam et
al. 1995) and may be a crucial component in the cellular response to injury.
Recent studies have also implicated LIF as a neuronal modulator in the sensory nervous
system. In this environment LIF synthesis is restricted to Schwann cells at the injury site and
secreted LIF is retrogradely transported to the DRG. Thompson et al. (1997) have examined
this process in detail and report that the transport is undertaken solely by a population of fine
diameter nociceptive neurones. Furthermore, systemically administered LIF evokes
mechanical hypersensitivity in concious rats which suggests that LIF may have a function as
a nociceptive agent (Thompson et al. 1996). As in the sympathetic system, retrogradely
transported LIF induces changes in the chemical phenotype of sensory nerves, (Corness et al.
1996; Sun and Zigmond, 1996) and the increased synthesis and release of neuropeptides
from central terminals may partly account for this pro-nociceptive role of LIF.
The functional diversity of LIF's actions in the peripheral nervous system makes it an
interesting candidate for study in the spinal cord. Very few studies have addressed the role or
distribution of LIF in the central nervous system, although the related cytokine IL-6 has
recently attracted some attention with the demonstration that it may be involved in the
regulation of spinal neuronal responses to peripheral nerve injury (DeLeo et al. 1996). We
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have examined the action of LIF in the spinal cord. Initially, its spinal distribution was
investigated and this was compared to expression after peripheral inflammation and nerve
injury. We report that LIF mRNA is located in the spinal cord and is upregulated in response
to peripheral injury. Therefore LIF may have a similar function in the central nervous system
to its regulatory action on gene expression in peripheral ganglia. This was tested by assessing
the effects of chronic intrathecal LIF application on the expression of NKi receptor and
EAAT2 mRNA and measuring subsequent behavioural responses to intrathecally infused
LIF. LIF increased the expression of NK] receptors and decreased EAAT2 mRNA in dorsal
horn. Furthermore rats developed behavioural hypersensitivity to mechanical and thermal
stimuli.
This is the first report of a nociceptive role for LIF in the spinal cord. In agreement with data
on its role in the peripheral nervous system, LIF appears to be evoking behavioural
hypersensitivity via increased expression of key components of nociceptive transmission.
However, there is a basal expression of LIF in the spinal cord, and whilst this is increased by
peripheral injury, these changes occur at sites removed from the actual injury zone. This
would suggest that in this situation, spinal LIF does not have a function as a regeneration
factor but may be more important in regulating neuronal hyperexcitability via changes in
gene expression. It is also possible that LIF might have fast actions in the central nervous
system. Recently, factors associated with trophic functions such as NGF and other members
of the neurotrophin family, have been demonstrated to acutely alter synaptic efficacy and
contribute to behavioural hyperalgesia (Lewin et al. 1993; Lewin and Barde, 1996). It is
therefore possible that LIF might also evoke rapid changes in dorsal horn neuronal responses
by directly modifying the strength of synaptic connections. This has not yet been
investigated.
LIF is an injury-induced regeneration factor in the peripheral nervous system with important
functions in sympathetic and sensory tissue. This study provides new evidence for a role in
the central nervous system. LIF mRNA expression is upregulated in the spinal cord in
response to a peripheral injury and it induces behavioural hypersensitivity when applied
intrathecally. We report that this may be due to increased synthesis of a number of pro-
nociceptive components such as NKi receptors and EAAT2 glutamate transporters. LIF
might therefore be a critical regulator of the central changes that occur following peripheral
injury and could contribute to the development of inflammatory and neuropathic pain states
associated with these changes.
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ANTAGONISTS AT THE GLYCINE MODULATORY SITE OF THE NMDA
RECEPTOR REVERSE NEUROKININ] RECEPTOR AGONIST FACILITATION OF
NMDA RECEPTOR EVOKED ACTIVITY IN THE RAT DORSAL HORN.
P A. Heppenstall. S.M. Fleetwood-Walker* and T, Dickinson. Department of Preclinical
Veterinary Sciences. University of Edinburgh, Summerhall, Edinburgh. EH9 1QH. U.K.
Evidence that substance P (SP) and glutamate coexist in fine primary afferent terminals,
and that NK| and NMDA receptors interact synergistically (Randic. M. et al., J.
Neurophvsiol. 63: 265-286 (1992)) suggests a potential role for these receptors in the central
hyperexcitability that is bought about by sustained activity in nociceptive afferents.
Indications that SP may have more than a simple direct action in acute nociception are
supported by evidence that glycine is released from local inhibitory interneurons by SP
(Maehara. T. et al., Reuul. Peptides Suppl. 1, S102. (1992)). Following sustained activity,
glycine might now co-activate the glycine recognition site of the NMDA receptor
(Gly]\jM[)A) and contribute to the NK] and NMDA interaction. We have investigated this
hypothesis using extracellular recordings from laminae III-V dorsal horn neurons of
anaesthetised rats.
Ionophoresis of the selective NMDA agonist l-aminocyclobutane-cv.s-1.3-dicarboxylic acid
(ACBD) produced a 945±343% increase in the firing rate. The highly selective NK1 receptor
agonist acetyl-fArg^.Sar^.MetiCb)' ']-SPg.] j facilitated this response by 223±37% percent,
but had no effect when applied without ACBD at the same current. In the presence of the
GIvnmDA antagonists 7-chlorothiokynurenic acid or 7-chloro-3-(cyclopropylcarbonvl)-l-
hydroxy-2( 1 H)-quinoline (L701,252) this increment was reduced by 89±30% and 98±29°o
while the antagonists had no effect on ACBD evoked activity alone.
This suggest that the co-operation between NMDA and NK] receptors is mediated, in part,
by the glycine site of the NMDA receptor, perhaps by means of glycine, released from an
interneuron in response to SP.
INTERACTION BETWEEN NEUROKININ, AND NMDA RECEPTORS MEDIATED BY
THE GLYCINE SITE OF THE NMDA RECEPTOR IN RAT DORSAL HORN
P.A. Heppenstall* and S.M. Fleetwood-Walker (SPON: A. Iggo), Department of Preclinical
Veterinary Sciences, University of Edinburgh, Edinburgh. EH9 1QH, U.K.
Aim of Investigation: Neurokinin, (NK,) receptors may contribute to spinal nociceptive
processing by modulating excitatory amino acid-mediated transmission, particularly through
potentiation of NMDA receptor activity [Randic, M. et aJ. Physiol. 63: 265-286 (1992)].
There is also evidence that substance P acting at NK, receptors increases release of glycine
from local interneurons [Maehara, T. et al., Reuul. Peptides Suppl. 1, S102 (1992)]. The present
experiments were carried out to investigate the effects of NK,-induced glycine release on the
glycine site of the NMDA receptor (glynmda) and to establish the role of the G1vnmda site in the
NK,/NMDA interaction.
Methods: Extracellular recordings were made from laminae III-V dorsal horn neurons
of anaesthetised rats. NMDA agonist l-aminocyclobutane-cis-1.3-dicarboxylic acid (ACBD)
was ionophoresed either alone, or followed by NK, agonist acetvl-[Arg6,Sar,,Met(02)"]-SPo.|
When the activity had stabilised G1vnmda, antagonists 2-carboxy-4.6-dichloro-( 1 H)-indole-3-
propanoic acid (MDL 29951), 7-chloro-3-(cyclopropylcarbonyl)-4-hvdroxy-2( 111)-quinoline
(L701,252), 5,7-dinitroquina\oline-2.3-dione (MNQX) or 7-chlorothiokvnurenic acid (7-CTK)
were applied. The GIvnmda antagonists were also tested on ACBD activity alone.
Results: Ionophoresis of ACBD produced a 945±343% increase in the tiring rate.
Acetyl-[Arg6,Sar;, MehCb/^-SP,,.,, facilitated this response by 223±37% but had no effect
when applied without ACBD at the same current. The GlyNMDA antagonists reduced this
increment to 49± 21% (MDL 29951), 111± 30% (L701.252). 129± 62% (MNQX) or 102+
29% (7-CTK) of activity elicited by ACBD alone, while the Glynmda antagonists had no effect
on ACBD-evoked activity alone at these currents. Inhibitory effects were seen at currents more
than 2 fold higher.
Conclusions: This study provides evidence for the involvement of the G1vnmda site in
the NK,/NMDA interaction. The relative contribution of pre- and postsynaptic effects of NK,
receptor activation, with respect to the influence of the GIyNMDA site on NMDA receptor
complex function, is yet to be clarified.
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Mediators of tachykinin/NMDA interactions in
nociception
Paul A. Heppenstall and Susan M. Fleetwood-Walker
Department of Preclinical Veterinary Sciences, Royal
(Dick) School of Veterinary Studies, University of
Edinburgh, Summer/tail, Edinburgh EH9 1QH
Neurokinin (XK,) and XMDA receptors are thought to be
important mediators of" the central hyperexcitability that
follows sustained activity in nociceptive afferents. Evidence
that substance P (SP) and glutamate exist in primary
afferent terminals (Battaglia & Rustioni, 1988) and that
X^iIDA receptor activity is augmented by XK, receptor
activation (Dougherty & Willis, 1990) implies that an
interaction between the two receptors may account for the
altered excitability. A number of potential means exist
whereby XK, receptor-mediated effects might facilitate
XMDA receptor function. One is suggested by evidence that
SP increases the levels of glycine in spinal cord (Smullin et
al. 1990). Glycine is a co-agonist at the XMDA receptor
(Johnson & Ascher, 1987); therefore we have investigated the
role of the glycine site of the XMDA (GlyXMDA) receptor
during interaction of XK1 and XMDA receptors.
Alternatively, the intracellular signalling pathways
activated by XIv, receptors, including protein kinase C, may
act to enhance the activation of XMDA channels (Chen &
Huang, 1992; Randic et al. 1993).
Extracellular recording were made from lamina III—V
dorsal horn neurons from sixty-two male Wistar rats
(250-400 g) anaesthetized with intravenous a-ehloralose
(60 mg kg-1) and urethane (1-2 g kg-1). Ionophoresis of the
selective XMDA agonist l-aminocyclobutane-cis-1,3-
dicarboxylic acid (ACBD) produced a steady increased tiring
rate. The XK, agonist acetyl-[Arg8, Sar°, Met (02)n]-SP,w,,
was then applied and facilitated the ACBD activity by
223 + 37% (mean+ s.e.m.), but had no effect when applied
alone. This enhanced activity was inhibited by the GlyXMDA
antagonists (2-carboxy-4,6-dichloro-(lH)-indoIe-3-propanoic
acid (MDL 29951), 7-ehloro-3-(cyclopropylcarbonyl)-4-
hydroxy-2(lH)-quinoline (L701.252), 5,7-dinitro-
quinaxoline-2,3-dione (MXQX) or 7-chlorothiokynurenic
acid (7-C'TK), but not by the AMPA receptor antagonist
6-nitro-7-sulphamoyll)enzo(f)quinoxaline-2,3-dione (XBQX).
AMPA-evoked activity was inhibited by XBQX, but not
unaffected by L701,252. The GlyXMDA antagonists had no
effect on activity evoked by ACBD alone until higher
currents were applied and were without effect on activity
evoked by AMTA. The role of the GlyXMDA site was further
investigated by applying GlyXMDA agonist 1-aminocyclo-
propanecarboxylic acid (ACPC) instead of the XK, agonist.
This potentiated the ACBD response by 88 ±11 % and
ejection of L701,252 reversed the increment in activity. The
selective PIvC inhibitors chelerythrine and GF109203X
inhibited the enhanced activity due to the combination of
XK, and XMDA agonists, but not that evoked by AMPA or
by ACBD alone.
These results indicate that the facilitation of XMDA
activity by XK, agonist is dependent on Iwth an intra¬
cellular pathway involving PKC and the status of the
xmda she.
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The glycine site of the NMDA receptor contributes to neurokinin) receptor
agonist facilitation of NMDA receptor agonist-evoked activity in rat dorsal
horn neurons
P.A. Heppenstall, S.M. Fleetwood-Walker
Department of Preclinical Veterinary- Sciences, Royal (DickI School of Veterinary Studies. University of Edinburgh, Summerhall, Edinburgh EH9 IQH.
UK
ELSEVIER
Somatosensory Systems, Pain neurone-port
Activation of spinal neurokinin, (NK,) receptors leads
to increases in the extracellular concentration of glycine
in the dorsal horn. We have investigated the role of
the inhibitory glycine receptor as a regulator of NK,
receptor-mediated effects on dorsal horn neurones. Iono-
phoretic application of GR82334, a selective NK, antag¬
onist, did not alter dorsal horn neuronal activity evoked
by cutaneous applications of mustard oil. However, in
the presence of the glycine antagonists, strychnine or
phenylbenzene-to-phosphono-a-amino acid (PMBA),
GR82334 displayed inhibitory properties. Therefore
inhibitory glycine receptors may mask the contribution
made by NK, receptors to nociceptive processing. This
is discussed with reference to the role of NK, receptors
during brief and long duration nociceptive transmission.
Key words: Dorsal horn; Glycine receptor; Mustard oil;
Neurokinin, receptor; Pain; Substance P
Introduction
The neurokinin, (NK,) receptor does not have a well-
defined role in spinal nociceptive transmission. From
electrophysiological and behavioural experiments, the
receptor appears to be involved only after severe or
chronic stimulation. For example, while behavioural
responses to a variety of sustained/inflammatory
models of pain are effectively reduced by NK, antag¬
onists, brief noxious inputs remain unaffected.1
Similarly, in electrophysiological experiments, these
antagonists will inhibit responses to long-term nox¬
ious stimulation such as intraplantar injection of
formalin without affecting acute C-fibre responses*
or short-term neuronal responses to the sensitizing
agent mustard oil.3 Therefore, both the intensity and
mode of sustained nociceptive stimulation may be
crucial in defining an NK, receptor involvement.
There could be a number of factors contributing
to the apparent lack of NK, receptor involvement in
acute responses. One possibility is the co-activation
of an inhibitory mechanism by substance P (SP).
Indeed an inhibitory effect of NK, receptors has
previously been reported for cat dorsal horn
neurones, where [Met-OMe"]SP (SPOMe), an NK,
agonist, reduced responses to innocuous brushing,4
and in mouse using intrathecal drug application,
where very low doses of SP reduced the behav¬
ioural responses to NMDA.- Furthermore, glycine is
released following bath application of SP in vitrob
and following microdialysis of SP into the spinal
cord in vivo,7 and it can have two opposing actions:
an excitatory effect via its co-agonist binding site on
the NMDA receptor and an inhibitory effect through
© Rapid Science Publishers
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the strychnine-sensitive glycine receptor.8 We have
previously reported that NK, receptor agonists elicit
a glycine-mediatcd facilitation of NMDA receptor
function,9 but we now propose that the strychnine-
sensitive receptor offers an alternative inhibitory
target for the released glycine (which is more obvious
during short-term nociception).
NK, receptor activation of a glycine interneurone
would initially obscure an NK, excitatory input until
the point was reached where the accumulation of
lasting intracellular changes such as phosphorylations
and NMDA receptor activation overcame the acute
inhibitory modulation. Effects of NK, antagonists
would therefore not be apparent in models with a
shorter time course such as mustard oil application.
However in those situations where the stimulus was
more severe, the combination of intracellular changes
and increased SP release would eventually lead to a
direct, measurable NK, receptor effect. We investi¬
gated this hypothesis using ionophoresis of selective
receptor agonists and antagonists and recording
extracellularlv from dorsal horn neurones of anaes¬
thetized rats.
Materials and Methods
Fifteen male Wistar rats (210—400 g) were anaes¬
thetized with halothane . followed by a-chloralose
(60 mg/kg, i.v.) and urethane (1.2 g/kg). Subsequent
doses of a-chloralose were given when required. The
trachea was cannulated and a light flow of oxygen
passed over the cannula. Body temperature was main¬
tained at 37°C using a thermostatically controlled
heat blanket. The spinal column was exposed and
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LIF MRNA DISTRIBUTION IN LUMBAR SPINAL CORD AND ITS MODIFICATION BY
PERIPHERAL INFLAMMATION AND NERVE INJURY
Paul A. Heppenstall, Susan M. Fleetwood-Walker, Stephen W.N. Thompson' and Hugo J. Spiers
Preclinical Veterinary Sciences, R(D)SVS, University of Edinburgh, Edinburgh EH9 1QH and
'Division of Physiology, UMDS, St. Thomas' Hospital Medical School, London SE1 7EH
Leukaemia inhibitory factor (LIF) is a neuroactive cytokine that is associated with peripheral
nerve injury. It is upregulated and retrogradely transported to the DRG by a specific population
of nociceptive specific neurones (Thompson, S.W.N, et al. (1997) Eur. J. Neurosci. 9 1244-
1251) where it may selectively influence neuropeptide expression (Sun, A.U. and Zigmond. R.E.
(1996) Eur. ./. Neurosci. 8 2213-2220). The present study examines the distribution of LIF
mRNA in the spinal cord and investigates its altered expression in the superficial dorsal horn
following peripheral inflammation or nerve injury.
Experiments were performed on male Wistar rats (200-400g) anaethetised with halothane.
Inflammation (n=3) was induced over a 52 hour period with a single unilateral intraplantar
injection of 150ul of Complete Freund's Adjuvant (CFA). In a second group (n=3). the L3
spinal nerve was tightly ligated (5/0 Mersilk) for 7 days and a third control group (n=3) received
no treatment. Spinal cords comprising segments L2-L4 were then removed from these animals
and sectioned at 15um on a cryostat. LIF expression was investigated using in siiu hybridisation
histochemistry (ISHH) with two [°S]-labelled oligonucleotide probes complimentary to base
sequences 86-133 and 434-478 of the LIF mRNA and which showed corresponding patterns of
distribution in control animals.
In control animals, dorsal horn expression of LIF was high in superficial laminae I-1I with only
light expression in the deeper laminae 11I-V. There was also expression around the central canal
that extended into the ventral horn and was observed on motorneurones. Both peripheral
inflammation and neuropathy significantly increased levels of LIF mRNA in the dorsal horn by
greater than 3 fold compared to control animals. This was most evident in the lateral superficial
laminae where the number of cells expressing this cytokine increased by 18±10% (mean±SEM)
(P<0.04; T-test) for inflammed animals and 44±5% (P<0.0001) for the neuropathic group.
Corresponding sense probe or RNAse treated sections showed no hybridisation.
These results show that LIF is normally expressed in the spinal cord in a specific laminar pattern
and this expression increases dramatically following peripheral inflammation or nerve damage.
LIF may therefore be a critical regulator of the central changes that occur following peripheral
injury and could contribute to the behavioural hyperalgesia associated with these changes.
New insights on the regulation and function of Galanin following peripheral axotomy
Stephen W.N. Thompson'. S. Fleetwood-Waikeri, P. HeppenstalF . M. Jones' and D. Wynick1.'
Division of Physiology, UMDS, St. Thomas' Hospitai Medicai School. London. UK; T Dept of Preciin. Vet Science.
University of Edinburgh, t Dept of Medicine, Bristol University. UK.
Following the initial characterisation in the early seventies of substance P as a undecapeptide present in
sensory neurons, numerous studies have expanded our knowledge upon the wealth of neuropeptides present in
these cells. Whilst the action of many of these peptides remains uncertain, there appears to be a general
consensus that many function under normal circumstances as neuromodulators of synaptic transmission within the
spinal cord (see Urban et al.,1994).
It is also now widely appreciated that the neurochemical phenotype of sensory neurons does not remain
constant but displays considerable plasticity following peripheral nerve injury. Thus following axotomy, small
diameter dorsal root ganglion (DRG) neurons, which under normal drcumstances are considered to be nociceptive
in function, lose substance P (SP), somatostatin (SOM) and calcitonin gene-related peptide (CGRP). Conversely
peptides which are constitutively expressed at very low levels or not at all in these cells such as vasoactive
intestinal polypeptide (VIP), galanin (GAL) and neuropeptide Y (NPY) are upregulated. Different changes occur in
neurones with larger diameter cell bodies and which under normal circumstances transmit low threshold non-
noxious information to the spinal cord. Thus, similar to small diameter neurons, they acquire NPY, VIP and GAL
whilst in addition a significant portion also upregulate SP.
The factors which control the de-novo expression of these neuropeptides within sensory neurons and their
function following peripheral axotomy is not well understood. Galanin is of particular interest. Following peripheral
axotomy, GAL gene expression within primary sensory neurons is partially dependent upon the upregulation of the
neuroactive cytokine Leukemia Inhibitory Factor (LIF) at the site of nerve trauma (Sun and Zigmond,1997,
Thompson et al.,1997; Thompson et al.,1998). LIF mRNA expression is also increased within the spinal cord
following peripheral axotomy (Heppenstall et al.,1998). LIF in turn also influences GAL mRNA expression within the
superficial dorsal horn of the spinal cord (Heppenstail et al.,1998). The function of GAL within sensory neurons and
the spinal cord remains equivocal. Early studies showed that GAL significantly depressed spinal reflex activity in
vivo , an effect which was more pronounced following axotomy (Wiesenfeld-Hallin et al.,1989). However the effect
of GAL upon reflex excitability is biphasic with an excitatory effect at low concentrations and an inhibitory effect only
at higher concentrations. We have studied behavioural responses to nerve injury in mice lacking a functional
galanin gene. Following sciatic axotomy, autotomy of the deafferented hindlimb is abolished in the knockout mice
whilst all wild type animals exhibit severe autotomy following a control lesion (Holmes et al.,1997). The excitability
of chronically axotomised primary sensory neurons to an intracellular depolarizing current pulse measured in an
acutely extirpated DRG preparation in vitro is significantly lower in GAL KO mice compared to wild types. It is a
possibility therefore that GAL regulates sensory neuron excitability following peripheral axotomy. The excitability of
spinal reflex activity following peripheral axotomy is currently being assessed in wild type and knockout mice.
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